User Image Cart Icon 0 Search Image
  • Home > Blog > Reverses And Prevents Fatty Liver

Reverses And Prevents Fatty Liver

  1. Metformin reverses fatty liver disease in obese, leptin-deficient mice
  2. Acanthopanax senticosus reverses fatty liver disease and hyperglycemia in ob/ob mice
  3. Spirulina maxima prevents fatty liver formation in CD-1 male and female mice with experimental diabetes
  4. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats
  5. Enalapril prevents fatty liver in nephrotic rats.
  6. Nutritional and management strategies for the prevention of fatty liver in dairy cattle
  7. Spirulina maxima prevents induction of fatty liver by carbon tetrachloride in the rat
  8. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver
  9. A novel aminosterol reverses diabetes and fatty liver disease in obese mice
  10. … disease and nonalcoholic steatohepatitis suggest a new therapeutic approach: Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese …
  11. Arachidonic acid prevents fatty liver induced by conjugated linoleic acid in mice
  12. Retracted: Genistein improves liver function and attenuates non‐alcoholic fatty liver disease in a rat model of insulin resistance
  13. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver
  14. Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism
  15. Studies on the preventive effect of Spirulina maxima on fatty liver development induced by carbon tetrachloride, in the rat
  16. Prevention of fatty liver in transition dairy cows by subcutaneous injections of glucagon
  17. Fish oil prevents sucrose‐induced fatty liver but exacerbates high‐safflower oil‐induced fatty liver in ddy mice
  18. … Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach: Lin Hz, Yang SQ, Chuckaree C, et al., Metformin’s reverses fatty liver Disease in Obese …
  19. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met
  20. Nonalcoholic fatty liver disease: a challenge for pediatricians
  21. Dietary carbohydrate stimulates alcohol diet ingestion, promotes growth and prevents fatty liver in rats
  22. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
  23. Protective effect of Arthrospira maxima on fatty acid composition in fatty liver
  24. Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)
  25. Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice
  26. Metabolic and nutritional considerations in nonalcoholic fatty liver
  27. Nonalcoholic fatty liver disease: an agenda for clinical research
  28. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease
  29. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study
  30. Reply to’TNF-α is not the cause of fatty liver disease in obese diabetic mice’
  31. Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease
  32. Nonalcoholic fatty liver disease: a review of current understanding and future impact
  33. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver
  34. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
  35. fatty liver: You Can Reverse it
  36. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet
  37. Invited review: pathology, etiology, prevention, and treatment of fatty liver in dairy cows
  38. fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature
  39. The anti-fatty liver effects of garlic oil on acute ethanol-exposed mice
  40. Effects of fat and methionine hydroxy analog on prevention or alleviation of fatty liver induced by feed restriction
  41. An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high …
  42. Non-alcoholic fatty liver disease: a brief review
  43. Current status of therapy in nonalcoholic fatty liver disease
  44. Probucol prevents the progression of fatty liver in MSG obese mice
  45. Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element–binding protein-1c
  46. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis …
  47. New insights from rodent models of fatty liver disease
  48. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment
  49. Effects of a High‐Fiber Diet on Hepatocyte Apoptosis and liver Regeneration After Partial Hepatectomy in Rats With fatty liver
  50. Splanchnic haemodynamics in non-alcoholic fatty liver disease: effect of a dietary/pharmacological treatment: a pilot study
  51. fatty liver induced by injection of L-tryptophan
  52. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance
  53. Treatment of non-alcoholic fatty liver disease
  54. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
  55. Hepatic lipid metabolism and non-alcoholic fatty liver disease
  56. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids
  57. Non-alcoholic fatty liver disease and childhood obesity
  58. Nonalcoholic fatty liver disease as a complication of insulin resistance
  59. Preventive influence of certain amino acids on experimental fatty liver of portal type.
  60. fatty liver of growing rats fed excess lysine and its prevention by adenine or allopurinol
  61. Melatonin ameliorates nonalcoholic fatty liver induced by high‐fat diet in rats
  62. Effect of aureomycin on liver fat and liver function
  63. Aspects of lipid metabolism in ethanol-induced fatty liver
  64. Therapy of nonalcoholic fatty liver disease: current status
  65. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
  66. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice
  67. The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
  68. Uncoupling proteins and non-alcoholic fatty liver disease
  69. Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins
  70. Non-alcoholic fatty liver and insulin resistance: a cause–effect relationship?
  71. Treatment of preestablished diet-induced fatty liver by oral fatty acid–bile acid conjugates in rodents
  72. Clinicopathological features of non‐alcoholic fatty liver disease
  73. AICAR, an AMPK activator, has protective effects on alcohol‐induced fatty liver in rats
  74. myo-Inositol Metabolism during Lactation and Development in the Rat. The Prevention of Lactation-Induced fatty liver by Dietary myo-Inositol
  75. Etiology, pathophysiology, and prevention of fatty liver in dairy cows
  76. Non-alcoholic fatty liver disease: an under-recognized cause with emerging importance
  77. Strong relationships between mediators of the acute phase response and fatty liver in dairy cows
  78. The prevention of alcoholic fatty liver using dietary supplements: Dihydroxyacetone, pyruvate and riboflavin compared to arachidonic acid in pair‐fed rats
  79. Burning hepatic fat: Therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease#
  80. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role
  81. Hypertension and fatty liver: guilty by association?
  82. IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines
  83. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice
  84. Novel insights into the pathophysiology of nonalcoholic fatty liver disease
  85. The treatment of NAFLD
  86. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
  87. Lipid metabolism and liver inflammation. II. fatty liver disease and fatty acid oxidation
  88. Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid
  89. Pathogenesis and management issues for non-alcoholic fatty liver disease
  90. Prevention of fatty liver and maintenance of systemic valine depletion using a newly developed dual infusion system
  91. The blind men ‘see’the elephant-the many faces of fatty liver disease
  92. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis
  93. Treatment of nonalcoholic fatty liver: present and emerging therapies
  94. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
  95. Mechanism of the fatty liver induced by cycloheximide and its reversibility by adenosine
  96. Therapeutic potential of interleukin-6 in preventing obesity-and alcohol-associated fatty liver transplant failure
  97. Non‐alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases
  98. Non-alcoholic fatty liver disease and the metabolic syndrome: an update
  99. Leptin: the prototypic adipocytokine and its role in NAFLD
  100. Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease
  101. Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats
  102. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats [S]
  103. Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy
  104. Treatment of nonalcoholic fatty liver disease
  105. Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats
  106. Metabolic changes in blood and liver during development and early treatment of experimental fatty liver and ketosis in cows
  107. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
  108. Gentiana manshurica Kitagawa reverses acute alcohol-induced liver steatosis through blocking sterol regulatory element-binding protein-1 maturation
  109. Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol …
  110. Effects of adenosine on ethanol-induced modifications of liver metabolism: Role of hepatic redox state, purine and fatty acid metabolism
  111. Alpha‐lipoic acid decreases hepatic lipogenesis through adenosine monophosphate‐activated protein kinase (AMPK)‐dependent and AMPK‐independent pathways
  112. Current best treatment for non-alcoholic fatty liver disease
  113. Effects of prepartum milking on dry matter intake, liver triglyceride, and plasma constituents
  114. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease
  115. Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice
  116. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration
  117. Nonalcoholic fatty liver disease: treatment
  118. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells
  119. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease
  120. Nonalcoholic fatty liver disease
  121. Efficacy of sodium borate in the prevention of fatty liver in dairy cows
  122. Supplemental choline for prevention and alleviation of fatty liver in dairy cattle
  123. Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment
  124. The effect of lifestyle changes in non-alcoholic fatty liver disease
  125. Dietary sphingolipids ameliorate disorders of lipid metabolism in Zucker fatty rats
  126. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
  127. Pediatric nonalcoholic fatty liver disease in 2009
  128. Effect of the inducer of interleukin‐6 (ME3738) on rat liver treated with ethanol
  129. Dietary Oxidized Fat prevents Ethanol-Induced Triacylglycerol Accumulation and Increases Expression of PPARα Target Genes in Rat liver
  130. Current and emerging therapies in nonalcoholic fatty liver disease
  131. Lipid metabolism during lactation: a review of adipose tissue-liver interactions and the development of fatty liver
  132. Nonalcoholic fatty liver disease in children
  133. The role of AMP-activated protein kinase in the action of ethanol in the liver
  134. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease
  135. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population
  136. Advances in the understanding and treatment of nonalcoholic fatty liver disease
  137. Thyroid hormones concentrations during the mid-dry period: An early indicator of fatty liver in Holstein-Friesian dairy cows
  138. Alcohol-induced steatosis in liver cells
  139. The role of insulin resistance in nonalcoholic fatty liver disease
  140. Mechanisms of disease: adipocytokines and visceral adipose tissue—emerging role in nonalcoholic fatty liver disease
  141. Hepatic triacylglycerol accumulation induced by ethanol and carbon tetrachloride: interactions with essential fatty acids and prostaglandins
  142. What Causes fatty liver after Pancreatectomy-An Unresolved and Forgotten Controversy: The 1936-1954 Years of Controversy
  143. Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats
  144. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease
  145. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic
  146. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
  147. Acute effects of subcutaneous injection of glucagon and/or oral administration of glycerol on blood metabolites and hormones of holstein dairy cows affected with fatty …
  148. Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
  149. Novel approaches to diagnosis and prevention of bovine fatty liver
  150. Nonalcoholic fatty liver disease from the perspective of an internist
  151. Managing the transition cow-emphasis on ketosis and fatty liver syndrome
  152. Accentuation of white phosphorus induced fatty liver by phenobarbitone in male rats compared to female rats
  153. Treatment of non-alcoholic fatty liver disease
  154. Obesity and liver disease
  155. Decrease of Ethanol-Induced fatty liver by Ethyl α-p-Chlorophenoxyisobutyrate.
  156. Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease
  157. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice
  158. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver
  159. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver Improvement with Rosiglitazone Therapy (FLIRT) …
  160. liver injury in the setting of steatosis: crosstalk between adipokine and cytokine
  161. Non-alcoholic fatty liver disease
  162. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status
  163. Ineffectiveness of carnitine as a choline substitute in the prevention of fatty livers of rats maintained on a choline-deficient diet
  164. Therapeutic options in nonalcoholic fatty liver disease
  165. Induction of HSP72 in rat liver by chronic ethanol consumption combined with exercise: association with the prevention of ethanol‐induced fatty liver by exercise
  166. … disease and nonalcoholic steatohepatitis suggest a new therapeutic approach: Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese …
  167. The Clinical Usefulness of Serum Aminotransferase Activities for Predicting fatty liver in Obese Children
  168. Emerging nutritional treatments for nonalcoholic fatty liver disease
  169. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study
  170. … Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach: Lin Hz, Yang SQ, Chuckaree C, et al., Metformin’s reverses fatty liver Disease in Obese …
  171. Green tea prevents fatty liver
  172. Relevance of TNF-α gene polymorphisms in nonalcoholic fatty liver disease
  173. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target
  174. Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1
  175. Alcoholic fatty liver: a nutritional problem of carbohydrate deprivation and concomitant ethanol ingestion
  176. Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?
  177. Pathophysiology and clinical management of non-alcoholic fatty liver disease
  178. Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular …
  179. The activity of the metabolic form of hepatic phosphatidate phosphohydrolase correlates with the severity of alcoholic fatty liver in human beings
  180. Behaviour of lipoperoxidation in rat liver during orotic acid treatment
  181. Rosiglitazone prevents fatty liver via attenuating SREBP-1 and chREBP in diabetic animal model
  182. Update on the treatments of non-alcoholic fatty liver disease (NAFLD)
  183. fatty acid oxidation is decreased in the liver of ovariectomized rats
  184. Choline metabolism. 1. The occurrence and prevention of hemorrhagic degeneration in young rats on a low choline diet.
  185. Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins
  186. Insulin reverses fatty liver disease in diabetic mice induced with high fat diet
  187. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease
  188. Nutritional Supplementation Arachidonic acid prevents fatty liver induced by conjugated linoleic acid in mice. D. Oikawa, S. Tsuyama, Y. Akimoto, Y. Mizobe & M …
  189. The role of the endocannabinoid system in liver diseases
  190. Animal models of steatohepatitis
  191. Treatment options for nonalcoholic fatty liver disease
  192. Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
  193. Update on nonalcoholic fatty liver disease
  194. Is malnutrition necessary for the development of alcoholic fatty liver in the rat?
  195. fatty liver in the rat after intravenous infusion of orotic acid
  196. Nonalcoholic fatty liver disease: a review and update
  197. Nonalcoholic fatty liver disease: a review
  198. Origin and treatment of fatty liver in fish.
  199. Metformin in non-alcoholic steatohepatitis
  200. Non‐Alcoholic fatty liver Disease
  201. Present and future therapeutic strategies in non-alcoholic fatty liver disease
  202. Protein balance studies in patients with liver damage. II. The role of lipotropic agents
  203. Non‐alcoholic steatohepatitis in children
  204. Alcohol deranges hepatic lipid metabolism via altered transcriptional regulation.
  205. Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease
  206. The endocannabinoid system and liver diseases
  207. Decosahexaenoic acid (DHA) but not eicosapentaenoic acid (EPA) reverses trans‐10, cis‐12‐conjugated linoleic acid (t10, c12‐CLA) induced insulin resistance in …
  208. Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions
  209. Adipokines in liver diseases
  210. Pharmacologic management of nonalcoholic fatty liver disease
  211. Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats
  212. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in …
  213. liver lipid response to intravenous rare earths in rats
  214. Role of dietary γ‐linolenic acid in liver lipid metabolism in Japanese quail
  215. fatty liver syndrome in mink: causes and metabolic consequences.
  216. Etiology of lipid-related metabolic disorders in periparturient dairy cows
  217. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin
  218. Metformin and the fate of fat
  219. Docosahexaenoic Acid (DHA) But Not Eicosapentaenoic Acid (EPA) prevents Trans-10, Cis-12 Conjugated Linoleic Acid (CLA)–Induced Insulin Resistance in Mice
  220. fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance
  221. Study of fatty liver syndrome frequency in dairy cattle by evaluating NEFA, APO-A, Ammoniac, Tsh and Total Bilirobin serum values in Tabriz
  222. Environmental and genetic determinants of fatty liver in humans
  223. Study of fatty liver syndrome frequency in dairy cattle by evaluating BHBA, urea, total protein, cholesterol and NEFA serum values in Tabriz
  224. Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis
  225. fatty liver & its impact: HIV, treatment, pathogenesis
  226. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets
  227. Ethanol-induced fatty liver: Protective action of (+)-catechin compounds
  228. Mode of action of choline. IV. Activity of the enzymes related to fatty acid synthesis and the levels of metabolic intermediates in choline-deficient rats
  229. Effects of lipid-supplemented total parenteral nutrition on fatty liver disease in a premature neonatal piglet model
  230. Impaired hepatobiliary lipid metabolism in liver fatty acid binding protein 1 (FABP1) knockout mice
  231. Therapy for nonalcoholic fatty liver disease
  232. Metformin prevents tobacco carcinogen–induced lung tumorigenesis
  233. Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2
  234. Obesity and alcoholic liver disease
  235. Study of fatty liver syndrome frequency in dairy cattle by evaluating ALT, ALP, LDH and NEFA serum values in Tabriz
  236. Practical approach to the diagnosis and management of people with fatty liver diseases
  237. Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat?
  238. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status [S]
  239. Effect of rice polishing concentrate on liver lipids.
  240. Low n-6: n-3 fatty acid ratio, with fish-or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice
  241. Dietary inositol hexakisphosphate, but not myo-inositol, clearly improves hypercholesterolemia in rats fed casein-type amino acid mixtures and 1, 1, 1-trichloro-2, 2-bis …
  242. Management of nonalcoholic fatty liver disease: weight control
  243. THE ADD-ON EFFECTS OF GYNOSTEMMA PENTAPHYLLUM ON NONALCOHOLIC: fatty liver DISEASE.
  244. Intraocular hemorrhages in choline deficiency
  245. Metabolic conditions of fatty liver in non-diabetic obese women
  246. Acute Effects of Postpartal Subcutaneous Injection of Glucagon and/or Oral Administration of Glycerol on Blood Metabolites and Hormones and liver Lipids and …
  247. Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings
  248. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats
  249. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 …
  250. Alcohol and lipid metabolism
  251. Hepatic lipid metabolism in transition dairy cows fed flaxseed
  252. Steatohepatitis in obese individuals
  253. Glycogenic induction of thyroid hormone conversion and leptin system activation in the liver of postpartum dairy cows
  254. Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates
  255. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis
  256. Gene expression of tumor necrosis factor [alpha] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
  257. Non-Alcoholic fatty liver Disease in Children
  258. Insulin resistance in NAFLD: Potential mechanisms and therapies
  259. Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise
  260. Plasma adiponectin—an independent indicator of liver fat accumulation
  261. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West
  262. Behavioral aspects of nonalcoholic fatty liver disease: diet, causes, and treatment
  263. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
  264. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease
  265. Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study
  266. Ethanol‐induced hepatotoxicity and protective effect of betaine
  267. Nonalcoholic fatty Disease: pathogenesis and treatment
  268. liver transplantation for nonalcoholic fatty liver disease
  269. The effect of drugs and nutraceuticals on the prevention and treatment of non-alcoholic fatty liver disease using rats as a model for humans
  270. The effect of lipid peroxide on the lipid and carbohydrate metabolism in rat liver
  271. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome
  272. Studies of the Mechanism of Prevention of fatty livers by the Administration of Adenosine Triphosphate
  273. Methyl‐group donors cannot prevent apoptotic death of rat hepatocytes induced by choline‐deficiency
  274. The comparative effects of pentoxifylline and ursodeoxycholic acid on IL-1β, Il-6, Il-8 and TNF-α levels in nonalcoholic fatty liver
  275. RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice
  276. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
  277. Empirical study of flavone from hawthorn biloba in preventing and treating insulin resistance and fatty liver in rats (Chinese)
  278. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver
  279. Recurrence of insulin resistant metabolic syndrome following liver transplantation
  280. Adipose tissue metabolism in periparturient cows: Relationship to the development of fatty liver
  281. Nonalcoholic fatty liver Diseases: Clinical and Pathophysiological Features
  282. Articles in PresS. Am J Physiol Gastrointest liver Physiol (August 27, 2009). doi: 10.1152/ajpgi. 00088.2009
  283. fatty liver and displaced abomasums in a TMR-fed dairy herd
  284. Inflammatory mediators of hepatic steatosis
  285. Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats
  286. liver and biliary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention.
  287. Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists
  288. Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis
  289. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis
  290. The ins and outs of mitochondrial dysfunction in NASH
  291. Cystathionine β synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver
  292. The effect of celecoxib on hepatic fatty changes induced by a high-fat diet in type 2 diabetic rats
  293. Influence of Vitamin B12 and Glucose Cycloacetoacetate Hydrolysate on Oxidative Phosphorylation in liver Mitochondria of Rats Fed an Atherogenic Diet
  294. Production of acute pancreatitis with ethionine and its prevention by methionine.
  295. Irbesartan improves endothelial dysfunction, abnormal lipid profile, proteinuria and liver dysfunction in Zucker diabetic fatty rats independent of glucose and …
  296. Alcoholic liver disease may be prevented with adequate nutrients
  297. Non-alcoholic fatty liver disease in the metabolic syndrome
  298. Role of dietary lipids and butylated hydroxy anisol (BHA) administration on albino rats. Part II. liver and heart unsaturated fatty acids
  299. Study of fatty liver syndrome frequency in dairy cattle by evaluating NEFA, albumin, GGT and APO-B serum values in Tabriz. and blood pressure
  300. Alpha Lipoic AcidTreatment in Different Steatohepatitis Model
  301. Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice
  302. Sphingolipids and hepatic steatosis
  303. hronic consumption of excess alcohol is hepatotoxic C in hunans and produces an accumulation of hepatic triglycerides to cause steatosis. These changes are …
  304. CCAAT/enhancer-binding protein β deletion reduces adiposity, hepatic steatosis, and diabetes in Leprdb/db mice
  305. NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis
  306. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders
  307. Effects of mineral and vitamin supplementation on the alcohol‐induced fatty liver and microsomal induction
  308. The new therapeutic frontier–nuclear receptors and the liver
  309. Dietary intervention with AHP, a functional formula diet, improves both serum and hepatic lipids profile in dyslipidemia mice
  310. Choline: an important nutrient in brain development, liver function and carcinogenesis.
  311. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice
  312. Nonalcoholic fatty liver disease
  313. Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling
  314. Characterization of recovery from liver damage by choline deficiency: Effect of biochemical modulators of lipid metabolism?
  315. The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease
  316. A brief review of etiology and nutritional prevention of metabolic disorders in dairy cattle
  317. New technology for continuous intravenous infusion via the central and portal veins in the rat
  318. Lipid transport in experimental dietary hepatic injury in rats
  319. Taurine prevents ethanol-induced alterations in lipids and ATPases in rat tissues
  320. Effects of choline deficiency and carnitine on palmitic acid oxidation by rat liver homogenates
  321. Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis
  322. Choline in the feeding of broiler chickens.
  323. Pathophysiology of nonalcoholic steatohepatitis
  324. Mechanisms and clinical implications of hepatocyte lipoapoptosis
  325. Role of AMP-activated protein kinase in mechanism of metformin action
  326. The Comparative effects of synthetic choline and herbal choline on hepatic lipid metabolism in broilers
  327. Effect of Energy Concentration in the Feed and Milking Frequency on liver LCFA Metabolism in Early Lactating Dairy Cows
  328. Growth performance, vitamin E status, and proximate and fatty acid composition of channel catfish, Ictalurus punctatus, fed diets containing various levels of fish oil …
  329. Practical management of the increasing burden of non-alcoholic fatty liver disease
  330. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management
  331. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice
  332. Effects of β‐aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity
  333. Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line
  334. Narrative review: hepatobiliary disease in type 2 diabetes mellitus
  335. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
  336. Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice
  337. Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors
  338. Nutritional strategies for a healthy transition to lactation: an update
  339. Effects of short day photoperiod on prolactin signaling in dry cows: A common mechanism among tissues and environments?,
  340. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice
  341. Management of NASH: current and future perspectives on treatment
  342. Insulin resistance and nonalcoholic steatohepatitis: fat or fiction?
  343. Methionine and methylating agents in laying rations.
  344. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report
  345. Roles of Kupffer cells in alcoholic liver disease
  346. The development of a biotin deficiency in domestic fowl given wheat-based diets
  347. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease
  348. Antidiabetic treatment for NASH?
  349. Correlation between mammary gland activity and fatty degeneration of liver in high productive cows
  350. Pharmacologic therapy of non-alcoholic steatohepatitis
  351. Non‐alcoholic steatohepatitis
  352. Autophagy in nonalcoholic steatohepatitis
  353. Molecular mediators of hepatic steatosis and liver injury
  354. Anti-obesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet
  355. A review of the effects of feeding niacin to early lactating dairy cows
  356. Choline, an essential nutrient for humans
  357. Treatment of Alcoholic liver Disease: Complications and Long-Term Management
  358. Nonalcoholic steatohepatitis
  359. A pilot study of pioglitazone for the treatment of non-alcoholic fatty liver disease
  360. Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH)
  361. Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones
  362. Warm ischemia-reperfusion injury is decreased by tacrolimus in steatotic rat liver
  363. Experimental methods of ethanol administration
  364. A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells
  365. Effect of oral administration of propylene glycol during periparturient period on blood biochemical parameters and liver triacylglycerol accumulation in …
  366. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat
  367. Quantification of liver fat with magnetic resonance imaging
  368. Super-dosing effects of phytase in poultry and other monogastrics
  369. Inhibition by nicotinic acid of hepatic steatosis and alcohol dehydrogenase in ethanol-treated rats
  370. Lecithin and choline in human health and disease
  371. Effect of inhibitors of drug metabolizing enzymes on carbon tetrachloride hepatotoxicity
  372. Nutrition, microbiota, and endotoxin-related diseases in dairy cows
  373. Insulin resistance and HCV: will new knowledge modify clinical management?
  374. Effects of Thyroxine and KSCN on Capacity of Rat Thyroid Gland to Accumulate Astatine211.
  375. Role of inflammation in nonalcoholic steatohepatitis
  376. Mitochondrial free cholesterol loading sensitizes to TNF-and Fas-mediated steatohepatitis
  377. The effect of lecithin supplementation on the biochemical profile and morphological changes in the liver of rats fed different animal fats
  378. Methyl transfering enzyme system of microsomes in the biosynthesis of lecithin (phosphatidylcholine)
  379. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake
  380. Post‐mortem findings in familial partial lipodystrophy, Dunnigan variety
  381. The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact
  382. SREBPs: transcriptional mediators of lipid homeostasis
  383. Effects of oxidized cooking oil and α-lipoic acid on liver antioxidants: enzyme activities and lipid peroxidation in rats fed a high fat diet
  384. The effectiveness of metformin in patients with metabolic syndrome and nonalcoholic fatty liver disease
  385. Non-alcoholic fatty liver diseases. a metabolic syndrome on the increase
  386. Possible interrelationship of ethanol metabolism and choline oxidation in the liver
  387. Phosphatidylcholine levels and their fatty acid compositions in teleost tissues and squid muscle
  388. Indian National Association for Study of liver
  389. Re: Thamet al.—Safety of Ercp During Pregnancy
  390. Hepato-Biliary Complications of Parenteral Nutrition
  391. Non-Alcoholic Steatohepatitis (NASH)
  392. The 100-day contract with the dairy cow: 30 days prepartum to 70 days postpartum
  393. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?
  394. NASH as part of the metabolic (insulin resistance) syndrome
  395. liver lipid content is reduced in rat given 7-day administration of angiotensin II
  396. Intervention study of Ginkgo biloba extract in rat model of lipid-induced insulin resistance
  397. The role of Niemann-Pick C1-Like 1 (NPC1L1) protein in cholesterol transport and metabolic diseases
  398. Dietary medium-chain triglycerides attenuate hepatic lipid deposition in growing rats with protein malnutrition
  399. Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats
  400. AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability
  401. The emerging problem of nonalcoholic steatohepatitis (NASH)
  402. Exercise and spirulina control non-alcoholic hepatic steatosis and lipid profile in diabetic Wistar rats
  403. Protective effect of dandelion extracts on ethanol-induced acute hepatotoxicity in C57BL/6 mice
  404. Lipoperoxidation after carbon tetrachloride poisoning in rats previously treated with antioxidants
  405. Dietary docosahexaenoic acid‐rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J‐Lepob/ob mice
  406. Healing Hepatitis & liver Disease Naturally: Detoxification. liver Gallbladder Flush. Alternative Remedies for Hepatitis C. Heal Hepatitis B with Natural …
  407. Inhibition of pantothenate synthesis by streptomycin
  408. Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism
  409. Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches
  410. Non-alcoholic steatohepatitis
  411. Prevention of pancreatic cancer induction in hamsters by metformin
  412. Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes
  413. Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter
  414. Current concepts in the pathogenesis of alcoholic liver injury
  415. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats
  416. Should protected choline or Niacin be fed to periparturient dairy cows?
  417. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription
  418. Targeting the AMPK pathway for the treatment of Type 2 diabetes
  419. Metabolic effects of abomasal L-carnitine infusion and feed restriction in lactating Holstein cows
  420. Hepatic Steatosis an emerging epidemic
  421. Increased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter …
  422. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
  423. Liquid diet technique of ethanol administration: 1989 update
  424. Nonalcoholic steatohepatitis
  425. Etiologija i preventiva metaboličnih poremećaja u mliječnih krava
  426. Animal models of steatohepatitis
  427. Methionine and serine synergistically suppress hyperhomocysteinemia induced by choline deficiency, but not by guanidinoacetic acid, in rats fed a low casein diet
  428. Hepatotoxicity related to total parenteral nutrition: comparison of low-lipid and lipid-supplemented solutions
  429. Failure of bran to alter diet-induced hyperlipidemia in the rat
  430. Biochemistry of alcoholic liver disease
  431. Hypolipidemic and antioxidant effects of mulberry (Morus alba L.) fruit in hyperlipidaemia rats
  432. The trials and tribulations of the treatment of nonalcoholic fatty–liver disease
  433. liver fibrosis: a balance of ACEs?
  434. Current and novel therapies for the treatment of nonalcoholic steatohepatitis
  435. Management of nonalcoholic steatohepatitis: an analytic review
  436. The role of PKC-epsilon in models of alcohol-and toxin-induced liver disease
  437. Effect of dietary phytic acid on hepatic activities of lipogenic and drug-metabolizing enzymes in rats fed 1, 1, 1-trichloro-2, 2-bis (P-chlorophenyl) ethane (DDT)
  438. Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
  439. Anti-diabetic effect and mechanism of Korean red ginseng in C57BL/KsJ db/db mice
  440. The role of acyl‐CoA: diacylglycerol acyltransferase (DGAT) in energy metabolism
  441. Nonalcoholic steatohepatitis: what we know in the new millennium
  442. Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
  443. Inflammatory Mediators of Hepatic Steatosis
  444. Choline, methyl-group donors, and liver cell death
  445. Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low–density lipoproteins
  446. Treatment of non-alcoholic steatohepatitis
  447. Molecular aspects of alcohol metabolism: transcription factors involved in early ethanol-induced liver injury
  448. Novel treatment modalities for nonalcoholic steatohepatitis
  449. Effect of L‐glutamine on hepatic lipids at different energy levels in rats receiving total parenteral nutrition
  450. Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study
  451. Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRα
  452. Effects of adenine, ATP, and methionine on L-ethionine inhibition of RNA synthesis in mouse liver
  453. Aflatoxin contamination in some Nigerian feeds and feedingstuffs: highlights of some nutritional, physiopathological and economic implications
  454. Nonalcoholic steatohepatitis: clinical presentation, diagnosis, and treatment
  455. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes
  456. The Relationship Between Parturient Paresis and Fat Cow Syndrome in Dairy Cows
  457. Metabolic responses of lactating dairy cows to exogenous glucagon
  458. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E
  459. Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1−/− mice
  460. liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet
  461. Special Aspects of Dairy Cattle Nutrition–Etiology and Nutritional Prevention of Metabolic Disorders
  462. Nonalcoholic steatohepatitis: role of leptin in pathogenesis and benefits of metformin in treatment
  463. Further studies on the antihepatotoxic activity of jigrine
  464. A resistance movement in NASH
  465. Gene Expression of Tumor Necrosis Factor α and TNF-α Receptors (p55 and p75) in Nonalcoholic Steatohepatitis Patients
  466. Clerodendron glandulosum. Coleb extract ameliorates high fat diet/fatty acid induced lipotoxicity in experimental models of non-alcoholic steatohepatitis
  467. Nuclear transcription factors and lipid homeostasis in liver
  468. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
  469. Mechanisms underlying nonalcoholic steatohepatitis
  470. The role of liver in leptin metabolism in experimental nephrotic syndrome
  471. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport
  472. Influence of Moulded Feed with and without Thiamine Supplementation on Rumen Protozoa in Cattle (in vitro)
  473. Influence of Northern German Moulds and Anorganic Salts on Ruminal Cellulase Activity (in vitro)
  474. Definition, Consequences and Prediction of an Elevated Ketone Body Status in High Yielding Dairy Cows
  475. Nonviral hepatitis
  476. Peroxisome proliferator–activated receptor-α gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice
  477. Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats
  478. GENETIC DISRUPTION OF ACETYL COA CARBOXYLASE PHOSPHORYLATION BY AMP-ACTIVATED PROTEIN KINASE INCREASES liver LIPID …
  479. Trans-10, cis-12-CLA-caused lipodystrophy is associated with profound changes of fatty acid profiles of liver, white adipose tissue and erythrocytes in mice: possible …
  480. Dietary trans fatty Acid Isomers Differ in Their Effects on Mammary Lipid Metabolism As Well As Lipogenic Gene Expression in Lactating Mice
  481. Mitochondria in steatohepatitis
  482. Effect of metformin on adipose tissue resistin expression in db/db mice
  483. Mechanisms of non-alcoholic steatohepatitis
  484. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice
  485. Induction of malnutrition in chronic alcoholism: role of gastric emptying
  486. Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levels
  487. Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?
  488. Modification of skin composition by conjugated linoleic acid alone or with combination of other fatty acids in mice
  489. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity
  490. Probucol in the treatment of nonalcoholic steatohepatitis
  491. Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis
  492. Carnitine blood concentrations and fat utilization in parenterally alimented premature newborn infants
  493. The potential health benefits of algae and micro algae in medicine: a review on Spirulina platensis
  494. Prevention of hepatocellular carcinoma in chronic viral hepatitis patients with cirrhosis by carotenoid mixture
  495. Protein nutrition of dry cows
  496. Decreased accumulation of ultrasound contrast in the liver of nonalcoholic steatohepatitis rat model
  497. Mitochondria and redox signaling in steatohepatitis
  498. Drugs and the liver: advances in metabolism, toxicity, and therapeutics
  499. Incorporation of 14C into tissue lipids after oral administration of [1-14C] linoleic acid in rats fed different levels of essential fatty acids
  500. The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis
  501. Non-alcoholic fatty liver disease and malignancy as complications of insulin resistance
  502. Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy
  503. V. Mitochondrial dysfunction in steatohepatitis
  504. Metformin: new understandings, new uses
  505. Effect of feeding polyhydric alcohols on tissue lipids and the resistance of rats to extreme cold
  506. AMP-activated protein kinase and metabolic control
  507. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations
  508. Nutritional management of the prepartum dairy cow
  509. Phospholipids/lecithin: a class of nutraceutical lipids
  510. Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and …
  511. Stéatopathies hépatiques non alcooliques
  512. Trans-10, cis-12-conjugated linoleic acid alters hepatic gene expression in a polygenic obese line of mice displaying hepatic lipidosis
  513. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice
  514. Thyroid Hormone
  515. Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice
  516. Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues
  517. Impairment of fat oxidation under high-vs. low-glycemic index diet occurs before the development of an obese phenotype
  518. The effects of betaine treatment on rats fed an acute bolus of ethanol at 3 and 12 h post bolus: a microarray analysis
  519. Insulin resistance syndrome in children
  520. Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice
  521. Effects of ethnicity and metabolic factors on treatment responses and liver injury in chronic hepatitis C
  522. Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label …
  523. Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets
  524. The epidemic of type 2 diabetes mellitus: its links to obesity, insulin resistance, and lipotoxicity
  525. ethanol-induced liver damage
  526. Dose-dependent lipotropic effect of carnitine in chronic alcoholic rats
  527. Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction
  528. with Cirrhosis by Carotenoid Mixture
  529. Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models
  530. PEMT gene polymorphism and human choline requirement
  531. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome
  532. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury
  533. A calcified and cystic peripancreatic mass
  534. Inflammatory responses in alcoholic liver disease
  535. Stéatohépatite non alcoolique: 2. Aspects physiopathologiques
  536. Dietary choline requirement for juvenile cobia, Rachycentron canadum
  537. AMP-Activated Protein Kinase in liver
  538. Pathophysiology of NASH
  539. Therapeutic value of melatonin in an experimental model of liver injury and regeneration
  540. Use of insulin sensitizers in NASH
  541. Nutrition, microbiota, and endotoxin-related diseases in dairy cows
  542. THE VITAMIN B2 COMPLEX
  543. Medical treatment of non-alcoholic steatohepatitis
  544. Free methionine supplementation limits alcohol‐induced liver damage in rats
  545. Remodeling glucose and lipid metabolism through AMPK activation: relevance for treating obesity and type 2 diabetes
  546. Metformin beyond diabetes: new life for an old drug
  547. Carnitine deficiency
  548. Some physiological responses of pregnant Egyptian buffalo to niacin supplementation
  549. Compensatory capabilities of islets of BBWor rats exposed to sustained hyperglycemia
  550. Effects of Water Extracts from Mulberry Leaves on Hepatic HMG-CoA Reductase and Acyl-CoA-Cholesterol Acyl Transferase Activity in Rats Fed High Cholesterol …
  551. Nonalcoholic steatohepatitis
  552. Pathogenesis and management of non-alcoholic steatohepatitis
  553. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats
  554. Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects
  555. Hypolipidemic and body fat-lowering effects of Fatclean in rats fed a high-fat diet
  556. Nonalcoholic steatohepatitis
  557. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
  558. Hepatic complications of parenteral nutrition
  559. Dietary addition of cellular metabolic intermediates and carcass fat deposition in broilers
  560. CCR2 modulates inflammatory and metabolic effects of high-fat feeding
  561. THE EFFECT OF ETHANOL ON CHOLINE UTILIZATION BY THE ISOLATED PERFUSED liver.
  562. D. PESSAYRE, A. BERSON, B. FROMENTY and A. MANSOURI
  563. Metformin prevents endotoxin-induced liver injury after partial hepatectomy
  564. Prevention of alcohol toxicity by adequate nutrients: mechanism and potential application
  565. Hypocholesterolemic effect of Nostoc commune var. sphaeroides Kützing, an edible blue-green alga
  566. Hepatocyte mitochondrion electron-transport chain alterations in CCl4 and alcohol induced hepatitis in rats and their correction with simvastatin
  567. Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis
  568. Effect of microalga Spirulina platensis (Arthrospira platensis) on hippocampus lipoperoxidation and lipid profile in rats with induced hypercholesterolemia
  569. Alcohol-related diseases and carcinogenesis
  570. Effects of choline deficiency and methotrexate treatment upon hepatic function in the rat
  571. Nutritional issues in hepatobiliary surgery
  572. Pathways involved in lipid-induced insulin resistance in obesity
  573. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice
  574. The effect of adding metformin to the treatment of hepatitis C: a preliminary report of a randomized controlled trial
  575. Implication of Long-Chain fatty Acids in Glucose-Induced Insulin Secretion in the Pancreatic Beta-Cell
  576. Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone
  577. Optimisation of transition period energy status for improved health and reproduction
  578. THE INFLUENCE OF SEX AND DIET ON THE BIOSYNTHESIS OF PHOSPHATIDYL CHOLINEIN RAT liver
  579. Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis
  580. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat
  581. Lipotrophic substances
  582. Effects of high fat diets and Spirulina Platensis supplementation in New Zealand White rabbit
  583. The effects of Spirulina on anemia and immune function in senior citizens
  584. Effects of Spirulina platensis or furazolidone on the performance and immune response of broiler chickens fed with aflatoxin contaminated diet
  585. Differential digestibility of a synthetic slowly digestible peptide, oligo-L-methionine, in rats fed soybean protein or its hydrolysates
  586. Mechanisms underlying the differential effects of ethanol on the bioavailability of riboflavin and flavin adenine dinucleotide.
  587. Nutritional solutions to heat stress
  588. Resveratrol, sirtuins, and the promise of a DR mimetic
  589. Nutrition and nutritional disease
  590. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial
  591. Effects of glucagon, glycerol, and glucagon plus glycerol on gluconeogenesis, lipogenesis, and lipolysis in periparturient Holstein cows
  592. Migration of the methyl group in the body
  593. Effects of dietary oils low in n-6: n-3 fatty acid ratio on cardiovascular risk in mice: the impact of the source of n-3 fatty acids
  594. The Diabetes Prevention Program and the Metabolic Syndrome
  595. The Diabetes Prevention Program and the metabolic syndrome
  596. Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis
  597. Miso: Production, Properties, and
  598. Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism
  599. Altered amino acid homeostasis in subjects affected by fibromyalgia
  600. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats
  601. The Diabetes Prevention Program and the metabolic syndrome
  602. Targeting the AMPK pathway for the treatment of Type 2 diabetes
  603. Total pancreatectomy
  604. Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance
  605. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells
  606. Increasing fructose 2, 6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes
  607. Low birth weight and insulin resistance associated with lean body adiposity in an adolescent onset diabetic patient
  608. Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice
  609. Metformin suppresses interleukin (IL)-1β-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells
  610. Antioxidative and hepatoprotective effects of Spirulina
  611. Influence of subclinical hypocalcemia on plasma biochemical parameters, liver histologic changes, and common postpartum diseases in dairy cows
  612. The Effects of Chronic AMPK Activation on Hepatic Triglyceride Accumulation and Glycerol-3-Phosphate AcyltransferaseActivity with High Fat Feeding
  613. C-reactive protein and risk for colorectal cancer
  614. Effects of Taurine Supplementation on Mitochondrial Function in Chronic Ethanol Administered Rats
  615. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
  616. Dissociation of effects on protein synthesis and ribosomes from membrane changes induced by carbon tetrachloride
  617. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J
  618. The management of type 2 diabetes mellitus in children and adolescents
  619. C-Reactive Protein and Risk for Colorectal Cancer
  620. l-Thyroxine plus Liothyronine in Hypothyroidism
  621. Nutritional considerations section II
  622. Effects of the AT1 receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic …
  623. l-Thyroxine plus Liothyronine in Hypothyroidism
  624. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients
  625. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 …
  626. Protein density and its influence on metabolite concentration and nitrogen retention by Holstein cows in late gestation
  627. Isolation of an Antihypertensive Peptide from Alcalase Digest of Spirulina platensis
  628. Enteral macronutrients abolish high blood alcohol levels in chronic alcoholic rats
  629. Xenobiotic lipids: the inclusion of xenobiotic compounds in pathways of lipid biosynthesis
  630. alcohol-induced liver injury
  631. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration
  632. Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus
  633. Growth, carcass quality and serum constituents of slow growing chicks as affected by betaine addition to diets containing 1. Different levels of choline
  634. Hepatic transmethylation and blood alcohol levels
  635. The genesis of alcoholic brain tissue injury
  636. The synthesis and metabolism of certain hydroxybetaines related to choline
  637. Renin–angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression
  638. Maternal high-fat diet consumption results in fetal malprogramming predisposing to the onset of metabolic syndrome-like phenotype in adulthood
  639. Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice
  640. In vitro and in vivo safety assessment of edible blue-green algae, Nostoc commune var. sphaeroides Kützing and Spirulina plantensis
  641. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin
  642. The Endocrine Society meeting: topics in insulin sensitivity and hypertension
  643. Hypoglycaemic activity of marine cyanobacteria in alloxan induced diabetic rats
  644. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
  645. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy
  646. Effect of 4-(4′-chlorobenzyloxy) benzyl nicotinate (KCD-232) on cholesterol metabolism in rats fed an amino acid imbalance diet
  647. Lipid peroxidation in the etiology of alcohol liver injury and cancer: Modulatory role of vitamin E
  648. Effects of prolonged ethanol consumption on hepatic lipids and hepatotoxicity in C57BL/6 female mice
  649. Manipulation of sinapine, choline and betaine accumulation in Arabidopsis seed: towards improving the nutritional value of the meal and enhancing the seedling …
  650. ARSENIC-INDUCED STEATOSIS IN C57BL/6J MALE MICE CHRONICALLY EXPOSED THROUGH DRINKING WATER.
  651. The essential fatty acid requirements of rainbow trout (Salmon gairdneri)
  652. High fat diet in arteriosclerosis: the role of cholesterol in the production of arteriosclerosis
  653. Atherogenesis: Historical perspective, biochemical mechanism, and current status
  654. Adult obesity: Metabolic syndrome, diabetes and non-alcoholic steatohepatitis
  655. Possible mechanisms of local tissue renin-angiotensin system activation in the cardiorenal metabolic syndrome and type 2 diabetes mellitus
  656. Effects of dietary Spirulina maxima on vasomotor responses of aorta rings from rats fed a fructose-rich diet
  657. Application of acute phase proteins for monitoring inflammatory states in cattle
  658. Linking Hepatic Transcriptional Changes to High–Fat Diet Induced Physiology for Diabetes-Prone and Obese-Resistant Mice
  659. The effects of angiotensin-converting enzyme inhibitors on the fibrous envelope around mammary implants
  660. “Short” double-balloon enteroscope for diagnostic and therapeutic ERCP in patients with altered gastrointestinal anatomy
  661. Antisense oligonucleotides as therapeutics for hyperlipidaemias
  662. The rationale of therapy in hepatic disease
  663. Effect of adlay, buckwheat and barley on lipid metabolism and aorta histopathology in rats fed an obesogenic diet
  664. Effects of the cellcultured Acanthopanax senticosus extract on antioxidative defense system and membrane fluidity in the liver of type 2 diabetes mouse
  665. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis
  666. Development of metabolic health assessment: Paving the way to disease prevention through personalized nutrition
  667. A review of the energy and protein nutrition of dairy cows through their dry period and its impact on early lactation performance
  668. Animal models to study environmental epigenetics
  669. Health aspects of oxidized dietary fats
  670. Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury
  671. The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
  672. Nutrient requirements of the mouse
  673. PC Liposomal Encapsulation Technology
  674. Evaluation of protective efficacy of Spirulina platensis against collagen-induced arthritis in rats
  675. ER stress and SREBP-1 activation are implicated in β-cell glucolipotoxicity
  676. Chromatin remodeling complex interacts with ADD1/SREBP1c to mediate insulin-dependent regulation of gene expression
  677. Prognosis and therapy of Wernicke’s encephalopathy after obesity surgery
  678. Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-Ay mice
  679. Evaluation of Spirulina on the performance and pigmentation of Rainbow Trout
  680. liver and Bile
  681. The effectiveness of vitamin E and lecithin as an alternative treatment for dyslipidemia
  682. Influence of spirulina intake on metabolism of exercised rats
  683. Animal models of alcoholic liver disease
  684. Milk fever control principles: a review
  685. Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells
  686. Milk of sheep, goat, and buffalo: a public health review
  687. Statins and hepatitis C virus: More caution and less enthusiasm
  688. Differential regulation of insulin action and tumor necrosis factor α system activity by metformin
  689. Articles in PresS. Am J Physiol Endocrinol Metab (January 11, 2011). doi: 10.1152/ajpendo. 00502.2010
  690. Endoscopic-guided versus cotton-tipped applicator methods of nasal anesthesia for transnasal esophagogastroduodenoscopy
  691. Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo
  692. The Regulation of Adiponectin by Ethanol Feeding and Taurine Supplementation
  693. Mycophenolate sodium: effective treatment for therapy-refractory intestinal Behçet’s disease, evaluated with enteroscopy
  694. and Duncan HF Mak Hong Kong University of Science and Technology Hong Kong, China
  695. Cotton pledget method for nasal decongestive anesthesia prior to transnasal endoscopy
  696. Effects of the Chinese prescription Kangen‐karyu and its crude drug Tanjin on ageing process in rats
  697. Effect of biotin supplementation on performance of chicken broilers
  698. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats
  699. Effect of pueraria flavonoid on diabetes in mice complicated by hyperlipidemia
  700. Hepatic fibrosis and the renin-angiotensin system
  701. Reply to Dr Goldstein about HCV and Fluvastatin: Less Armchair and More Science
  702. The influence of the dietary addition of dihydroxyacetone and pyruvate on carcass fat accumulation in growing-finishing swine
  703. Columnar-lined esophagus without intestinal metaplasia should not be dismissed as having no cancer risk
  704. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats
  705. Growth and liver morphology after long-term ethanol consumption of rats
  706.  Should High Grade Dysplasia or Degree of Villous Change in Colonic Polyps be Reported? Previously Reported in American Journal of Gastroenterology, Reply to …
  707. Natural dairy cow health
  708. BILIARY COMPLICATIONS OF OBESITY: CHOLELITHIASIS
  709. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
  710. COFFEE BEAN EXTRACT
  711. Comments regarding “consensus recommendations for gastric emptying scintigraphy”
  712. Endoscopic-guided versus cotton-tipped applicator methods of nasal anesthesia for transnasal esophagogastroduodenoscopy
  713. Effect of captopril on TNF-α and IL-10 in the livers of bile duct ligated rats
  714. Columnar-lined Esophagus without Intestinal Metaplasia should not be Dismissed as having no Cancer Risk
  715. Reply to Letter from Dr. Jerry Gardner about: Balancing Drug Risk and Benefit: Toward Refining the Process of FDA Decisions Affecting Patient Care
  716. Histone acetylation by ethanol as a mechanism for alcohol dehydrogenase I gene expression in liver
  717. What State Do You Live In?: The Consequences of Obesity
  718. Impact of renin-angiotensin system in hepatocellular carcinoma
  719. Relationship of lipid metabolism to arteriosclerosis
  720. α-Defensins and Clostridium difficile Recent Growing Concerns in Inflammatory Bowel Disease
  721. Response to Dr. Gardner
  722. Response to Dr. Dumonceau et al.
  723. Edited for the Nutrition Society
  724. Diagnostic Problems in the Evaluation of Colorectal Adenomas
  725. Diagnostic Problems in the Evaluation of Colorectal Adenomas
  726. Clinicians and FDA Decisions
  727. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate
  728. Clinicians and FDA Decisions
  729. Supplemental biotin effects on performance and dynamics of fat mobilization and on in vitro fiber digestion using periparturient Holstein cows
  730. Inhibition of mTOR for the treatment and prevention of lung cancer
  731. Clinicians and FDA Decisions
  732. Non-alcoholic steatohepatitis: second hit or strike out?
  733. Columnar-lined Esophagus without Intestinal Metaplasia should not be Dismissed as having no Cancer Risk
  734. The acute effects of metformin on glucose oxidation and fatty acid metabolism in rodent skeletal muscle
  735. Effects of Spirulina, a blue-green alga, on bone metabolism in ovariectomized rats and hindlimb-unloaded mice
  736. The new tolerable upper intake levels: When it comes to vitamins and minerals, you can get too much of a good thing
  737. AMPK in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.
  738. The metabolic consequences of mouse betaine homocysteine S-methyltransferase deficiency
  739. Alcohol and energy intake
  740. The Importance of Dispensable Amino Acids in Protein Nutrition
  741. Pharmacogenomics of membrane transporters: Focus on the organic cation transporter, Oct1
  742. Effects of alcohol on vitamin metabolism
  743. Inhibitory effects of Du-zhong (Eucommia ulmoides Oliv.) against low-density lipoprotein oxidative modification
  744. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression
  745. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-α
  746. AMP-activated protein kinase, Sirtuin 1, and p53 interactions in HEPG2 cells
  747. The effects of rumen undegradable choline in the nutrition and metabolism of dairy cows
  748. Effect of Shilianhua extract and its fractions on body weight of obese mice
  749. Effects of conjugated linoleic acids on PGE₂, PGF₂α and progesterone production by bovine luteal cells in vitro
  750. Insulin resistance syndrome in childhood and beyond
  751. ASSOCIATION BETWEEN TYPE II DIABETES AND OBESITY
  752. Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage
  753. Effect of Captopril on TNF-α and IL-10 in the livers of Bile Duct Ligated Rats.
  754. Alcohol, calories, and appetite
  755. SECTION III: Insulin Resistance and Its Complications
  756. PROTEIN NUTRITIONAL VALUE OF METHIONINE LIMITED FOODS AS INFLUENCED BY PRODUCT FORMULATION AND SUPPLEMENTATION.
  757. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats
  758. The influence of ethanol on the biotransformation and genotoxicity of benzo (a) pyrene
  759. Nutrigenomics, β-Cell function and type 2 diabetes
  760. An Evidence-Based Perspective of Camellia Sinensis (Green Tea) for Cancer Patients
  761. The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women
  762. Nutrition of juvenile and adult fish
  763. Esteatohepatitis no alcohólica
  764. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice
  765. Carbohydrate intake determines pancreatic acinar amylase activity and release despite chronic alcoholemia in rats
  766. Notes on clinical biochemistry
  767. Code of practice for the care and handling of dairy cattle: Review of scientific research on priority issues
  768. The Effect of Age and of Heat on the” Ferment” in Cascara sagrada
  769. The New Template for Recovery: How to Quit Drinking and Build a Better Life
  770. Physiologic and pathologic events mediated by intramembranous and juxtamembranous proteolysis
  771. Denovo synthesized fatty acids as regulators of milk fat synthesis
  772. Good Whiskey, Drunk Driving, and Innocent Bystanders: The Responsibility of Manufacturers of Alcohol and Other Dangerous Hedonic Products for Bystander Injury
  773. Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats
  774. Evaluation of the nitrogenous factors in rice for meeting the protein requirement of human adults
  775. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta
  776. INCREASED CYTOCHROME P450 2E1 EXPRESSION SENSITIZES HEPATOCYTES TO c-JUN-MEDIATED CELL DEATH FROM TNF-αα
  777. Growth and homocysteine remethylation in the chicken: Impact of age, methionine source and dietary levels of sulfur amino acids and related compounds
  778. Clinical outcomes of diabetic foot management with Circulat
  779. No effect of metformin on the innate airway hyperresponsiveness and increased responses to ozone observed in obese mice
  780. Sports supplements: a modern case of caveat emptor
  781. Primary sclerosing cholangitis
  782. Good Whiskey, Drunk Driving, and Innocent Bystanders: The Responsibility of Manufacturers of Alcohol and Other Dangerous Hedonic Products for Bystander …
  783. Preventive effects of Spirulina platensis on skeletal muscle damage under exercise-induced oxidative stress
  784. Energy values and chemical composition of spirulina (Spirulina platensis) evaluated with broilers
  785. Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1G93A Mouse Model of ALS and Is Harmful in Female Mice
  786. Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes
  787. Natural dairy cow health: a guide to keeping your herd healthy with herbs and other natural products
  788. Anthropometric, dietary, and hormonal correlates of serum adiponectin in Asian American women
  789. The role of the renin-angiotensin system in hepatic fibrosis
  790. Design and Evaluation of a Complex Phytoceutical Formulation for Circulatory Diseases
  791. Experimentally induced hyperoxaluria in MCP-1 null mice
  792. Antigipertenzivnaya terapiya u patsientov s patologiey pecheni: rol’blokatorov renin-angiotenzinovoy sistemy
  793. Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats
  794. Anticlastogenic effect of Spirulina maxima extract on the micronuclei induced by maleic hydrazide in Tradescantia
  795. Some Aspects of Choline Metabolism
  796. Effect of short and long-term ethanol feeding on the extent of metabolic tolerance in female rats
  797. Antiviral activity of Spirulina maxima against herpes simplex virus type 2
  798. Clinical Study on the Effect of Moorchita Tila Taila Shamana Sneha and Navaka Guggulu in Hyperlipidemia-A Comparative Study
  799. Nutrient Requirements of Mink and Foxes: 1982
  800. Nephrocalcinosis in animal models with and without stones
  801. Antioxidant and NO-scavenging activities of Acanthopanax senticosus var. subinermis leaf extracts prepared using ethanol and extrusion processing
  802. Antihypertensive therapy in patients with liver diseases. Can we decrease the risk of liver fibrosis by affecting renin-angiotensin system?
  803. Evaluation of Clinical Efficacy of an Indegenous Compound in Hyperlipidemia
  804. Livestock and poverty reduction in India: findings from the ODI Livelihood Options Project
  805. Standardization of Eleutherococcus species and HPLC method validation for quantitative analysis
  806. Nutrition and Alcoholthe CRC Series in Physiology of Drug Abuse
  807. Effect of blue green alga (Spirulina platensis) on haematological, biochemical and fertility parameters of egg type male chicken
  808. Lab oratory Animals
  809. The precancerous mouth lesions of avitaminosis B: Their etiology, response to therapy and relationship to intra-oral cancer
  810. Evaluation of Hypolipidaemic Activity of Shimshapa (Dalbergia Sissoo Roxb.) Churna
  811. Metformin and liver glycogen synthase activity in obese Zucker rats.
  812. The vitamin cure for alcoholism: Orthomolecular treatment of addictions
  813. The animal phospholipids: their structure, metabolism and biological significance
  814. Effects of Alcohol and Cocaine Abuse on the Antioxidant Systems, Nutritional Status, and liver Damage
  815. The effects of genotype and environment on traits and their correlations in layers
  816. Alcohol: the balancing act
  817. Normal weight obesity–therapeutic implications
  818. Is conjugated linoleic acid (CLA) a protective factor in atherosclerosis? Study with the use of neural networks.
  819. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
  820. Moro orange juice prevents fatty liver in mice
  821. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
  822. SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease
  823. Betaine supplementation prevents fatty liver induced by a high-fat diet: effects on one-carbon metabolism
  824. Metformin prevents fatty liver and improves balance of white/brown adipose in an obesity mouse model by inducing FGF21
  825. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in …
  826. Green tea extract rich in epigallocatechin-3-gallate prevents fatty liver by AMPK activation via LKB1 in mice fed a high-fat diet
  827. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein
  828. Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice
  829. Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase
  830. Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD)
  831. Dietary phytic acid prevents fatty liver by reducing expression of hepatic lipogenic enzymes and modulates gut microflora in rats fed a high-sucrose diet
  832. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice
  833. Herbal medicines and nonalcoholic fatty liver disease
  834. Schisandra chinensis prevents Alcohol-Induced fatty liver Disease in Rats
  835. TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice
  836. Creatine supplementation as a possible new therapeutic approach for fatty liver disease: early findings
  837. The role of skeletal muscle in development of nonalcoholic fatty liver disease
  838. liver fibrosis and fatty liver in Asian HIV‐infected patients
  839. Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease
  840. Secondary causes of nonalcoholic fatty liver disease
  841. JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis
  842. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice
  843. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance
  844. Crude Extracts from Lycium barbarum Suppress SREBP-1c Expression and Prevent Diet-Induced fatty liver through AMPK Activation
  845. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease
  846. Phosphatidylcholine functional foods and nutraceuticals: A potential approach to prevent non‐alcoholic fatty liver disease
  847. Hepatic NAD+ deficiency as a therapeutic target for non‐alcoholic fatty liver disease in ageing
  848. Treatment with buckwheat bran extract prevents the elevation of serum triglyceride levels and fatty liver in KK-Ay mice.
  849. Enhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementations
  850. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver
  851. Modulation of hepatic steatosis by dietary fatty acids
  852. Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)
  853. Natural products on nonalcoholic fatty liver disease
  854. Increasing whole grain intake as part of prevention and treatment of nonalcoholic fatty liver disease
  855. Fenretinide ameliorates insulin resistance and fatty liver in obese mice
  856. Function of autophagy in nonalcoholic fatty liver disease
  857. Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: role of adipokines
  858. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats
  859. Management of non-alcoholic fatty liver disease and steatohepatitis
  860. The role of metformin in the management of NAFLD
  861. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms
  862. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease
  863. Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease
  864. Dietary treatment of fatty liver: High dietary protein content has an antisteatotic and antiobesogenic effect in mice
  865. Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic fatty liver disease
  866. Uridine prevents tamoxifen-induced liver lipid droplet accumulation
  867. Roles of PPARs in NAFLD: potential therapeutic targets
  868. Non-alcoholic fatty liver disease and nutritional implications: special focus on copper
  869. Nonalcoholic fatty liver disease: new treatments
  870. Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease
  871. Audio–visual aid in teaching “fatty liver”
  872. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice
  873. Autophagy and lipid droplets in the liver
  874. Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease
  875. Treatment of nonalcoholic fatty liver disease: role of AMPK
  876. Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism
  877. Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis
  878. Thyroid hormone analogues and derivatives: actions in fatty liver
  879. Nonalcoholic fatty liver: a possible new target for type 2 diabetes prevention and treatment
  880. Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease
  881. Dietary β-conglycinin prevents acute ethanol-induced fatty liver in mice
  882. Genetically modified mouse models for the study of nonalcoholic fatty liver disease
  883. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
  884. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
  885. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and-independent fatty liver
  886. Emerging roles of SIRT1 in fatty liver diseases
  887. Etiology and prevention of fatty liver and ketosis in dairy cattle
  888. Gastric bypass surgery is protective from high‐fat diet‐induced non‐alcoholic fatty liver disease and hepatic endoplasmic reticulum stress
  889. Nonalcoholic fatty liver in children and adolescents: an overview
  890. Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic fatty liver
  891. Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease
  892. Mechanisms involved in the protective effects of metformin against nonalcoholic fatty liver disease
  893. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)
  894. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
  895. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease
  896. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK–mTOR–SREBP signaling pathway
  897. Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice
  898. What is Non‐Alcoholic fatty liver Disease (NAFLD), and Why is it Important?
  899. Molecularly defined unfolded protein response subclasses have distinct correlations with fatty liver disease in zebrafish
  900. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD)
  901. Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
  902. Sulfur amino acids in diet-induced fatty liver: a new perspective based on recent findings
  903. Betaine chemistry, roles, and potential use in liver disease
  904. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice
  905. Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease
  906. The roles of lipocalin-2 in small-for-size fatty liver graft injury
  907. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population
  908. Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease
  909. Physical activity as a protective factor for development of non-alcoholic fatty liver in men
  910. Nonalcoholic fatty liver disease: a nutritional approach
  911. Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition
  912. Noninvasive markers of improvement of liver steatosis achieved by weight reduction in patients with nonalcoholic fatty liver disease
  913. Serum iron: ferritin ratio predicts healthy body composition and reduced risk of severe fatty liver in young adult women
  914. Role of diet on non-alcoholic fatty liver disease: An updated narrative review
  915. Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease.
  916. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population
  917. Sirtuins and nonalcoholic fatty liver disease
  918. Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
  919. Developmental programming of nonalcoholic fatty liver disease: the effect of early life nutrition on susceptibility and disease severity in later life
  920. In ovo injection of betaine alleviates corticosterone-induced fatty liver in chickens through epigenetic modifications
  921. Preventive effect of total glycosides from Ligustri Lucidi Fructus against nonalcoholic fatty liver in mice
  922. liver-specific deletion of the signal transducer and activator of transcription 5 gene aggravates fatty liver in response to a high-fat diet in mice
  923. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy
  924. Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis
  925. Dietary egg yolk supplementation improves low-protein-diet-induced fatty liver in rats
  926. Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance
  927. Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients
  928. Natural active compounds from plant food and Chinese herbal medicine for nonalcoholic fatty liver disease
  929. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese
  930. Independent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levels
  931. The role of the gut microbiota in NAFLD
  932. Exercise and the regulation of hepatic metabolism
  933. Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats
  934. liver specific depletion of mitochondrial ATP transporter enhances uncoupled respiration and prevents fatty liver and obesity
  935. Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD)
  936. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver
  937. Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway
  938. Hepatoprotective and anti‐inflammatory cytokines in alcoholic liver disease
  939. Association of serum glutamic pyruvic transaminase and non-alcoholic fatty liver disease in controlled and uncontrolled diabetes
  940. fatty liver disease, women, and aldosterone: Finding a link in the Jackson heart study
  941. Molecular insights into the mechanisms of liver‐associated diseases in early‐lactating dairy cows: hypothetical role of endoplasmic reticulum stress
  942. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
  943. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?
  944. The antioxidant, anti-inflammatory, and antiapoptotic effects of wolfberry in fatty liver disease
  945. Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPARγ Ligand-Dependent Dysregulation in Nonalcoholic fatty liver …
  946. An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function
  947. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
  948. The role of lifestyle change in the prevention and treatment of NAFLD
  949. Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine
  950. Living donor liver transplantation for progressive familial intrahepatic cholestasis type 1: two reported cases
  951. Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery
  952. Adiponectin negatively correlates with alcoholic and non‐alcoholic liver dysfunction: health check‐up study of Japanese men
  953. The potential protective effect of captopril and irbesartan on experimentally induced non-alcoholic fatty liver in rats
  954. Acetyl-CoA carboxylase 2−/− mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions
  955. Nonalcoholic fatty liver disease and liver transplantation
  956. Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD
  957. Effects of a plant product consisting of green tea and curcuma extract on milk production and the expression of hepatic genes involved in endoplasmic stress response …
  958. Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes …
  959. Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome
  960. Enhanced prevention of progression of non alcoholic fatty liver to steatohepatitis by incorporating pumpkin seed oil in nanoemulsions
  961. fatty liver disease induced by perfluorooctane sulfonate: Novel insight from transcriptome analysis
  962. Effects of transcutaneous electrical stimulation of lower limb muscles on experimental fatty liver
  963. Nonalcoholic fatty liver disease
  964. Effect of Phaseolus angularis seed on experimental cellular model of nonalcoholic fatty liver disease
  965. Alcoholic liver Disease and Nonalcoholic fatty liver Disease
  966. Research Article Enhanced Amelioration of High-Fat Diet-Induced fatty liver by Docosahexaenoic Acid and Lysine Supplementations
  967. Redox imbalance due to the loss of mitochondrial NAD (P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice
  968. The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver …
  969. Effect of dietary blueberry (Vaccinium ashei Reade) leaves on serum and hepatic lipid levels in rats
  970. Articles in PresS. Am J Physiol Gastrointest liver Physiol (October 25, 2012). doi: 10.1152/ajpgi. 00328.2012
  971. Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 mice
  972. Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis
  973. Non-alcoholic fatty liver disease: The diagnosis and management
  974. Protective effects of moderate alcohol consumption on fatty liver: A spurious association?
  975. The liver cleansing diet
  976. Dietary creatine supplementation lowers hepatic triacylglycerol by increasing lipoprotein secretion in rats fed high-fat diet
  977. Reversal of NAFLD Through Selective Increased Intracellular Hepatic Cholesterol Catabolism: 1309
  978. Histopathological Studies on fatty liver Disease
  979. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
  980. Preventive effect of a Fraxinus excelsior L seeds/fruits extract on hepatic steatosis in obese type 2 diabetic mice
  981. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function
  982. Specific modulation of hepatic estrogen receptor alpha prevents fatty liver but also obesity and insulin resistance induced by a high fat diet in mice
  983. Effect of caloric restriction and AMPK activation on hepatic nuclear receptor, biotransformation enzyme, and transporter expression in lean and obese mice
  984. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet–fed mice
  985. Glycemic Status and Lipid Profiles Changes among the Incidentally Diagnosed fatty liver Patients
  986. “Free” Raptor–a novel regulator of metabolism
  987. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
  988. Treatment of Non-Alcoholic fatty liver Disease (NAFLD): Role of AMPK 3
  989. Sex impact on the quality of fatty liver and its genetic determinism in mule ducks
  990. Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity
  991. In vitro inhibition of lipid accumulation induced by oleic acid and in vivo pharmacokinetics of chitosan microspheres (CTMS) and chitosan-capsaicin microspheres …
  992. Role of estrogens in the regulation of liver lipid metabolism
  993. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes
  994. Effect of Jungmanbunso-hwan extract on HepG2 cell model of nonalcoholic fatty liver disease caused by palmitate
  995. Detection of AMP Deaminase Activity in Patients with fatty liver in Hilla City
  996. Soy ß-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver
  997. Prevention and reversal of hepatic steatosis with a high-protein diet in mice
  998. Metformin superior to lowfat diet for the treatment of patients with nonalcoholic fatty liver disease and/or steatohepatitis
  999. Non-alcoholic fatty liver disease: from epidemiology to diagnosis
  1000. Associations between white blood cell count and the development of incidental nonalcoholic fatty liver disease
  1001. liver Derangement and fatty liver Changes in Type 2 Diabetes Mellitus
  1002. Therapeutic potential of peroxisome proliferator-activated receptor modulation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
  1003. Fish oil prevents excessive hepatic lipid accumulation without inducing oxidative stress
  1004. Dietary fatty Acids and Alcoholic liver Disease
  1005. Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats
  1006. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials
  1007. Long-chain (n-3) PUFA and non-alcoholic fatty liver disease
  1008. The fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms improves insulin resistance and hepatic lipid accumulation by modulation of liver adenosine …
  1009. Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice
  1010. Beneficial effects of metformin in diet-induced obesity associated non-alcoholic fatty liver disease
  1011. Molecular cloning and feature analysis of heart-type fatty acid-binding protein H-FABP gene from obscure puffer (Takifugu obscurus).
  1012. Isoquercitrin activates the AMP–activated protein kinase (AMPK) signal pathway in rat H4IIE cells
  1013. A longitudinal proteomic approach to investigate liver metabolism in periparturient dairy cows with different body fat mobilization
  1014. Ginsenoside Rb2 alleviates hepatic lipid accumulation by restoring autophagy via induction of Sirt1 and activation of AMPK
  1015. Non-alcoholic fatty liver disease
  1016. 2 fatty liver Vulnerability to Hypoxic and Inflammatory Stress
  1017. The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway
  1018. Metformin prevents and reverses Inflammation in a Non-Diabetic Mouse
  1019. Menhaden Oil Decreases High-Fat Diet–Induced Markers of Hepatic Damage, Steatosis, Inflammation, and Fibrosis in Obese Ldlr−/− Mice
  1020. Molecular mechanisms of protection by dietary polyphenols against free fatty acid-induced mitochondrial dysfunction and endoplasmic reticulum stress in an in vitro …
  1021. Degradation of PHLPP2 by KCTD17, via a glucagon-dependent pathway, promotes hepatic steatosis
  1022. Red wine and wine pomace reduced the development of insulin resistance and liver steatosis in HFD-fed mice
  1023. The Effect of High-Fat Diet and Exercise on Non-Alcoholic fatty liver Disease and Glycemic Control
  1024. Farnesoid x receptor agonists: what they are and how they might be used in treating liver disease
  1025. Metformin prevents and reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic
  1026. Metformin activates AMPK through the lysosomal pathway
  1027. Ice Plant (Mesembryanthemum crystallinum) Extract Promotes Lipolysis in Mouse 3T3-L1 Adipocytes Through Extracellular Signal-Regulated Kinase Activation
  1028. fatty liver Index in a general population visiting the master health check up in a Tertiary Care Centre
  1029. Indicators of Inflammation in the Fasting Induced fatty liver of the American Mink (Neovison vison)
  1030. Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making
  1031. Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan
  1032. Choline and Methionine for Transition Cows: Separating Fact from Fiction
  1033. Management of Non-Alcoholic fatty liver Disease and New Therapeutic Approaches
  1034. Growth hormone inhibits hepatic de novo lipogenesis in adult mice
  1035. Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes
  1036. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and-independent pathways
  1037. Kaempferol Isolated from Nelumbo nucifera Inhibits Lipid Accumulation and Increases fatty Acid Oxidation Signaling in Adipocytes
  1038. Metabolic Syndrome and the liver
  1039. Incretin-based antidiabetic agents for the management of non-alcoholic fatty liver disease
  1040. Lipid nutrition and healthy aging
  1041. Effect of dietary betaine supplementation on mRNA level of lipogenesis genes and on promoter CpG methylation of fatty acid synthase (FAS) gene in laying hens
  1042. Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade
  1043. CIDEC/FSP27 is regulated by peroxisome proliferator‐activated receptor alpha and plays a critical role in fasting‐and diet‐induced hepatosteatosis
  1044. Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells
  1045. Nonalcoholic steatohepatitis is associated with a state of betaine‐insufficiency
  1046. Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation
  1047. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity
  1048. Trial study comparing effect of cholmax (herbal choline) and synthetic choline chloride on growth performance in broiler chicken
  1049. Citrus limonin glucoside supplementation decreased biomarkers of liver disease and inflammation in overweight human adults
  1050. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis
  1051. Effects of luteolin 7-glucoside and its aglicone luteolin in liver lipid metabolism and plasma lipoproteins
  1052. INDY—A New Link to Metabolic Regulation in Animals and Humans
  1053. Solanum nigrum Polyphenol Extracts Inhibit Hepatic Inflammation, Oxidative Stress, and Lipogenesis in High-Fat-Diet-Treated Mice
  1054. Essential role of methyl donors in animal productivity
  1055. Dietary walnut reduces hepatic triglyceride content in high-fat-fed mice via modulation of hepatic fatty acid metabolism and adipose tissue inflammation
  1056. Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease
  1057. Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N‐methyltransferase
  1058. The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism
  1059. Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels
  1060. Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy
  1061. SREBP: a novel therapeutic target
  1062. Eicosapentaenoic acid attenuates hepatic accumulation of cholesterol esters but aggravates liver injury and inflammation in mice fed a cholate-supplemented high-fat …
  1063. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice
  1064. Emerging Targets to Relieve Fat Stress-Induced liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter
  1065. Increased anaplerosis, TCA cycling, and oxidative phosphorylation in the liver of dairy cows with intensive body fat mobilization during early lactation
  1066. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives
  1067. Berberine attenuates oxidative stress and hepatocytes apoptosis via protecting mitochondria in blunt snout bream Megalobrama amblycephala fed high-fat diets
  1068. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials
  1069. 14 Nutraceuticals in the Prevention and Treatment of fatty liver Disease
  1070. Characterizing Triacylglycerol in Cell Culture: Can LCMS replace HPTLC when assessing the effect of metformin in salmon in-vitro fatty liver model?
  1071. Effects of different amounts and types of dietary fatty acids on the body weight, fat accumulation, and lipid metabolism in hamsters
  1072. Melatonin role preventing steatohepatitis and improving liver transplantation results
  1073. Quantitative liver Proteomics for Biomarker Discovery in Non-Alcoholic fatty liver Disease
  1074. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells
  1075. liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop
  1076. Exercise and omega-3 polyunsaturated fatty acid supplementation for the treatment of hepatic steatosis in hyperphagic OLETF rats
  1077. Hepatic lipids and insulin resistance
  1078. Ginsenosides from stems and leaves of ginseng prevent ethanol-induced lipid accumulation in human L02 hepatocytes
  1079. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis
  1080. Sirtuin 7-dependent deacetylation of DDB1 regulates the expression of nuclear receptor TR4
  1081. Dietary açai attenuates hepatic steatosis via adiponectin-mediated effects on lipid metabolism in high-fat diet mice
  1082. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism
  1083. Choline and Phosphatidylcholine (Lecithin)
  1084. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice
  1085. Cyanidin 3-glucoside improves diet-induced metabolic syndrome in rats
  1086. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice
  1087. Dietary agents in the prevention of alcohol-induced hepatotoxicty: preclinical observations
  1088. Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice
  1089. Pathophysiology of NASH: perspectives for a targeted treatment
  1090. Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease
  1091. Molecular pathways: emerging roles of mammalian Sirtuin SIRT7 in cancer
  1092. Metabolic actions of FGF21: molecular mechanisms and therapeutic implications
  1093. Dietary conjugated linoleic acid and hepatic steatosis: species-specific effects on liver and adipose lipid metabolism and gene expression
  1094. Milk for humans: Evolving perceptions of an all-time mother science
  1095. Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
  1096. Cellular and molecular mechanisms of metformin: an overview
  1097. Chronic treatment with a carbon monoxide releasing molecule reverses dietary induced obesity in mice
  1098. Fermented Rhus verniciflua Stokes Extract Exerts an Antihepatic Lipogenic Effect in Oleic-Acid-Induced HepG2 Cells via Upregulation of AMP-Activated Protein …
  1099. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
  1100. Suppressive role of PPARγ-regulated endothelial nitric oxide synthase in adipocyte lipolysis
  1101. Short-and long-term soy diet versus casein protects liver steatosis independent of the arginine content
  1102. Gossypol ameliorates liver fibrosis in diabetic rats induced by high-fat diet and streptozocin
  1103. Antioxidant activity of penta-oligogalacturonide, isolated from haw pectin, suppresses triglyceride synthesis in mice fed with a high-fat diet
  1104. Mechanisms underlying the beneficial effect of soy protein in improving the metabolic abnormalities in the liver and skeletal muscle of dyslipemic insulin resistant rats
  1105. Nonalcoholic fatty liver Disease
  1106. MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis
  1107. SIRT7 and hepatic lipid metabolism
  1108. Hepatic metabolic effects of Curcuma longa extract supplement in high-fructose and saturated fat fed rats
  1109. Articles in PresS. Am J Physiol Endocrinol Metab (August 20, 2013). doi: 10.1152/ajpendo. 00133.2013
  1110. Neuronal androgen receptor: Molecular gateway to polycystic ovary syndrome?
  1111. Analysis of the liver lipidome reveals insights into the protective effect of exercise on high-fat diet-induced hepatosteatosis in mice
  1112. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B–a prospective cohort study with paired transient …
  1113. CLINICAL CHEMISTRY OF liver
  1114. Evaluation of beneficial metabolic effects of berries in high-fat fed C57BL/6J mice
  1115. Sir Ganga Ram Hospital Health Series: liver Disorders-e-book
  1116. Leucine restores murine hepatic triglyceride accumulation induced by a low-protein diet by suppressing autophagy and excessive endoplasmic reticulum stress
  1117. Coffee and tea breaks for liver health
  1118. Dietary and nutritional manipulation of the nuclear transcription factors peroxisome proliferator-activated receptor and sterol regulatory element-binding proteins as a …
  1119. Cow care for the winter-my view
  1120. Hypolipidemic effect of safflower yellow and primary mechanism analysis
  1121. Cannabinoid 1 receptors in pancreatic β cells: Function and therapeutic implications
  1122. The role of angiotensin II in nonalcoholic steatohepatitis
  1123. Metformin protects rat hepatocytes against bile acid-induced apoptosis
  1124. Effects of pasture versus confinement and marine oil supplementation on the expression of genes involved in lipid metabolism in mammary, liver, and adipose …
  1125. Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice
  1126. SIRT7 is an RNA-activated protein lysine deacylase
  1127. The CBS/CSE system: a potential therapeutic target in NAFLD?
  1128. Betaine affects muscle lipid metabolism via regulating the fatty acid uptake and oxidation in finishing pig
  1129. Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice
  1130. Lychee (Litchi chinensis Sonn.) Pulp Phenolic Extract Confers a Protective Activity against Alcoholic liver Disease in Mice by Alleviating Mitochondrial Dysfunction
  1131. SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway
  1132. Emerging drugs for non-alcoholic steatohepatitis
  1133. HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis
  1134. Vitamin C nutrition in cattle
  1135. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
  1136. Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
  1137. Effects of quercetin derivatives from mulberry leaves: Improved gene expression related hepatic lipid and glucose metabolism in short-term high-fat fed mice
  1138. Understanding liver Disorders-e-Book
  1139. Blueberry and mulberry juice prevent obesity development in C57BL/6 mice
  1140. Mesozeaxanthin protects the liver and reduces cardio-metabolic risk factors in an insulin resistant rodent model
  1141. Saponins, especially platycodin D, from Platycodon grandiflorum modulate hepatic lipogenesis in high-fat diet-fed rats and high glucose-exposed HepG2 cells
  1142. Molecular Mechanisms of NAFLD in Metabolic Syndrome
  1143. Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis
  1144. Exercise and Omega-3 Polyunsaturated fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic…
  1145. ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice
  1146. The regulatory effects of fish oil and chitosan on hepatic lipogenic signals in high-fat diet-induced obese rats
  1147. The technology of pancakes with balanced amino acid composition
  1148. Non-alcholic fatty liver disease in Type 2 Diabetes Mellitus: An independent predictor for Macro angiopathy and Micro angiopathy
  1149. Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise
  1150. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway
  1151. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis
  1152. Rafael Deminice, Robin P. da Silva, Simon G. Lamarre, Karen B. Kelly, René L. Jacobs, Margaret E. Brosnan & John
  1153. Nutritional approaches for managing obesity-associated metabolic diseases
  1154. Averrhoa carambola free phenolic extract ameliorates nonalcoholic hepatic steatosis by modulating mircoRNA-34a, mircoRNA-33 and AMPK pathways in leptin …
  1155. The small molecule indirubin-3′-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity
  1156. The Regulation Mechanisms of Anthocyanins on Lipid Metabolism in Non-Alcoholic fatty liver
  1157. SIRT1/HSF1/HSP pathway is essential for exenatide‐alleviated, lipid‐induced hepatic endoplasmic reticulum stress
  1158. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage
  1159. Nicht-alkoholische Fettleber und Blocker des Renin-Angiotensin Systems bei Patienten mit chronischer Nierenerkrankung
  1160. Flos Lonicera Combined with Metformin Ameliorates Hepatosteatosis and Glucose Intolerance in Association with Gut Microbiota Modulation
  1161. Effect of vildagliptin on hepatic steatosis
  1162. The potential of natural products for targeting PPARα
  1163. Effect of methanol extracts of three dietary plants growing in Egypt on mice fed with high fat diet
  1164. Sirtuins in metabolism, DNA repair and cancer
  1165. Prepartum feeding strategies for greater postpartum success
  1166. CD36/sirtuin 1 axis impairment contributes to hepatic steatosis in ACE2-deficient mice
  1167. Cancer Association of South Africa (CANSA)
  1168. The effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet
  1169. Possible modulation of FAS and PTP-1B signaling in ameliorative potential of Bombax ceiba against high fat diet induced obesity
  1170. Dietary Fenofibrate Reduces Hepatic Lipid Deposition by Regulating Lipid Metabolism in Yellow Catfish Pelteobagrus fulvidraco Exposed to Waterborne Zn
  1171. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis
  1172. Effects of dietary choline on growth performance, lipid deposition and hepatic lipid transport of grouper (Epinephelus coioides)
  1173. The metabolic vascular syndrome-guide to an individualized treatment
  1174. Effects of high-molecular-weight polyphenol (mitochondria activation factor) derived from black tea and oolong tea on mitochondria function.
  1175. Olanzapine-induced liver injury: Direct metabolic effects, exacerbation by high-fat diet, and protection with sulforaphane
  1176. Hypolipidemic Effects of Starch and γ-Oryzanol from wx/ae Double-Mutant Rice on BALB/c.KOR-Apoe shl Mice
  1177. Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice
  1178. Digestible methionine+ cystine requirement for Nile tilapia from 550 to 700 g
  1179. The soluble epoxide hydrolase determines cholesterol homeostasis by regulating AMPK and SREBP activity
  1180. Light-to-moderate ethanol feeding augments AMPK-α phosphorylation and attenuates SREBP-1 expression in the liver of rats
  1181. Recrystallization of ice crystals in trehalose solution at isothermal condition
  1182. Gold nanoparticles as an efficient drug delivery system for GLP-1 peptides
  1183. A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress
  1184. Acetic acid activates the AMP-activated protein kinase signaling pathway to regulate lipid metabolism in bovine hepatocytes
  1185. Hyperglycemia, oxidative stress, liver damage and dysfunction in alloxan-induced diabetic rat are prevented by Spirulina supplementation
  1186. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats
  1187. International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR)
  1188. Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus
  1189. MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice
  1190. Effects of long-term supplementation of blue-green algae on lipid metabolism in C57BL/6J mice
  1191. Hepatoprotective activity of Spirulina species
  1192. Strategies to Reduce Metabolic Dysfunctions Around Calving
  1193. Anthocyanins delay ageing-related degenerative changes in the liver
  1194. Rhodiola crenulata extract regulates hepatic glycogen and lipid metabolism via activation of the AMPK pathway
  1195. An apolipoprotein B100 mimotope prevents obesity in mice
  1196. Toxic Effects Of Corn Oil On liver Histology In Albino Rats
  1197. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
  1198. Hepatoprotective effect of peony total glucosides and the underlying mechanisms in diabetic rats
  1199. Protein reguirement of pregnantpregnancy Yakut mares
  1200. IL-33-ST2 axis in liver disease: progression and challenge
  1201. Blue maize extract improves blood pressure, lipid profiles, and adipose tissue in high-sucrose diet-induced metabolic syndrome in rats
  1202. Chronic inflammatory diseases and green tea polyphenols
  1203. Head to Head Comparison of Short-Term Treatment with the NAD+ Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese …
  1204. Learning from berberine: treating chronic diseases through multiple targets
  1205. Mechanisms of Obesity-Related Hepatocarcinogenesis
  1206. “Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man” by Hazlehurst JM, Oprescu AI, Nikolaou N., et al
  1207. Future therapy of portal hypertension in liver cirrhosis–a guess
  1208. Body weight reduction and biochemical parameters of the patients after RYGB and SG bariatric procedures in 12-month observation
  1209. HEALTH DISODERS OF CALVES AND COWS IN TIE-STALLS HOUSING SYSTEM
  1210. Rosiglitazone, a PPAR-γ agonist, fails to attenuate CLA-induced milk fat depression and hepatic lipid accumulation in lactating mice
  1211. Molecular mechanisms for anti‐aging by natural dietary compounds
  1212. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages
  1213. Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress
  1214. Effect of dietary advanced glycation end products on mouse liver
  1215. A REVIEW OF THE HEPAPROTECTIVE EFFECTS OF THE NTX PRODUCT
  1216. The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice
  1217. Dietary phytic acid modulates characteristics of the colonic luminal environment and reduces serum levels of proinflammatory cytokines in rats fed a high-fat diet
  1218. Metformin and other biguanides: pharmacology and therapeutic usage
  1219. Section and Laboratory of liver Disease, Nutrition and
  1220. Gut microbiota and metagenomic advancement in digestive disease
  1221. Metformin in nonalcoholic steatohepatitis: a randomized controlled trial
  1222. The efficacy of functional foods for the mitigation of obesity-related pathologies
  1223. Non-alcoholic steatohepatitis occurs in celiac disease and is associated with cellular stress
  1224. The short-term effects of insulin, metformin and insulin-metformin combination on the liver morphology in high fat diet/streptozotocin induced diabetic albino rats
  1225. Sugar replacers: from technological challenges to consequences on health
  1226. Effect of Aerobic Training with Ginger Supplementation on some liver Enzymes (AST, ALT, GGT) and Resistance to Insulin in Obese Women with Type 2 Diabetes.
  1227. Diabetes mellitus and risk of hepatocellular carcinoma
  1228. Stimulation of fat accumulation in hepatocytes by PGE2-dependent repression of hepatic lipolysis, β-oxidation and VLDL-synthesis
  1229. Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3
  1230. Tissue lipid metabolism and hepatic metabolomic profiling in response to supplementation of fermented cottonseedmeal in the diets of broiler chickens
  1231. The seven faces of SIRT7
  1232. Neuroimmune signaling: a key component of alcohol abuse
  1233. The Inhibitory Effects of Purple Sweet Potato Color on Hepatic Inflammation Is Associated with Restoration of NAD+ Levels and Attenuation of NLRP3 Inflammasome …
  1234. Pharmacological agents for NASH
  1235. Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
  1236. Cyanidin-3-O-β-glucoside protects against liver fibrosis induced by alcohol via regulating energy homeostasis and AMPK/autophagy signaling pathway
  1237. Articles in PresS. Am J Physiol Gastrointest liver Physiol (July 2, 2015). doi: 10.1152/ajpgi. 00010.2015
  1238. Modulation of PPAR expression and activity in response to polyphenolic compounds in high fat diets
  1239. Advances in the understanding and treatment of mitochondrial fatty acid oxidation disorders
  1240. Effects of Kamichunggantang on Lipoapoptosis and inflammation of NAFLD in db/db mice
  1241. Hypoglycemic effects of aqueous persimmon leaf extract in a murine model of diabetes
  1242. Protein acetylation in metabolism—metabolites and cofactors
  1243. FERMENTED SEA TANGLE (LAMINARIA JAPONICA) ATTENUATES ETHANOL‐INDUCED OXIDATIVE STRESS IN SPRAGUE‐DAWLEY RATS
  1244. Creatine supplementation decreased homocysteine plasma levels in rats but not humans: A critical review with meta-analysis
  1245. Metformin ameliorates acetaminophen hepatotoxicity via Gadd45β-dependent regulation of JNK signaling in mice
  1246. Molecular mechanism of betaine on hepatic lipid metabolism: inhibition of forkhead box O1 (FoxO1) binding to peroxisome proliferator-activated receptor gamma …
  1247. Combining Metformin and Aerobic Exercise Training in the Treatment of Type 2 Diabetes and NAFLD in OLETF Rats 2
  1248. An update of liver transplantation for nonalcoholic steatohepatitis
  1249. Plant-based foods as a source of lipotropes for human nutrition: a survey of in vivo studies
  1250. Resistance exercise prevents impaired homocysteine metabolism and hepatic redox capacity in Walker-256 tumor-bearing male Wistar rats
  1251. SIRT 7 clears the way for DNA repair
  1252. Angiotensin-II, a potent peptide, participates in the development of hepatic dysfunctions
  1253. Xanthorrhizol: A review of its pharmacological activities and anticancer properties
  1254. Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes
  1255. Biological effects of boron
  1256. Tetsuo Saitoa, Miyako Nishidaa, Masafumi Saitoa, Akari Tanabea, Takahiro Eitsukaa
  1257. Prolonged feeding with guanidinoacetate, a methyl group consumer, exacerbates ethanol-induced liver injury
  1258. Eggs as a source of nutraceuticals and biomedical substances in the prevention of civilization diseases
  1259. Molecular, Cellular, and Physiological Characterization of Sirtuin 7 (SIRT7)
  1260. The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver
  1261. Mulberry leaf polyphenol extract improves obesity by inducing adipocyte apoptosis and inhibiting preadipocyte differentiation and hepatic lipogenesis
  1262. Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects
  1263. Evolving aspects of liver transplantation for nonalcoholic steatohepatitis
  1264. Novel Approach of Oxidative Coupling Reaction with 1-Naphthol of the Simultaneous Metformin Drug Determination in Either Pharmaceutics Formulations or …
  1265. Attenuation of hepatic steatosis by purple sweet potato colour is associated with blocking Src/ERK/C/EBPβ signalling in high-fat-diet–treated mice
  1266. Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis
  1267. Division of Endocrinology-Metabolism, Department of Internal Medicine, Faculty of Medicine, Sumatra University/H. Adam Malik Hospital, Medan, Indonesia
  1268. Molecular pathogenesis of NASH
  1269. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo …
  1270. NAMPT-mediated NAD+ biosynthesis in adipocytes regulates adipose tissue function and multi-organ insulin sensitivity in mice
  1271. Application of Cell Block Technique on Fine Needle Aspiration from liver Disease in National Ribat University Hospital Khartoum state, Sudan 2014-2015
  1272. Ilex latifolia Thunb protects mice from HFD-induced body weight gain
  1273. Rationale for conducting a randomized trial to examine the efficacy of metformin in improving survival in cirrhosis: Pleiotropic effects hypothesis
  1274. Oncogenes strike a balance between cellular growth and homeostasis
  1275. Molecular Mechanisms of the Transition from Hepatic Insulin Resistance to Type 2 Diabetes
  1276. Lipid and fatty Acid Composition in the Flesh of an Edible Marine Fish: Amadi (Coilia reynaldi)
  1277. Bioengineering considerations in liver regenerative medicine
  1278. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice
  1279. Role of SIRT7 in hepatic lipid metabolism
  1280. Salvianolic acid B improves glucolipid metabolism by regulating adipogenic transcription factors in mice with diet-induced obesity
  1281. Sirtuins in glucose and lipid metabolism
  1282. Effect of lifestyle modification and metformin on fetuin-A in metabolic syndrome
  1283. Latent tuberculosis in patients with diabetes mellitus: prevalence, progression and public health implications
  1284. Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice
  1285. Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice
  1286. Preparation and application of fodder vitamin additive choline chloride B4 on the basis of dried beet pulp in premix composition
  1287. Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans—A comprehensive review
  1288. Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
  1289. The role of food peptides in lipid metabolism during dyslipidemia and associated health conditions
  1290. Effect of Spirulina (Arthrospira platensis) supplementation on the nutritional proteins in Côte d’Ivoire burn patients
  1291. Prevention Measures for Cirrhosis of liver and Its Progression
  1292. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver
  1293. Study of specific pharmacological activity of standardized composition of bee product substances for treatment of urogenital system
  1294. Novel LC/MS/MS and High-Throughput Mass Spectrometric Assays for Monoacylglycerol Acyltransferase Inhibitors
  1295. The Effect of Days in the Close Up Pen on 60 Day Cull Rates and Milk Production in the Subsequent Lactation
  1296. The effects on weight loss and gene expression in adipose and hepatic tissues of very-low carbohydrate and low-fat isoenergetic diets in diet-induced obese …
  1297. Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options
  1298. Clinical evaluation of Moro (Citrus sinensis (L.) Osbeck) orange juice supplementation for the weight management
  1299. Isoflavones and Inflammation in Adipose Tissue and Implications for Health
  1300. Effect of green tea extract on systemic metabolic homeostasis in diet-induced obese mice determined via RNA-seq transcriptome profiles
  1301. Metabolic Profiling of liver Tissue in Diabetic Mice Treated with Artemisia Capillaris and Alisma Rhizome Using LC-MS and CE-MS
  1302. Benefits of betaine in laying hen diets
  1303. Potential health benefits of Sea buckthorn oil-A review
  1304. Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating …
  1305. Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function
  1306. Meet Niagen: this new, patented form of vitamin [B. sub. 3] may hold the key for boundless energy and cellular rejuvenation
  1307. Influence of the APOE genotype on hepatic stress response: studies in APOE targeted replacement mice and human liver cells
  1308. Effects of metformin on burn-induced hepatic endoplasmic reticulum stress in male rats
  1309. Fasting alters protein expression of AMP-activated protein kinase in the hypothalamus of broiler chicks (Gallus gallus domesticus)
  1310. Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2)
  1311. Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics
  1312. Mitophagy and mitochondrial quality control mechanisms in the heart
  1313. Response of supplemental methionine and choline chloride on carcass quality traits, gut microbial count and cost economics of broiler chickens
  1314. Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity
  1315. Betaine applications in sows
  1316. Single ingestion of soy β-conglycinin induces increased postprandial circulating FGF21 levels exerting beneficial health effects
  1317. Metformin and metabolic diseases: a focus on hepatic aspects
  1318. Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction
  1319. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin
  1320. The ddY mouse: a model of postprandial hypertriglyceridemia in response to dietary fat
  1321. Anti-diabetic and anti-hyperlipidemic properties of Capparis spinosa L.: in vivo and in vitro evaluation of its nutraceutical potential
  1322. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action
  1323. Alleviation of metabolic abnormalities induced by excessive fructose administration in Wistar rats by Spirulina maxima
  1324. Citrus bioactive phenolics: Role in the obesity treatment
  1325. Immune therapy for nonalcoholic steatohepatitis: are we there yet?
  1326. Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders
  1327. Fermented miso with adzuki beans or black soybeans decreases lipid peroxidation and serum cholesterol in mice fed a high-fat diet
  1328. Nutritional management of the transition cow in the 21st century–a paradigm shift in thinking
  1329. Choline deprivation: an overview of the major hepatic metabolic response pathways
  1330. NAD+ loss, a new player in AhR biology: prevention of thymus atrophy and hepatosteatosis by NAD+ repletion
  1331. Healthy benefit of microalgal bioactive substances
  1332. Single cell protein production: a review
  1333. LKB1/AMPK pathway in the control of hepatic energy metabolism
  1334. Effect of in ovo methionine, glutamine, carnitine or betaine injection on hatchability, growth performance and physiological state
  1335. Sirtuins, metabolism, and DNA repair
  1336. Effects of adlay, buckwheat, and barley on transit time and the antioxidative system in obesity induced rats
  1337. NAD+ deficits in age-related diseases and cancer
  1338. Effect of conjugated linoleic acid mixtures and different edible oils on body composition and lipid regulation in mice
  1339. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice
  1340. Sirtuins in epigenetic regulation
  1341. Effect of supplementing essential fatty acids to prepartum Holstein cows and preweaned calves on calf performance, metabolism, immunity, health and …
  1342. Isoflavones and Inflammation in Adipose Tissue and Implications for Health
  1343. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation
  1344. The plasticizer BBP selectively inhibits epigenetic regulator sirtuin during differentiation of C3H10T1/2 stem cell line
  1345. Contribution to knowledge of calves and cows disorders in tie stalls housing system
  1346. Epigallocatechin-3-gallate upregulates miR-221 to inhibit osteopontin-dependent hepatic fibrosis
  1347. Theaflavin-3, 3′-digallate, a black tea polyphenol, stimulates lipolysis associated with the induction of mitochondrial uncoupling proteins and AMPK–FoxO3A …
  1348. Palm oil and cardiovascular disease: a randomized trial of the effects of hybrid palm oil supplementation on human plasma lipid patterns
  1349. A Study on The Preventive Effect of Mulberry (Morus alba l.) Fruits in Rats Exposed to Gamma Radiation
  1350. Garlic: an updated review on multipotential medicinal applications
  1351. Metformin suppresses lipid accumulation in skeletal muscle by promoting fatty acid oxidation
  1352. t-10, c-12 CLA Dietary Supplementation Inhibits Atherosclerotic Lesion Development Despite Adverse Cardiovascular and Hepatic Metabolic Marker Profiles
  1353. EFFECT OF IN OVOMETHIONINE, GLUTAMINE, CARNITINE OR BETAINE INJECTION ON HATCHABILITY, GROWTH PERFORMANCE AND PHYSIOLOGICAL …
  1354. Influence of herbal choline as a replacement of synthetic choline chloride in broiler diets on serum biochemical profile
  1355. Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes
  1356. Practical prospects for boosting hepatic production of the “pro-longevity” hormone FGF21
  1357. Effects of feeding betaine-containing liquid supplement to transition dairy cows
  1358. Efectos de mezclas de conjugados del ácido linoléico y diferentes aceites comestibles sobre la composición corporal y regulación de lípidos en ratones
  1359. Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo
  1360. The function of SIRT7 in cellular stress response and tissue maintenance
  1361. Optimization of leucrose production by dextransucrase from Streptococcus mutans and its application as an adipogenesis regulator
  1362. Choline: a limiting nutrient for transition dairy cows
  1363. Evaluation of Antiplasmodial activity of extracts and constituents from Ampelozizyphus amazonicus
  1364. Targeting aberrant cancer metabolism–The role of sirtuins
  1365. The role of liver in leptin metabolism in experimental nephrotic syndrome
  1366. Adenosine receptors and diabetes: focus on the A2B adenosine receptor subtype
  1367. Moutan cortex protects hepatocytes against oxidative injury through AMP-activated protein kinase pathway
  1368. Potential therapeutic effects of functionally active compounds isolated from garlic
  1369. Regulation of mammalian physiology by interconnected circadian and feeding rhythms
  1370. Classification and technological purposes of food additives: the European point of view
  1371. Gallocatechin gallate (GCG) inhibits 3T3-L1 differentiation and lipopolysaccharide induced inflammation through MAPK and NF-κB signaling
  1372. Methionine and choline supply during the periparturient period alter plasma amino acid and one-carbon metabolism profiles to various extents: Potential role in …
  1373. Liraglutide and metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease
  1374. Effects of angiotensin converting enzyme inhibitors on liver fibrosis in HIV and hepatitis C coinfection
  1375. Effects of Histidine Supplementation on Global Serum and Urine 1H NMR-based Metabolomics and Serum Amino Acid Profiles in Obese Women from a Randomized …
  1376. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats
  1377. Nutrient’Cocktail’Delays Aging and Extends Life Span
  1378. Garlic-derived organic polysulfides and myocardial protection
  1379. Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS …
  1380. Comparative effects of bile diversion and duodenal-jejunal bypass on glucose and lipid metabolism in male diabetic rats
  1381. New insights into the activation of sterol regulatory element-binding proteins by proteolytic processing
  1382. Metformin reduces the endotoxin-induced down-regulation of apolipoprotein E gene expression in macrophages
  1383. Hepatic activity and transcription of betaine-homocysteine methyltransferase, methionine synthase, and cystathionine synthase in periparturient dairy cows are altered …
  1384. In search of new therapeutic targets in obesity treatment: sirtuins
  1385. Creatine supplementation prevents hyperhomocysteinemia, oxidative stress and cancer-induced cachexia progression in Walker-256 tumor-bearing rats
  1386. Nuclear DNA damage signalling to mitochondria in ageing
  1387. Therapeutic role of telmisartan against acetaminophen hepatotoxicity in mice
  1388. Conjugated linoleic acid: potential health benefits as a functional food ingredient
  1389. Modulating NAD+ metabolism, from bench to bedside
  1390. Sir2 Acts through Hepatocyte Nuclear Factor 4 to maintain insulin Signaling and Metabolic Homeostasis in Drosophila
  1391. Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
  1392. Replacement of dietary soy-with air classified faba bean protein concentrate alters the hepatic transcriptome in Atlantic salmon (Salmo salar) parr
  1393. A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function
  1394. Metformin: from mechanisms of action to therapies
  1395. Diversity of mushrooms and their metabolites of nutraceutical and therapeutic significance
  1396. Metformin alleviates hepatosteatosis through Sirt1-mediated autophagy induction
  1397. Long-term phosphodiesterase 5 inhibitor administration reduces inflammatory markers and heat-shock proteins in cavernous tissue of Zucker diabetic fatty rat (ZDF/fa …
  1398. Maternal betaine supplementation throughout gestation and lactation modifies hepatic cholesterol metabolic genes in weaning piglets via AMPK/LXR-mediated …
  1399. Exendin-4 inhibits glucolipotoxic ER stress in pancreatic β cells via regulation of SREBP1c and C/EBPβ transcription factors.
  1400. Comparative study between the effects of some dietary sources and metformin drug on weight reduction in obese rats
  1401. Study of the influence of Egyptian apple against oxidative stress in gamma-irradiated rats
  1402. Journal of Cytology & Histology
  1403. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation
  1404. Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis
  1405. Effect of supplementation of protected methionine, lysine and choline on performance of lactating cows-A review
  1406. Effect of supplementation with fish oil or microalgae on milk fatty acid composition and lipogenic gene expression in cows managed in confinement or pasture systems
  1407. Pathogenesis of glucocorticoid-induced avascular necrosis: a microarray analysis of gene expression in vitro
  1408. Sex-dependent nutritional programming: fish oil intake during early pregnancy in rats reduces age-dependent insulin resistance in male, but not female, offspring
  1409. Age-related changes in sirtuin 7 expression in calorie-restricted and refed rats
  1410. The cooperative effect of local angiotensin-II in liver with adriamycin hepatotoxicity on mitochondria
  1411. Functional analysis of hepatic FOXO3 signalling in glucose and lipid metabolism
  1412. Effects of dietary betaine on productive traits and reproductive health of dairy cows
  1413. MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice
  1414. The Clinician’s handbook of natural medicine E-book
  1415. Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model
  1416. Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies
  1417. Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes
  1418. Nutrient sensing and the oxidative stress response
  1419. Expression analysis, single nucleotide polymorphisms within SIRT4 and SIRT7 genes and their association with body size and meat quality traits in Qinchuan cattle
  1420. Dynamics of protein metabolism in draft dogs under influence of herbal feed additive Gastroatsyd
  1421. Alternative grains as potential raw material for gluten–free food development in the diet of celiac and gluten–sensitive patients
  1422. Anti-cancer effects of green tea by either anti-or pro-oxidative mechanisms
  1423. Crystal structure of the N‐terminal domain of human SIRT7 reveals a three‐helical domain architecture
  1424. Advances in Biochemistry & Applications in Medicine
  1425. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models
  1426. Examining the Relationship Between Plasma Choline Status and Dietary Intake of Choline in Pregnant Women
  1427. The role of mammalian sirtuins in cancer metabolism
  1428. Recent Advances and Challenges in microRNA-Based Cancer Therapeutics
  1429. The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome
  1430. Jussara (Euterpe edulis Mart.) Supplementation During Pregnancy and Lactation 1 Modulates the Uncoupling Protein 1 (UCP-1) and Inflammation Biomarkers …
  1431. Reductive carboxylation is a major metabolic pathway in the retinal pigment epithelium
  1432. Small molecule adenosine 5′-monophosphate activated protein kinase (AMPK) modulators and human diseases
  1433. Effect of hydroxylated polymethoxyflavones and acetylated polymethoxyflavones on adipogenesis in vivo and in vitro
  1434. Dietary restriction and the pursuit of effective mimetics
  1435. Mediterranean diet and health: food effects on gut microbiota and disease control
  1436. EFFECT OF PARTIAL OR TOTAL INCLUSION OF BETAINE AND/OR CHOLINE INSTEAD OF ADDED METHIONINE IN BROILER DIETS ON: 2-CARCASS …
  1437. Cardioprotective effects of diet with different grains on lipid profiles and antioxidative system in obesity-induced rats
  1438. One-Carbon Metabolism Nutrients and Epigenetics: A Mechanistic Link Between Aberrant One-Carbon Metabolism and Cancer Risk?
  1439. Manipulating Lipolysis to Reduce Fatness and Improve Carcass Composition in Commercial Broilers
  1440. The metabolic impact on histone acetylation and transcription in ageing
  1441. Metabolomic analysis of rat plasma following chronic low-dose exposure to dichlorvos
  1442. AICAR inhibits ceramide biosynthesis in skeletal muscle
  1443. The Eczema Diet: Eczema-safe food to stop the itch and prevent eczema for life
  1444. Influence of dietary choline levels on growth performance and carcass characteristics of growing Japanese quail
  1445. The multifaceted functions of sirtuins in cancer
  1446. Genetically obese (ob/ob) mice are resistant to the lethal effects of thioacetamide hepatotoxicity
  1447. Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption
  1448. Ischemia/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1
  1449. Impact of carbohydrates on weight regain
  1450. Effects of nutrition, disease, and body condition score during the transition period on dairy cattle liver gene expression
  1451. ANIMAL NUTRITION: NEW STRATEGIES FOR NUTRITIONAL OPTIMIZATION
  1452. Dicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents
  1453. Antioxidant plants and diabetes mellitus
  1454. Pharmacokinetic and pharmacological effects of β-hydroxyphosphocarnitine in animal models
  1455. Role of the Alternate RAS in liver Disease and the GI Tract
  1456. Chronic stress effects of high doses of vitamin D3 on Megalobrama amblycephala
  1457. Insights to the Mechanism of Type 2 Diabetes Remission Following Roux-en-Y Gastric Bypass Surgery
  1458. Determinants of change in insulin resistance response to Nordic walking in community-dwelling elderly women
  1459. Aging biology and novel targets for drug discovery
  1460. Metabolic aspects of alcoholism
  1461. Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
  1462. Journal Homepage:-www. journalijar. com
  1463. Preventing and treating obesity and metabolic dysfunctions with antioxidants
  1464. Journal of Clinical Gerontology & Geriatrics
  1465. The plasticizer BBP selectively inhibits epigenetic regulator sirtuins
  1466. Multi-target pharmacological effects of platycodin D
  1467. Bioactivities and action mechanisms of Acanthopanax species
  1468. Determination of the Effect of Raspberry Ketone on Markers of Obesity in High-fat Fed C57BL/6 Male Mice
  1469. METABOLISM OF ORALLY ADMINISTERED””” Zn IN PATIENTS WITH SHORT BOWEL SYNDROME AS COMPARED TO CONTROL SUBJECTS
  1470. Flavonol glycosides with lipid accumulation inhibitory activity and simultaneous quantitative analysis of 15 polyphenols and caffeine in the flower buds of Camellia …
  1471. SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors
  1472. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
  1473. Metformin ameliorates methotrexate-induced hepatotoxicity
  1474. The controversy around sirtuins and their functions in aging
  1475. Communication from tubular epithelial cells to podocytes through Sirt1 and nicotinic acid metabolism
  1476. Studies on mechanisms of antiepilepsy and antiobesity in experimental animal models
  1477. Perspective and Direction for Future Research: Modification of High Calorie Diet Needed for Optimal Health of Human Visceral and Brain Tissues
  1478. SIRT7 is activated by DNA and deacetylates histone H3 in the chromatin context
  1479. Anti-diabetic effect of neem and spirulina in alloxan induced diabetic mice
  1480. Endoplasmic reticulum stress enhances fibrosis through IRE 1α‐mediated degradation of miR‐150 and XBP‐1 splicing
  1481. Tahlab (Spirulina) and few other medicinal plants having anti-oxidant & immunomodulatory properties described in Unani medicine-a review
  1482. The alkaline way in digestive health
  1483. Prediction of novel drugs for hepatocellular carcinoma based on multi-source random walk
  1484. Renal and cardiovascular sensory receptors and blood pressure regulation
  1485. Function and regulation of Steroid Receptor Coactivator 2. Transcriptional regulation of cellular metabolism
  1486. Sirtuins in Cancer–Emerging Role as Modulators of Metabolic Reprogramming
  1487. The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-β1-induced cellular damage
  1488. Metabolic effects of dipeptyl peptidase 4 inhibitor in type 2 diabetes
  1489. Effects of a wide range of dietary nicotinamide riboside concentrations on metabolic flexibility and white adipose tissue of mice fed a mildly obesogenic diet
  1490. Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming
  1491. Recent research progress in natural bioactive constituents against lipid metabolic diseases
  1492. Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery
  1493. The Microalga Spirulina platensis Presents Anti-inflammatory Action as well as Hypoglycemic and Hypolipidemic Properties in Diabetic Rats
  1494. Jussara (Euterpe edulis Mart.) supplementation during pregnancy and lactation modulates UCP-1 and inflammation biomarkers induced by trans-fatty acids in …
  1495. Metformin affects cortical bone mass and marrow adiposity in diet-induced obesity in male mice
  1496. Suppression of microRNA-142-5p attenuates hypoxia-induced apoptosis through targeting SIRT7
  1497. Complementary and alternative medicine in child and adolescent bipolar disorder
  1498. 17 Beyond Subcutaneous Fat
  1499. The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms
  1500. SIRTain regulators of premature senescence and accelerated aging
  1501. Biochemistry
  1502. Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes
  1503. Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk
  1504. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications
  1505. Effect of metformin on the proliferation, migration, and MMP-2 and-9 expression of human umbilical vein endothelial cells
  1506. Advancing insights on the anti-obesity biochemical mechanism of (−)-epigallocatechin gallate (EGCG) by inhibiting α-amylase activity
  1507. Insights into Cellular Stress Revealed by SIRT7
  1508. Mitonuclear communication in homeostasis and stress
  1509. Recent discovery of plant-derived anti-diabetic natural products
  1510. Nrf2 as a nutrient sensitive transcription factor
  1511. Biochemical properties of the plasma of rats with the experimentally induced hepatitis after oral administration of sodium diclofenac
  1512. Anti-Diabetic Effects of Niclosamide Ethanolamine and Metformin in Mouse Models. J Diabetes Endocrinol Metab Disord 2017: 1-8
  1513. Compounds with antioxidant capacity as potential tools against several oxidative stress related disorders: fact or artifact?
  1514. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging
  1515. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
  1516. Novel mucosal vaccines to improve immune and health status of periparturient dairy cows and increase their productive potentials
  1517. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation
  1518. Reversing stem cell aging
  1519. Maternal betaine supplementation during gestation enhances expression of mtDNA-encoded genes through D-loop DNA hypomethylation in the skeletal muscle of …
  1520. Dietary vitamin D3 requirement of Wuchang bream (Megalobrama amblycephala)
  1521. Schistosome sirtuins as drug targets
  1522. The Discovery Of Novel Enzymatic Activities And Activation Mechanism Of Sirt7
  1523. Anti-Diabetic Effects of Niclosamide Ethanolamine and Metformin in Mouse Models
  1524. Effect of using spirulina platensis and chlorella vulgaris as feed additives on growing rabbit performance
  1525. Permeability Study of Polyphenols Derived from a Phenolic-Enriched Hibiscus sabdariffa Extract by UHPLC-ESI-UHR-Qq-TOF-MS
  1526. NAD and the aging process: Role in life, death and everything in between
  1527. Expression of peroxisome proliferator-activated receptors is regulated by gonadotropins and steroid hormones in in vitro porcine ovarian follicles
  1528. Effect of angiotensin-converting enzyme inhibitor, lisinopril on morphological and biochemical aspects of fibrotic liver regeneration
  1529. Sirtuins in cancer: a balancing act between genome stability and metabolism
  1530. Ethanol Extract of Orthosiphon Stamineus Benth. Exhibits Antiobesity Effect by Inhibiting Angiogenesis and Pancreatic Lipase
  1531. Hepatic triglyceride metabolism in response to acute and chronic exercise: A tale of two intensities
  1532. The role of Sirtuin 6 in maintaining vascular integrity
  1533. Alleviation of chronic heat stress in broilers by dietary supplementation of betaine and turmeric rhizome powder: dynamics of performance, leukocyte profile, humoral …
  1534. Regulatory Mechanisms inBiosystems
  1535. Effect of postpartum uterine diseases on milk yield, milk components, and reproduction in lactating dairy cows under certified organic management
  1536. Spirulina effectiveness study on child malnutrition in Zambia
  1537. Stabilization of SIRT7 deacetylase by viral oncoprotein HBx leads to inhibition of growth restrictive RPS7 gene and facilitates cellular transformation
  1538. Effects of Cyclo-His-Pro-enriched yeast hydrolysate on blood glucose levels and lipid metabolism in obese diabetic ob/ob mice
  1539. Water Stress Proteins from Nostoc commune Vauch. Exhibit Anti-Colon Cancer Activities in Vitro and in Vivo
  1540. Nutritional strategies and their influence on the expression of nutrient sensing G protein-coupled receptors in adipose tissue of dairy cows
  1541. Green Tea Attenuates Oxidative Stress and Downregulates the Expression of Angiotensin II AT1 Receptor in Renal and Hepatic Tissues of Streptozotocin …
  1542. Preventive Effects of Eleutherococcus senticosus Bark Extract in OVX-Induced Osteoporosis in Rats
  1543. Role of Blueberry Polyphenols on Markers of Oxidative Stress, Inflammation and Hepatic Lipid Accumulation
  1544. Functional food relevance of whey protein: A review of recent findings and scopes ahead
  1545. Guidelines for developing healthy nutrition in business hotel
  1546. Anti-adipogenic effect of Glycoside St-E2 and Glycoside St-C1 isolated from the leaves of Acanthopanax henryi (Oliv.) Harms in 3T3-L1 cells
  1547. Sirt7 promotes adipogenesis in the mouse by inhibiting autocatalytic activation of Sirt1
  1548. Nutritional Supplements for the Veterinary Practice: A Pocket Guide
  1549. Regional changes in CNS and retinal glycerophospholipid profiles with age: a molecular blueprint
  1550. Spirulina maxima Extract prevents Neurotoxicity via Promoting Activation of BDNF/CREB Signaling Pathways in Neuronal Cells and Mice
  1551. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model
  1552. Sirtuin inhibitors as anticancer agents
  1553. The properties and regulation of the hepatic cytoplasmic lipid droplet
  1554. 4-Week toxicity and toxicokinetic oral gavage study with polydatin in rats
  1555. Sirtuins as a Double-Edged Sword in Cancer: From Molecular Mechanisms to Therapeutic Opportunities
  1556. Contamination by Microcystis and microcystins of blue–green algae food supplements (BGAS) on the italian market and possible risk for the exposed population
  1557. MiR-93 controls adiposity via inhibition of Sirt7 and Tbx3
  1558. Nicotinamide Riboside and the Aortic Response to Angiotensin II Infusion in Mice
  1559. Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases
  1560. Spirulina: possible pharmacological evaluation for insulin-like protein
  1561. Modulatory effects of one polysaccharide from Acanthopanax senticosus in alloxan-induced diabetic mice
  1562. Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I
  1563. IMPACT OF PHYSICAL FACTORS OF INDUSTRIAL ENVIRONMENT ON PROTEIN METABOLISM IN THE BODY OF EXPERIMENTAL ANIMALS
  1564. Role of the histone deacetylase SIRT7 in tumor invasion and metastasis through epigenetic regulation of E-cadherin
  1565. Impacts on sirtuin function and bioavailability of the dietary bioactive compound dihydrocoumarin
  1566. SIRT7 exhibits oncogenic potential in human ovarian cancer cells
  1567. Studying sirtuin inhibitors with in silico and in vitro approaches
  1568. Natural compounds in the control of diabetes associated dyslipidemia: effects in the liver and small intestine
  1569. The effects of metformin on fibroblast growth factor 19, 21 and fibroblast growth factor receptor 1 in high-fat diet and streptozotocin induced diabetic rats
  1570. Inhibitory effects of dietary Spirulina platensis on UVB-induced skin inflammatory responses and carcinogenesis
  1571. Structural and functional analysis of various globulin proteins from soy seed
  1572. Maternal one-carbon nutrient status and effects on DNA methylation and hydroxymethylation in newborn infants
  1573. Blockade of renin angiotensin system increased resistance to STZ-induced diabetes in rats with long-term high-fat diet
  1574. Caracterización de compuestos solubles en piensos para los animales domésticos
  1575. Selenium-enriched Spirulina protects INS-1E pancreatic beta cells from human islet amyloid polypeptide-induced apoptosis through suppression of ROS-mediated …
  1576. The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance
  1577. New hopes for metformin-Towards a better understanding of its mechanisms of action
  1578. Metabolic regulation at the intersection of genes and environment
  1579. Metformin suppresses prostaglandin E2-induced cytochrome P450 aromatase gene expression and activity via stimulation of AMP-activated protein kinase in human …
  1580. Epigenetics and cancer cell metabolism: cross-talk and therapeutic opportunities
  1581. Ginseng and Ginseng Products 101: What are You Buying?
  1582. SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
  1583. The Effect of Scutellariae Radix Combined with Metformin on Obesity-Relating Biomarker in High Fat Fed C57BL/6 Mice
  1584. Articles in PresS. J Neurophysiol (May 4, 2016). doi: 10.1152/jn. 00874.2015
  1585. Marker-assisted selection for elevated concentrations of the α’subunit of β-conglycinin, evaluation of its influence on agronomic and seed traits, and mapping …
  1586. Emerging health issues of cyanobacterial blooms
  1587. MicroRNA‑3666 inhibits breast cancer cell proliferation by targeting sirtuin 7
  1588. Sirtuin 7: a new marker of aggressiveness in prostate cancer
  1589. Getting ahead of the curve: women’s health: the varied needs of women offer unique entry points to many of the largest and fastest growing condition-specific markets
  1590. Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice
  1591. Investigating the Effective Factors on Learning Mathematical Concepts in Pre-School Students of 1st District of Zahedan in the Academic Year
  1592. PGC-1β prevents statin-associated myotoxicity in oxidative skeletal muscle
  1593. MILK fatty ACIDS AS EARLY BIOMARKERS OF REPRODUCTION PROBLEMS IN DAIRY CATTLE
  1594. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine
  1595. SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing
  1596. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of microcystins in blue-green algal dietary …
  1597. Antiedema effects of Siberian ginseng in humans and its molecular mechanism of lymphatic vascular function in vitro
  1598. Ultimate Wellness
  1599. Excitotoxicity-induced prostaglandin D2 production induces sustained microglial activation and delayed neuronal death
  1600. Wild berries in Ukraine
  1601. Regulation of Mitochondrial Bioenergetics via PTEN (Phosphatase and tensin homolog deleted on chromosome 10)/Estrogen-related Receptor alpha (ERRα) …
  1602. Elucidation of the Developmental and Physiological Roles of NAD+ Biosynthetic Pathways
  1603. Sirtuins and DNA damage repair: SIRT7 comes to play
  1604. Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity
  1605. Effect of red orange juice consumption on body composition and nutritional status in overweight/obese female: a pilot study
  1606. International Journal of Research and Review
  1607. Myocardial recovery from ischemia–reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4
  1608. Biomedical implant capsule formation: lessons learned and the road ahead
  1609. Immune modulation in the prevention of pathologies relating to diet-induced obesity
  1610. Expression of myofibroblasts and identification of angiotensin receptors in capsular contracture disease around mammary implants
  1611. Angiotensin-converting enzyme inhibitors in lipid metabolism and atherosclerosis: An ace up the sleeve?
  1612. Spatial dynamics of SIRT1 and the subnuclear distribution of NADH species
  1613. Metformin suppresses MHC-restricted antigen presentation by inhibiting co-stimulatory factors and MHC molecules in APCs
  1614. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response
  1615. Extrusion process of Acanthopanax senticosus leaves enhances the gastroprotective effect of compound 48/80 on acute gastric mucosal lesion in rats
  1616. Potential Role of Metformin in Mesenchymal Stem Cell-based Osteogenic and Angiogenic Coupling
  1617. Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse
  1618. Environmental enteric dysfunction: an overview
  1619. The Effects of a Wild Blueberry Diet on Hepatic and Aortic Morphology in the Obese Zucker Rat, A Model of the Metabolic Syndrome
  1620. Defining the Molecular Pathogenesis of the Neurodegenerative Disease Spinoecerebellar Ataxia Type 7
  1621. Regulation of serine-threonine kinase Akt activation by NAD+-dependent deacetylase SIRT7
  1622. Efficiency of the algae Spirulina platensis as antidiabetic agent
  1623. Animal Models for the Study of Human Disease: Chapter 21. Animal Models of Calcium Oxalate Kidney Stone Formation
  1624. Potential nutritional benefits of current citrus consumption
  1625. The Role of Choline in Cognitive Performance and Cerebrovascular Health of Older Adults
  1626. Analysis and characterization of anthocyanin from phalsa (Grewia asiatica)
  1627. Transcriptional adaptation of adipose tissue in dairy cows in response to energy overfeeding
  1628. Effects of a follow-on formula containing isomaltulose (Palatinose™) on metabolic response, acceptance, tolerance and Safety in infants: a randomized …
  1629. Flavonol glycosides with lipid accumulation inhibitory activity from Sedum sarmentosum
  1630. Biotechnological production of eleutherosides: current state and perspectives
  1631. The mitochondrial metabolic checkpoint and aging of hematopoietic stem cells
  1632. Mineral and Energy Imbalances of the Transition Period in Dairy Cows
  1633. Peanut by-products utilization technology
  1634. Do we need to diagnose normal weight metabolic obesity?
  1635. Structural and Functional Analysis of Various Globulin Proteins from Soy Seed
  1636. Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis
  1637. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut–liver axis
  1638. Inactivation of SREBP-1a phosphorylation prevents fatty liver disease in mice: identification of related signaling pathways by gene expression profiles in liver and …
  1639. Impact of the co-administration of N-3 fatty acids and olive oil components in preclinical nonalcoholic fatty liver disease models: a mechanistic view
  1640. Preventive efficiency of green tea and its components on nonalcoholic fatty liver disease
  1641. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
  1642. Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective
  1643. Dietary fish oil supplementation during early pregnancy in rats on a cafeteria-diet prevents fatty liver in adult male offspring
  1644. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease
  1645. Green tea prevents NAFLD by modulation of miR-34a and miR-194 expression in a high-fat diet mouse model
  1646. Effects of a carbohydrate‐restricted diet on hepatic lipid content in adolescents with non‐alcoholic fatty liver disease: a pilot, randomized trial
  1647. The relationship between liver enzymes and insulin resistance in type 2 diabetes patients with nonalcoholic fatty liver disease
  1648. Pharmacologic inhibition of epidermal growth factor receptor suppresses nonalcoholic fatty liver disease in a murine fast‐food diet model
  1649. Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease
  1650. Diosgenin prevents high-fat diet-induced rat non-alcoholic fatty liver disease through the AMPK and LXR signaling pathways
  1651. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease
  1652. Folic acid supplementation prevents high fructose-induced non-alcoholic fatty liver disease by activating the AMPK and LKB1 signaling pathways
  1653. Dietary intervention reverses fatty liver and altered gut microbiota during early-life undernutrition
  1654. Idebenone and coenzyme Q10 are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases
  1655. Future therapy for non‐alcoholic fatty liver disease
  1656. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
  1657. Dietary protein insufficiency: an important consideration in fatty liver disease?
  1658. Prevention of tamoxifen-related nonalcoholic fatty liver disease in breast cancer patients
  1659. Vegetarian diet, food substitution, and nonalcoholic fatty liver
  1660. Effective food ingredients for fatty liver: soy protein β-conglycinin and fish oil
  1661. Protective actions of polyphenols in the development of nonalcoholic fatty liver disease
  1662. Glucocorticoid-induced fatty liver disease
  1663. Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease
  1664. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
  1665. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice
  1666. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
  1667. Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism
  1668. Combined effects of lifestyle risk factors on fatty liver index
  1669. Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: A randomized, double blind, placebo-controlled …
  1670. Impact of mitophagy and mitochondrial unfolded protein response as new adaptive mechanisms underlying old pathologies: sarcopenia and non-alcoholic fatty liver …
  1671. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats
  1672. Cyanidin-3-O-β-glucoside regulates the activation and the secretion of adipokines from brown adipose tissue and alleviates diet induced fatty liver
  1673. fatty liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
  1674. One-carbon metabolism in fatty liver disease and fibrosis: one-carbon to rule them all
  1675. Sphingosine 1-phosphate receptor blockade affects pro-inflammatory bone marrow-derived macrophages and relieves mouse fatty liver injury
  1676. AMPK re-activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development
  1677. Deletion of NLRX1 increases fatty acid metabolism and prevents diet-induced hepatic steatosis and metabolic syndrome
  1678. Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ
  1679. Monascus purpureus-fermented common buckwheat protects against dyslipidemia and non-alcoholic fatty liver disease through the regulation of liver metabolome …
  1680. A PPAR pan agonist, MHY2013 alleviates age-related hepatic lipid accumulation by promoting fatty acid oxidation and suppressing inflammation
  1681. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic …
  1682. Effects of sodium–glucose cotransporter 2 inhibitors on non‐alcoholic fatty liver disease in patients with type 2 diabetes: a meta‐analysis of randomized controlled …
  1683. Parenteral betaine as a strategy to prevent fatty liver and improve docosahexaenoic acid and arachidonic acid distribution in parenterally fed neonatal piglets
  1684. Role of gut microbiota in the development of non-alcoholic fatty liver disease
  1685. Modeling the natural history of fatty liver using lifestyle–related risk factors: Effects of body mass index (BMI) on the life–course of fatty liver
  1686. Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease
  1687. Hepatic growth hormone-JAK2-STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression
  1688. Mitochondrial oxidative injury: A key player in nonalcoholic fatty liver disease
  1689. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
  1690. Green tea polyphenol EGCG alleviates metabolic abnormality and fatty liver by decreasing bile acid and lipid absorption in mice
  1691. Effects of some food components on non-alcoholic fatty liver disease severity: results from a cross-sectional study
  1692. Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress
  1693. Preventive effects of total flavonoid C-glycosides from Abrus mollis on nonalcoholic fatty liver disease through activating the PPARα signaling pathway
  1694. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease
  1695. Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease
  1696. AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosis
  1697. Alteration of serum amino acid profiles by dietary adenine supplementation inhibits fatty liver development in rats
  1698. A review of current and upcoming treatment modalities in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
  1699. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non …
  1700. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease
  1701. Nicotinamide and NAFLD: is there nothing new under the sun?
  1702. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies
  1703. Folic acid reduced triglycerides deposition in primary chicken hepatocytes
  1704. Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease
  1705. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice
  1706. The emerging role of hepatocellular eNOS in Non-alcoholic fatty liver disease development
  1707. Sinapine-enriched rapeseed oils reduced fatty liver formation in high-fat diet-fed C57BL/6J mice
  1708. Aqueous Extract of Pepino (Solanum muriactum Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic fatty liver Disease
  1709. Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exercise
  1710. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD+ metabolism
  1711. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
  1712. Physiological disturbance in fatty liver energy metabolism converges on IGFBP2 abundance and regulation in mice and men
  1713. Renalase attenuates mouse fatty liver ischemia/reperfusion injury through mitigating oxidative stress and mitochondrial damage via activating SIRT1
  1714. Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
  1715. A Novel Micronutrient Supplement to Preserve Male Metabolic Health and Prevent fatty liver (P21-007-19)
  1716. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation
  1717. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology
  1718. Gastrointestinal peptides and nonalcoholic fatty liver disease
  1719. Beneficial effects of insect extracts on nonalcoholic fatty liver disease
  1720. A metabolomic study on the intervention of traditional Chinese medicine Qushi Huayu decoction on rat model of fatty liver induced by high-fat diet
  1721. Microbiota, obesity and NAFLD
  1722. A novel fibroblast growth factor 1 variant reverses nonalcoholic fatty liver disease in type 2 diabetes.
  1723. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
  1724. Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4
  1725. Non-Alcoholic fatty liver Disease
  1726. Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice
  1727. Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice
  1728. Changes in the gut microbiota caused by ASBTi suppress intrahepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD)
  1729. Mitochondrial dysfunction and signaling in chronic liver diseases
  1730. liver macrophages mediate effects of downhill running and caloric restriction on nonalcoholic fatty liver disease of high fat diet-fed mice
  1731. Nonalcoholic fatty liver disease in children
  1732. Modulation of lipid metabolism by trans-anethole in hepatocytes
  1733. An AGTR1 variant worsens nonalcoholic fatty liver disease and the metabolic syndrome
  1734. Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis
  1735. Serum vitamin E as a significant prognostic factor in patients with dyslipidemia disorders
  1736. Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity
  1737. Potential therapeutic benefits of herbs and supplements in patients with NAFLD
  1738. Hepatoprotective and immunomodulatory effects of copper-nicotinate complex against fatty liver in rat model
  1739. Raw orange intake is associated with higher prevalence of non-alcoholic fatty liver disease in an adult population
  1740. Hepatoprotective effects of MHY3200 on high-fat, diet-induced, non-alcoholic fatty liver disease in rats
  1741. NAFLD and atherosclerosis: two sides of the same dysmetabolic coin?
  1742. Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction
  1743. Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty …
  1744. Xiaochaihu Decoction reduces hepatic steatosis and improves D-GalN/LPS-induced liver injury in hybrid grouper (Epinephelus lanceolatus♂× Epinephelus …
  1745. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway
  1746. Advancement of hepatic fibrosis among general women with/without NAFLD
  1747. Hepatic peroxisomal β-oxidation suppresses lipophagy via RPTOR acetylation and MTOR activation
  1748. Enzyme deficiency worsens fatty liver disease
  1749. Lipotoxicity and the gut-liver axis in NASH pathogenesis
  1750. Fibroblast growth factor 21 for non-alcoholic steatohepatitis
  1751. Genistein Ameliorates Non-alcoholic fatty liver Disease by Targeting the Thromboxane A2 Pathway
  1752. Potential of Olive Oil Extract (Olea europaea) For Affecting Lipid Profile, Lipid Oxidative and fatty liver on Hiperlipemic Rats (Rattus norvegicus)
  1753. Adipocyte JAK2 regulates hepatic insulin sensitivity independently of body composition, liver lipid content, and hepatic insulin signaling
  1754. Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance
  1755. liver activation of hepatocellular nuclear factor-4α by small activating RNA rescues dyslipidemia and improves metabolic profile
  1756. Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation
  1757. Search of New Opportunities of Pharmacological Protection at the Early Stages of a Non-Alcoholic fatty liver Disease Associated With Obesity and Metabolic …
  1758. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in …
  1759. New insights into potential nutritional effects of dietary saponins in protecting against the development of obesity
  1760. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis
  1761. Betaine increases mitochondrial content and improves hepatic lipid metabolism
  1762. Efficacy of Surya Namaskar on Non Alcoholic fatty liver Patients: A Interventional study
  1763. Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease
  1764. The effect of lipotropic agents on the nutritional induction of fatty liver syndrome in broilers
  1765. A high fat containing chicken egg-only diet suppresses fatty liver induced by a lipid-rich methionine and choline deficient diet
  1766. Relationships between prevalence of fatty liver and dietary patterns among workers in Datong Coal Mine Group
  1767. Taurine is involved in energy metabolism in muscles, adipose tissue, and the liver
  1768. Spirulina maxima extract prevents cell death through BDNF activation against amyloid beta 1-42 (Aβ1-42) induced neurotoxicity in PC12 cells
  1769. Systems analyses reveal physiological roles and genetic regulators of liver lipid species
  1770. Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
  1771. Repin1 deficiency in liver tissue alleviates NAFLD progression in mice
  1772. Maternal obesity has sex‐dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring
  1773. Hydrogen sulfide and hepatic lipid metabolism–a critical pairing for liver health
  1774. Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD)
  1775. Identification of Shared Gene Signatures in Different Stages of Non-Alcoholic fatty liver Disease Using Integrated Microarray Dataset
  1776. The role of carbohydrate response element–binding protein in the development of liver diseases
  1777. Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases
  1778. Dietary polyphenols protect against oleic acid-induced steatosis in an in vitro model of NAFLD by modulating lipid metabolism and improving mitochondrial function
  1779. Apple pomace and rosemary extract ameliorates hepatic steatosis in fructose-fed rats: Association with enhancing fatty acid oxidation and suppressing …
  1780. High glycemic index metabolic damage–a pivotal role of GIP and GLP-1
  1781. Commensal microbes modulate gut-systemic impacts of malnutrition: from neurocognitive function to NAFLD
  1782. Dietary Momordica Cochinchinensis aril ameliorates metabolic dysfunction, nonalcoholic fatty liver, and gut microbiota in diet-induced obese mice
  1783. Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway
  1784. Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice
  1785. Poly (ADP-ribose) polymerase inhibitor PJ34 attenuated hepatic triglyceride accumulation in alcoholic fatty liver disease in mice
  1786. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathway
  1787. The role of Heat shock protein 40 Member C1 in hepatic lipid metabolism
  1788. Serum Vitamin D Level and Risk of Nonalcoholic fatty liver Disease
  1789. Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation
  1790. Gut peptide and neuroendocrine regulation of hepatic lipid and lipoprotein metabolism in health and disease
  1791. Chia seed oil prevents high fat diet induced hyperlipidemia and oxidative stress in mice
  1792. Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis
  1793. Fish oil alleviates circadian bile composition dysregulation in male mice with NAFLD
  1794. A potential role for mitochondrial DNA in the activation of oxidative stress and inflammation in liver disease
  1795. Phytic acid actions on hepatic lipids and gut microbiota in rats fed a diet high in sucrose is influenced by dietary fat level
  1796. Hepatocyte–stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids
  1797. Anti-obesity Effects of Mulberry Leaf and Yacon Extract in Obese Rats
  1798. Implications of altered NAD metabolism in metabolic disorders
  1799. Regulation of hepatic genes related to lipid metabolism and antioxidant enzymes by sodium butyrate supplementation
  1800. LRH-1 signaling and control of liver intermediary metabolism: impact on nonalcoholic fatty liver disease
  1801. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
  1802. Effect of lesimarin against thioacetamide-induced liver cirrhosis in rat
  1803. Maternal green tea extract intake during lactation attenuates hepatic lipid accumulation in adult male rats exposed to a continuous high-fat diet from the foetal …
  1804. Evaluation of the” Vigozin” in broiler chickens cross” Kobb-500″ on liver status.
  1805. A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice
  1806. Predictive effect of GIPR SNP rs10423928 on glucose metabolism liver fat and adiposity in prediabetic and diabetic subjects
  1807. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
  1808. The traditional medicine and phytoconstituents from natural products for liver disease: A review
  1809. STUDY OF CELLULAR SENESCENCE AND VITAMIN D DEFICIENCY IN NON-ALCOHOLIC fatty liver DISEASE AND THE POSSIBLE PROTECTIVE EFFECT OF …
  1810. Autophagy and liver diseases
  1811. Intake of phytic acid and myo-inositol lowers hepatic lipogenic gene expression and modulates gut microbiota in rats fed a high-sucrose diet
  1812. The combination extract of pare and apples (APa) reduces risk of atherosclerosis through reduction of interleukin 17 and aggregate focus of liver inflammation …
  1813. Gut microbiota’s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics
  1814. LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity
  1815. Human hepatic 3D spheroids as a model for steatosis and insulin resistance
  1816. First person–Jens Tiefenbach
  1817. CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model
  1818. Nicotinamide and ascorbic acid nanoparticles against the hepatic insult induced in rats by high fat high fructose diet: A comparative study
  1819. Effects of dietary supplementation with apple peel powder on the growth, blood and liver parameters, and transcriptome of genetically improved farmed tilapia …
  1820. Shikonin attenuates hepatic steatosis by enhancing beta oxidation and energy expenditure via AMPK activation
  1821. Maternal betaine supplementation attenuates glucocorticoid-induced hepatic lipid accumulation through epigenetic modification in adult offspring rats
  1822. Use of nanovesicles from orange juice to reverse diet-induced gut modifications in diet-induced obese mice
  1823. Improvement in menopause-associated hepatic lipid metabolic disorders by herbal formula HPC03 on ovariectomized rats
  1824. The pharmacology of CD38/NADase: an emerging target in cancer and diseases of aging
  1825. Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: Role of gut-liver …
  1826. Evaluation of polyherbal formulation and synthetic choline chloride on choline deficiency model in broilers: implications on zootechnical parameters, serum …
  1827. Evaluation Of Hepatokine And liver Enzymes Changes In Obese Rats With The High-Fat Diet To Different Training Modalities: An Experimental Study
  1828. Mitochondrial Dysfunction in the Transition from NASH to HCC
  1829. Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage
  1830. Evaluation of lipotropic effect of herbal formulation on hepatic fat accumulation in rats fed with methionine-choline deficient diet
  1831. Lipid pathway in liver cells and its modulation by dietary extracts
  1832. CREBH regulates systemic glucose and lipid metabolism
  1833. Effects of apoptosis on liver aging
  1834. Foie gras and liver regeneration: A fat dilemma
  1835. Non alcoholic fatty liver disease: pathogenesis, role of (TNF-α, IL-6) in hepatic inflammation and future potential nutraceutical treatment
  1836. The protective effect of nicotinamide riboside against age-induced hepatic disease in mice
  1837. Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene
  1838. Divergent roles of Kupffer cell TLR2/3 signaling in alcoholic liver disease and the protective role of EGCG
  1839. Time-restricted feeding prevents obesity and metabolic syndrome in mice lacking a circadian clock
  1840. Study on the correlation between small intestinal dendritic cells and non-alcoholic fatty liver disease in mice
  1841. Icariin and its metabolites regulate lipid metabolism: from effects to molecular mechanisms
  1842. Molecular basis for pathogenesis of steatohepatitis: contemporary understanding and new insights
  1843. Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis
  1844. Tamoxifen-induced hepatotoxicity via lipid accumulation and inflammation in zebrafish
  1845. A Small Molecule, UAB126, reverses Diet-Induced Obesity and its Associated Metabolic Disorders
  1846. Exercise and organ cross talk
  1847. Creatine supplementation exacerbates ethanol-induced hepatic damage in mice
  1848. Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways
  1849. A cell-based assay to investigate hypolipidemic effects of nonalcoholic fatty liver disease therapeutics
  1850. Betaine supplementation enhances lipid metabolism and improves insulin resistance in mice fed a high-fat diet
  1851. Antihyperlipidemic effects of MLYE in obese rats
  1852. Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments
  1853. Allomyrina dichotoma Larva Extract Ameliorates the Hepatic Insulin Resistance of High-Fat Diet-Induced Diabetic Mice
  1854. Association between hypertension and nonalcoholic fatty liver disease
  1855. Green tea polyphenols positively impact hepatic metabolism of adiponectin-knockout lean mice
  1856. Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic …
  1857. HERBAL FLAVONOIDS IN TREATMENT OF HEPATIC DISEASES: A
  1858. Developments of rapid test for canine IgE against respiratory/contact allergens
  1859. Developments of rapid test for canine IgE against food allergens
  1860. The effect of TUDCA on the cryopreservation of Hanra horse semen
  1861. Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice
  1862. Metformin attenuates lipid accumulation in hepatocytes of blunt snout bream (Megalobrama amblycephala) via activation of AMP-activated protein kinase
  1863. Enhanced GIP secretion in obesity is associated with biochemical alteration and miRNA contribution to the development of liver steatosis
  1864. Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes
  1865. Nicotinamide riboside induces a thermogenic response in lean mice
  1866. Betaine treatment protects liver through regulating mitochondrial function and counteracting oxidative stress in acute and chronic animal models of hepatic …
  1867. Metformin and its benefits for various diseases
  1868. When to initiate weight loss medications in the NAFLD population
  1869. Leucrose, a sucrose isomer, suppresses hepatic fat accumulation by regulating hepatic lipogenesis and fat oxidation in high-fat diet-induced obese mice
  1870. Senescent hepatocytes in decompensated liver show reduced UPRMT and its key player, CLPP, attenuates senescence in vitro
  1871. Efficacy of ACEI or ARB in the Treatment of Non-alcoholic fatty liver Disease: a Meta Analysis
  1872. miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate–Activated Protein Kinase α1 in Male Mice
  1873. Calves and dairy cows’s health and nutrition in intensive breeding
  1874. Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis
  1875. Z-ligustilide and n-butylidenephthalide isolated from the aerial parts of angelica tenuissima inhibit lipid accumulation in vitro and in vivo
  1876. Nicotinamide N-Methyltransferase Interacts with Enzymes of the Methionine Cycle and Regulates Methyl Donor Metabolism
  1877. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet
  1878. Gene Set Enrichment Analysis (GSEA) of differentially expressed genes in green tea against methionine-choline deficient diet in high-fat patients in the development …
  1879. Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice
  1880. Overexpression of NRK1 ameliorates diet-and age-induced hepatic steatosis and insulin resistance
  1881. Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity
  1882. Nicotinamide phosphoribosyltransferase knockdown leads to lipid accumulation in HepG2 cells through the SIRT1-AMPK pathway
  1883. Live cell imaging of cytosolic NADH/NAD+ ratio in hepatocytes and liver slices
  1884. Capsaicin targets lipogenesis in HepG2 cells through AMPK activation, AKT inhibition and PPARs regulation
  1885. Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH)
  1886. liver fibrogenesis: un update on established and emerging basic concepts
  1887. Maternal betaine supplementation affects fetal growth and lipid metabolism of high-fat fed mice in a temporal-specific manner
  1888. Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
  1889. Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 Cell Extracts Inhibit Adipogenesis in 3T3-L1 and HepG2 Cells
  1890. Effect of HIIT Exercises with Thyme Supplement on Plasma Lipoproteins and liver Enzymes of Men with fatty liver: A Semi-experimental Study
  1891. Trans Fats and Metabolic Syndrome
  1892. Risk factors for hazardous drinking in university students from South Africa and Belgium
  1893. Chop/Ddit3 depletion in β-cells alleviates ER stress and corrects hepatic steatosis
  1894. Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice
  1895. The effects of dietary Lycium barbarum extract on growth performance, liver health and immune related genes expression in hybrid grouper (Epinephelus lanceolatus …
  1896. Effects of caffeine and chlorogenic acid on nonalcoholic steatohepatitis in mice induced by choline-deficient, l-amino acid-defined, high-fat diet
  1897. Oral administration of palatinose vs sucrose improves hyperglycemia in normal C57BL/6J mice
  1898. Dietary mung bean protein reduces high-fat diet-induced weight gain by modulating host bile acid metabolism in a gut microbiota-dependent manner
  1899. Adiponectin: A potential therapeutic target for metabolic syndrome
  1900. Pathogenesis of NASH: the impact of multiple pathways
  1901. Adverse Effects of Long-Term Ice-Cold Water Drink on Rat liver Function and Histology
  1902. Glycine betaine rather than acting only as an osmolyte also plays a role as regulator in cellular metabolism
  1903. Chronic aerobic exercise improves insulin sensitivity and modulates Nrf2 and NF‑κB/IκBα pathways in the skeletal muscle of rats fed with a high fat diet
  1904. The therapeutic potential of targeting the peripheral endocannabinoid/CB1 receptor system
  1905. Rhodiola crenulata root extract ameliorates fructose-induced hepatic steatosis in rats: Association with activating autophagy
  1906. The systemic role of SIRT1 in exercise mediated adaptation
  1907. Hepatic fat content is associated with fasting-induced fibroblast growth factor 21 secretion in mice fed soy proteins
  1908. Oral administration of a new HRI activator as a new strategy to improve high‐fat‐diet‐induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia …
  1909. (–)-Epigallocatechin-3-Gallate ameliorates atherosclerosis and modulates hepatic lipid metabolic gene expression in apolipoprotein E knockout mice …
  1910. Genetic regulation of plasma lipid species and their association with metabolic phenotypes
  1911. Differentiating the biological effects of linoleic acid from arachidonic acid in health and disease
  1912. Activation of peroxisome proliferator-activated receptor gamma/small heterodimer partner pathway prevents high fat diet-induced obesity and hepatic steatosis in …
  1913. Intravenous triacylglycerol infusion promotes ceramide accumulation and hepatic steatosis in dairy cows
  1914. Spam/ham e-mail classification using machine learning methods based on bag of words technique
  1915. Adiponectin homolog osmotin, a potential anti-obesity compound, suppresses abdominal fat accumulation in C57BL/6 mice on high-fat diet and in 3T3-L1 adipocytes
  1916. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) dysregulates hepatic one carbon metabolism during the progression of steatosis to steatohepatitis with fibrosis …
  1917. Alpha-1 antitrypsin deficiency-mediated liver toxicity: why do some patients do poorly? What do we know so far?
  1918. Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease
  1919. Hepatic Expression of PEMT, but Not Dietary Choline Supplementation, reverses the Protection against Atherosclerosis in Pemt−/−/Ldlr−/− Mice
  1920. AMPK activation reduces hepatic lipid content by increasing fat oxidation in vivo
  1921. Comparative analysis of fecal metabolite profiles in HFD-induced obese mice after oral administration of huangjinya green tea extract
  1922. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis
  1923. Targeting the inositol pyrophosphate biosynthetic enzymes in metabolic diseases
  1924. Protection by different classes of dietary polyphenols against palmitic acid-induced steatosis, nitro-oxidative stress and endoplasmic reticulum stress in HepG2 …
  1925. Spatiotemporal compartmentalization of hepatic NADH and NADPH metabolism
  1926. Metformin and systemic metabolism
  1927. Effects of ovariectomy and exercise training intensity on energy substrate and hepatic lipid metabolism, and spontaneous physical activity in mice
  1928. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 …
  1929. High-fat diet modifies expression of hepatic cellular senescence gene p16 (INK4a) through chromatin modifications in adult male rats
  1930. Betaine attenuates pathology by stimulating lipid oxidation in liver and regulating phospholipid metabolism in brain of methionine‐choline–deficient rats
  1931. Emerging role of AMPK in brown and beige adipose tissue (BAT): implications for obesity, insulin resistance, and type 2 diabetes
  1932. liver enzyme trends in patients taking uninterrupted metformin before and after coronary surgery
  1933. Oat β-glucan inhibits adipogenesis and hepatic steatosis in high fat diet-induced hyperlipidemic mice via AMPK signaling
  1934. Physiological effects of carotenoids on hyperglycemia and associated events
  1935. Comparative whole-transcriptome profiling of liver tissue from Wistar rats fed with diets containing different amounts of fat, fructose, and cholesterol
  1936. Role of histone acetylation and methylation in obesity
  1937. Berberine reduces pyruvate-driven hepatic glucose production by limiting mitochondrial import of pyruvate through mitochondrial pyruvate carrier 1
  1938. Beneficial effects of green coffee and green tea extract combination on metabolic syndrome improvement by affecting AMPK and PPAR-α gene expression
  1939. Mechanisms of Fibrogenesis in NASH
  1940. The role of the tryptophan-nicotinamide pathway in a model of severe malnutrition induced liver dysfunction 2
  1941. Silymarin protects against high fat diet-evoked metabolic injury by induction of glucagon-like peptide 1 and sirtuin 1
  1942. Undernutrition‐induced lipid metabolism disorder triggers oxidative stress in maternal and fetal livers using a model of pregnant sheep
  1943. The effect of fish oil supplements on serum levels of albumin, lipid profiles, and kidney function in patients with hypoalbuminemia admitted to an intensive care unit …
  1944. Sirtuins and insulin resistance
  1945. Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH) Miniperspective
  1946. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients
  1947. Systematic investigation on the chemical basis of anti‐NAFLD Qushi Huayu Fang. Part 1: A study of metabolic profiles in vivo and in vitro by high‐performance liquid …
  1948. The effect of eight weeks of aerobic training on the levels of enzymes associated with non-alcoholic fatty liver in obese children
  1949. Metabolic Targets in Nonalcoholic Steatohepatitis: Treating the Disease at the Metabolic Root
  1950. The role of the tryptophan-nicotinamide pathway in a model of severe malnutrition induced liver dysfunction
  1951. Impact of Allograft Steatosis on Cardiovascular Outcomes
  1952. The correlation between percent liver weight (PLW) and percent fat cells (PFC) of liver in HFD-STZ induced diabetic rats in comparison with insulin, metformin and …
  1953. Programming of hepatic lipid metabolism in a rat model of postnatal nicotine exposure–Sex-related differences
  1954. WDR76 mediates obesity and hepatic steatosis via HRas destabilization
  1955. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice
  1956. Basil essential oil and its nanoemulsion mitigate non alcoholic steatohepatitis in rat model with special reference to gut microbiota
  1957. Distinctive roles of sirtuins on diabetes, protective or detrimental?
  1958. Chemical Constituents from Albiziae Cortex and Their Ability to Ameliorate Steatosis and Promote Proliferation and Anti-Oxidation In Vitro
  1959. The roles of H2S on hepatic acetyl-CoA and lipid metabolism
  1960. De novo NAD+ synthesis enhances mitochondrial function and improves health
  1961. Dietary β-conglycinin modulates insulin sensitivity, body fat mass, and lipid metabolism in obese Otsuka Long-Evans Tokushima fatty (OLETF) rats
  1962. The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases
  1963. Novel Roles for Ifn-β in the Regulation of Energy Metabolism in Mice
  1964. The gut microbiota-produced indole-3-propionic acid confers the antihyperlipidemic effect of mulberry-derived 1-deoxynojirimycin
  1965. Research Article Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on In Vitro Hepatic Lipogenesis …
  1966. β-Conglycinin and Skeletal Muscle
  1967. Administration of nicotinamide mononucleotide (NMN) reduces metabolic impairment in male mouse offspring from obese mothers
  1968. Stearoyl-CoA desaturase (scd1a) is epigenetically regulated by broodstock nutrition in gilthead sea bream (Sparus aurata)
  1969. Metformin ameliorates experimental-obesity-associated autoimmune arthritis by inducing FGF21 expression and brown adipocyte differentiation
  1970. Production pectin oligosaccharides using Humicola insolens Y1-derived unusual pectate lyase
  1971. Zohreh Sadat Sangsefidi1, 2, Mahdieh Hosseinzadeh1, 2, Ali Mohammad Ranjbar3, 4, Mohsen Akhondi-Meybodi5
  1972. Maternal fats and pregnancy complications: Implications for long-term health
  1973. The effect of aerobic exercises on the biochemical factors and hepatic enzymes of the drug in addicts of the Shefa Clinic of the city of Dehdasht
  1974. Ramipril significantly attenuates the development of non-alcoholic steatohepatitis in hyperlipidaemic rabbits
  1975. Niacin: an old lipid drug in a new NAD+ dress
  1976. Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice
  1977. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway
  1978. Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH/ADMA pathway
  1979. Effect of fenofibrate on uric acid level in patients with gout
  1980. Lipid-lowering and antioxidative effects of Apium graveolens L. root flavonoid extracts
  1981. Chromatin and Nuclear Signaling: SIRT7 Function in the Nucleolus and Beyond
  1982. Factors Associated with Surveillance for Early Detection of Hepatocellular Carcinoma in liver Cirrhosis Patients
  1983. The Effect of a Family-Based Lifestyle Education Program on Dietary Habits, Hepatic Fat and Adiposity Markers in 8–12-Year-Old Children with Overweight/Obesity
  1984. Reviews in basic and clinical gastroenterology and hepatology
  1985. Mitochondria protecting amino acids: Application against a wide range of mitochondria-linked complications
  1986. Nucleophosmin/B23 contributes to hepatic insulin resistance through the modulation of NF-κB pathway
  1987. Ketone body, 3-hydroxybutyrate: minor metabolite-major medical manifestations
  1988. Low-Carbohydrate diets in the management of obesity and type 2 diabetes: a review from clinicians using the approach in practice
  1989. 3, 5-Diiodothyronine: a novel thyroid hormone metabolite and potent modulator of energy metabolism
  1990. Emodin exerts protective effect against palmitic acid-induced endoplasmic reticulum stress in HepG2 cells
  1991. Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes
  1992. C-peptide corrects hepatocellular dysfunction in a rat model of type 1 diabetes
  1993. EFFICACY OF RESISTANT STARCH AND ITS POTENTIAL APPLICATIONS IN FUNCTIONAL FOODS
  1994. The effect of 14 weeks aerobic exercise on resveratrol supplementation on protein UCP-1, SIRT1, PGC-1α in liver tissue, subcutaneous and visceral fat tissue in male …
  1995. Multi-Omic Predictors of Steatohepatitis and Advanced Fibrosis in Children
  1996. Therapeutic potential of boosting NAD+ in aging and age-related diseases
  1997. A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor
  1998. Soy β-conglycinin peptide attenuates obesity and lipid abnormalities in obese model OLETF rats
  1999. Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma
  2000. Renin–angiotensin system inhibition ameliorates CCl4-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B
  2001. Inositols and metabolic disorders: From farm to bedside
  2002. The Role of Choline and Methionine to Influence Hepatocyte Metabolism Underlying Ketosis and Lipid Accumulation
  2003. Insights into the Role of Phosphatidylethanolamine N-methyltransferase and the PC: PE Ratio in liver Function
  2004. Utilization of 4-chloro-7-nittobenzo-2-oxa-1, 3-diazol (NBD-CL) as chromogenic reagent for determination of metformin hydrochloride (MET) in pharmaceutical …
  2005. Protective Effect of Mulberry Leaf and Yacon Extract Induced Hyperlipidemia in Obese Rats
  2006. In-vitro synergistic effect of metformin and berberine on high glucose-induced lipogenesis
  2007. Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation
  2008. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway
  2009. Clinical metabolomics in neonatology: from metabolites to diseases
  2010. Time for a new perspective on prolactin in metabolism
  2011. Metabolomic analysis of the liver of a dextran sodium sulfate-induced acute colitis mouse model: implications of the gut–liver connection
  2012. Metformin intervention prevents cardiac dysfunction in a murine model of adult
  2013. Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids
  2014. The therapeutic potential of naringenin: a review of clinical trials
  2015. Age-dependent hepatic alterations induced by a high-fat high-fructose diet
  2016. Health Benefits of Green Tea in Obesity
  2017. Effect of Lifestyle Modification and Metformin on Fetuin-A and Transforming Growth Factor-ß (TGF-ß) in Metabolic Syndrome
  2018. Symposium review: One-carbon metabolism and methyl donor nutrition in the dairy cow
  2019. Ameliorative role of camel whey protein and rosuvastatin on induced dyslipidemia in mice
  2020. The effect of dietary lipid on gut microbiota in a senescence-accelerated prone mouse model (SAMP8)
  2021. Biliverdin reductase A (BVRA) knockout in adipocytes induces hypertrophy and reduces mitochondria in white fat of obese mice
  2022. Metformin: a prospective alternative for the treatment of chronic pain
  2023. Effects of urate-lowering therapy on risk of hyperlipidemia in gout by a population-based cohort study and on in vitro hepatic lipogenesis-related gene …
  2024. High-density lipoproteins from egg yolk’s effect on hyperlipidemia in a high-fat-diet obese mouse using lipidomic analysis
  2025. Nicotinamide riboside—the current state of research and therapeutic uses
  2026. Medicinal value and potential therapeutic mechanisms of Gynostemma pentaphyllum (Thunb.) Makino and its derivatives: An overview
  2027. Combined and singular effects of dietary PrimaLac® and potassium diformate (KDF) on growth performance and some physiological parameters of rainbow trout …
  2028. Elevated nicotinamide phosphoribosyl transferase in skeletal muscle augments exercise performance and mitochondrial respiratory capacity following …
  2029. The effect of supplementation different additional levels of choline to diet upon the performance of Japanese quails
  2030. Bacupari (Garcinia brasiliensis) extract modulates intestinal microbiota and reduces oxidative stress and inflammation in obese rats
  2031. Effect of mediterranean diet components on type 2 diabetes and metabolic syndrome
  2032. Sorghum (Sorghum bicolor) extract affects plasma lipid metabolism and hepatic macrophage infiltration in diabetic rats
  2033. Clinical Profile of Childhood Obesity in School Going Children Aged 5-16 Years in Davanagere City
  2034. Beneficial effects of citrus flavonoids on cardiovascular and metabolic health
  2035. Targeting the intestinal microbiota to prevent type 2 diabetes and enhance the effect of metformin on glycaemia: a randomised controlled pilot study
  2036. Updates on the epigenetic roles of sirtuins
  2037. A novel TNF-α converting enzyme (TACE) selective inhibitor JTP-96193 prevents insulin resistance in KK-Ay type 2 diabetic mice and diabetic peripheral neuropathy …
  2038. Epigallocatechin gallate modulates muscle homeostasis in type 2 diabetes and obesity by targeting energetic and redox pathways: a narrative review
  2039. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma
  2040. Muscat Bailey A grape stalk extract ameliorates high-fat diet‑induced obesity by downregulating PPARγ and C/EPBα in mice
  2041. A Review on:“Recent Updates on Poly-Adp-Ribosylation (Parylation) in Physiology and Pathology”
  2042. Anti-inflammatory strategies targeting metaflammation in type 2 diabetes
  2043. Diverse bioactive components from Ginkgo biloba fruit
  2044. Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients
  2045. Bioactive natural products for the prevention and treatment of diabetes mellitus
  2046. Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: Is TMAO serving as a marker for hepatic insulin resistance
  2047. Targeting the gut microbiota by Asian and Western dietary constituents: a new avenue for diabetes
  2048. Differential Expression of Gluconeogenic Enzymes in Early-and Late-Stage Diabetes: The Effect of Citrullus Colocynthis Seed Extract on Hyperglycemia and …
  2049. Targeted microbiome intervention by microencapsulated delayed-release niacin beneficially affects insulin sensitivity in humans
  2050. The timing effects of soy protein intake on mice gut microbiota
  2051. Protective effects of aqueous extract from Gei Herba on blood-deficiency mice: insights gained by a metabolomic approach
  2052. Green tea extracts ameliorate high-fat diet–induced muscle atrophy in senescence-accelerated mouse prone-8 mice
  2053. Supplementation exogenous bile acid improved growth and intestinal immune function associated with NF-κB and TOR signalling pathways in on-growing grass carp …
  2054. The obligatory role of host microbiota in bioactivation of dietary nitrate
  2055. Antioxidants in the fight against atherosclerosis: is this a dead end?
  2056. A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
  2057. The Efficacy of Royal Jelly in the Restoration of liver Injury in Irradiated Rats
  2058. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects
  2059. Gut microbiome-Mediterranean diet interactions in improving host health
  2060. Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes
  2061. Sirtuins and immuno-metabolism of sepsis
  2062. Green tea extracts reduce leukocyte cell–Derived chemotaxin 2 and selenoprotein P levels in the livers of C57BL/6J mice fed a high-fat diet
  2063. Reactive oxygen and nitrogen species regulate key metabolic, anabolic, and catabolic pathways in skeletal muscle
  2064. High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear …
  2065. Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice
  2066. Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: A meta-analysis
  2067. Future approaches in liver disorders: regenerative medicine
  2068. Metformin ameliorates body mass gain and early metabolic changes in ovariectomized rats
  2069. A new vision of mitochondrial unfolded protein response to the sirtuin family
  2070. Effects of spirulina on weight loss and blood lipids: a review
  2071. Metformin rescues rapamycin-induced mitochondrial dysfunction and attenuates rheumatoid arthritis with metabolic syndrome
  2072. Quercetin and epigallocatechin gallate in the prevention and treatment of obesity: From molecular to clinical studies
  2073. Targeting immunometabolism as an anti-inflammatory strategy
  2074. Metformin protects rat hepatocytes against bile acid-induced apoptosis
  2075. Hepatoprotective effects of red cabbage in hypercholesterolemic diet-induced oxidative stressed rabbits
  2076. Epigenetic regulation of metabolism and inflammation by calorie restriction
  2077. NAD+ intermediates: the biology and therapeutic potential of NMN and NR
  2078. Research advances in Akkermansia muciniphila and liver injury
  2079. Microbiota transplant in the treatment of obesity and diabetes: current and future perspectives
  2080. Linking bioenergetic function of mitochondria to tissue-specific molecular fingerprints
  2081. Age-induced changes in white, brite, and brown adipose depots: a mini-review
  2082. Circadian rhythms and proteomics: It’s all about posttranslational modifications!
  2083. Changes in the biochemical parameters of blood serum of laying hens by varying the feeding diet
  2084. The substantiation of the selection of medicinal plants and their rational application in diseases of the hepatobiliary system
  2085. Identification of a degradation signal at the carboxy terminus of SREBP2: A new role for this domain in cholesterol homeostasis
  2086. Dietary fatty acids change circulating fatty acids, microbial putrefactive postbiotics and betaine status in the cat
  2087. NAD+ modulation: Biology and therapy
  2088. Studying the Effects of Supplementing (Reashure) to Pregnant Sheep on Incidence of Ketosis and Health Status Pre and after Lambing
  2089. Effects of metformin combined with lactoferrin on lipid accumulation and metabolism in mice fed with high-fat diet
  2090. Effects of grape pomace and a polyphenolic plant product during the transition period of high-yielding dairy cows
  2091. Pgc1a is responsible for the sex differences in hepatic Cidec/Fsp27β mRNA expression in hepatic steatosis of mice fed a Western diet
  2092. Nutrition with Movement for Better Energy and Health
  2093. Tea and its components prevent cancer: A review of the redox-related mechanism
  2094. Therapeutic potential of nicotinamide adenine dinucleotide (NAD)
  2095. Dual effects of metformin on adipogenic differentiation of 3T3-L1 preadipocyte in AMPK-dependent and independent manners
  2096. Therapeutic potential of NAD-boosting molecules: the in vivo evidence
  2097. Sirtuins and Bile Acids: Potential Anti-obesity Strategies Targeting Mitochondria
  2098. Early prediction of liver disease using conventional risk factors and gut microbiome-augmented gradient boosting 2
  2099. Botanical Medicine and Phytochemicals in Healthy Aging and Longevity—Part 2
  2100. Endocannabinoids: the lipid effectors of metabolic regulation in health and disease
  2101. Production of single-cell protein from different substrates
  2102. Transcriptome analysis of hepatic gene expression and DNA methylation in methionine-and betaine-supplemented geese (Anser cygnoides domesticus)
  2103. Serum ethanolamine plasmalogen and urine myo-inositol as cognitive decline markers
  2104. Beneficial changes of gut microbiota and metabolism in weaned rats with Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 supplementation
  2105. The roles of sirtuins family in cell metabolism during tumor development
  2106. SIRT6, a mammalian deacylase with multitasking abilities
  2107. Activation of angiotensin type 2 receptors prevents diabetic complications in female db/db mice by nitric oxide‐mediated mechanisms
  2108. Moderate SIRT1 overexpression protects against brown adipose tissue inflammation
  2109. NAD+ repletion produces no therapeutic effect in mice with respiratory chain complex III deficiency and chronic energy deprivation
  2110. Metabolic impact of flavonoids consumption in obesity: From central to peripheral
  2111. Macronutrient modulation of mRNA and microRNA function in animals: A review
  2112. Histone deacetylase 5 regulates interleukin 6 secretion and insulin action in skeletal muscle
  2113. Systems Biochemistry Investigation into Lipid Metabolism and Lipid-Metabolizing Enzymes
  2114. Mammalian sirtuins SIRT4 and SIRT7
  2115. Metformin alleviates muscle wasting post-thermal injury by increasing Pax7-positive muscle progenitor cells
  2116. Role of endothelial NAD+ deficiency in age-related vascular dysfunction
  2117. The epigenetic regulator SIRT7 guards against mammalian cellular senescence induced by ribosomal DNA instability
  2118. Inflammation in liver Diseases
  2119. Effect of Late Gestational Betaine Supplementation on Intermediate Metabolites, Homocysteine and Lipid Peroxidation in Pregnant Ewes and Their Offspring
  2120. Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity
  2121. Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice
  2122. Maternal consumption of green tea extract during pregnancy and lactation alters offspring’s metabolism in rats
  2123. Herbals for Animal Health and Better Production
  2124. Gut microbiome contributes to liver fibrosis impact on T cell receptor immune repertoire
  2125. Effects of nicotinamide riboside on endocrine pancreatic function and incretin hormones in nondiabetic men with obesity
  2126. Protective effects of Allium sativum essential oil rich in disulfides against deltamethrin induced oxidative stress and hepatotoxicity in rats
  2127. The role of ERp44 in glucose and lipid metabolism
  2128. Is serum angiotensin converting enzyme level a useful non-invasive marker for liver fibrosis in patients with chronic hepatitis C?
  2129. Dihydronicotinamide riboside is a potent NAD+ concentration enhancer in vitro and in vivo
  2130. Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin
  2131. Study on Supplement Containing Moro (Citrus Sinensis (L.) Osbeck) Orange Extract of a Randomized Placebo-controlled Trial Part 2: Analysis of Efficacy on …
  2132. 1-Deoxynojirimycin (DNJ) Exerts Female-Prefered Anti-Hyperlipidemic Effect via Gender-Specifically Modulation of the Gut Microbiota and Promoted Indole-3 …
  2133. Aerobic exercise training induces the mitonuclear imbalance and UPRmt in the skeletal muscle of aged mice
  2134. Anti-obese related pharmacological effects of standard potato protein extracts on the 45% Kcal high fat diet supplied mice
  2135. Health functions and related molecular mechanisms of tea components: An update review
  2136. Gut microbiota composition changes associated with obesity: new lights from metagenomic analysis
  2137. Obesity in the Pathophysiology of Diabetes
  2138. Turbo Metabolism: 8 Weeks to a New You: Preventing and Reversing Diabetes, Obesity, Heart Disease, and Other Metabolic Diseases by Treating the …
  2139. LKB1 differently regulates adipogenesis in intramuscular and subcutaneous adipocytes through metabolic and cytokine-related signaling pathways
  2140. MicroRNA-148b-3p is involved in regulating hypoxia/reoxygenation-induced injury of cardiomyocytes in vitro through modulating SIRT7/p53 signaling
  2141. Advances in cellular characterization of the sirtuin isoform, SIRT7
  2142. Nicotinamide riboside reduces cardiometabolic risk factors and modulates cardiac oxidative stress in obese Wistar rats under caloric restriction
  2143. Understanding the effects of dietary components on the gut microbiome and human health
  2144. Effect of a novel strain of Lactobacillus brevis M8 and tea polyphenol diets on performance, meat quality and intestinal microbiota in broilers
  2145. Effects of metformin on metabolism of white and brown adipose tissue in obese C57BL/6J mice
  2146. Prospects for using plant extracts to correct fat and carbohydrate metabolism disorders
  2147. Characteristics of selected antioxidative and bioactive compounds in meat and animal origin products
  2148. INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES
  2149. Role of sirtuins in adipose tissue development and metabolism
  2150. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis
  2151. High dose of dietary nicotinamide riboside induces glucose intolerance and white adipose tissue dysfunction in mice fed a mildly obesogenic diet
  2152. Effect of the consumption of green tea extract during pregnancy and lactation on metabolism of mothers and 28d-old offspring
  2153. Incretin hormones: the link between glycemic index and cardiometabolic diseases
  2154. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy
  2155. Isolation, culture and characterization of cholestatic hepatocytes: an in vitro approach to study cholestasis
  2156. Advances of molecular markers and their application for body variables and carcass traits in Qinchuan cattle
  2157. Unraveling the regulation of hepatic gluconeogenesis
  2158. Metabolic Benefits of Plant-based N-3 Polyunsaturated fatty Acids on Brown Thermogenesis
  2159. SIRT7 regulates the TGF-β1-induced proliferation and migration of mouse airway smooth muscle cells by modulating the expression of TGF-β receptor I
  2160. NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase
  2161. Cardioprotective effect of the mitochondrial unfolded protein response during chronic pressure overload
  2162. Effects of grape pomace and a polyphenolic plant product during the transition period of high-yielding dairy cows-kumulative Dissertation
  2163. Hepatic 1-carbon metabolism enzyme activity, intermediate metabolites, and growth in neonatal Holstein dairy calves are altered by maternal supply of …
  2164. Alterations of lipid metabolism in cancer: implications in prognosis and treatment
  2165. The good, the bad, and the ugly of pregnancy nutrients and developmental programming of adult disease
  2166. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures
  2167. The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning
  2168. An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance
  2169. Stem cell metabolism and diet
  2170. Recent Advances in Understanding the Role of Genomic and Epigenomic Factors in Noncommunicable Diseases
  2171. Hepatic regeneration in aging: Cell type plasticity and redundancies
  2172. Citrus polymethoxyflavones: Biofunctional molecules of therapeutic interest
  2173. The Pharmacological Activity of Camellia sinensis (L.) Kuntze on Metabolic and Endocrine Disorders: A Systematic Review
  2174. Applications of Arthrospira platensis as an alternative source of food, maintaining nutritional security and awareness creation; there by reducing problems of …
  2175. Maternal rumen-protected methionine supplementation alters dairy calf development, postnatal growth, plasma biomarkers, and liver one-carbon metabolism
  2176. Physiological Responses to Feeding a Yeast Culture Supplement to Transition Dairy Cows
  2177. The Eczema Detox: The Low-chemical Diet for Eliminating Skin Inflammation
  2178. A role for plant science in underpinning the objective of global nutritional security?
  2179. Biochemical characterization of mono ADP ribosyl transferase activity of human sirtuin SIRT7 and its regulation
  2180. Response of Broiler Birds to Choline Chloride in Semi Arid Sokoto, Nigeria
  2181. Is the nutritional value of fish fillet related to fish maturation or fish age? Integrated analysis of transcriptomics and metabolomics in blunt snout bream (Megalobrama …
  2182. HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration
  2183. The pathomechanism of cytochrome c oxidase deficiency includes nuclear DNA damage
  2184. A biosensor for measuring NAD+ levels at the point of care
  2185. You are what you eat—the relationship between diet, microbiota, and metabolic disorders—a review
  2186. Pgc1a is responsible for the sex differences in hepatic Cidec/Fsp27β mRNA expression in hepatic steatosis of mice fed a Western diet 2
  2187. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells
  2188. Yahyah Aman1, Yumin Qiu2, Jun Tao2, Evandro F. Fang1, 2, 3 1Department of Clinical Molecular Biology, University of Oslo and Akershus University
  2189. Green Tea for Human Health Benefits: Phytonutrients and Their Therapeutic Potentials
  2190. Cancer: The Metabolic Disease Unravelled
  2191. Dolichos lablab L. extracts as pharmanutrient for stress-related mucosal disease in rat stomach
  2192. α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) …
  2193. Effects of Diet on Human Gut Microbiome and Subsequent Influence on Host Physiology and Metabolism
  2194. The regulation of the concentrations of peroxisome proliferator-activated receptor gamma coactivator 1-alpha and Sirtuin 1 protein in the soleus muscle by …
  2195. Vitamin B3 forms as precursors to NAD+: are they safe?
  2196. Strategies to improve meat products’ quality
  2197. Pleiotropic effects of metformin in managing type 2 diabetes and metabolic syndrome: evidences from experimental mouse model
  2198. Dihydronicotinamide riboside promotes cell-specific cytotoxicity by tipping the balance between metabolic regulation and oxidative stress
  2199. SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle
  2200. Sirtuin 7 deficiency ameliorates cisplatin-induced acute kidney injury through regulation of the inflammatory response
  2201. Green tea extracts attenuate brain dysfunction in high-fat-diet-fed SAMP8 mice
  2202. Targeting cellurlar dysfunction with green tea polyphenols to treat the underlying basis of the metabolic complications of obesity
  2203. Nicotinamide adenine dinucleotide metabolism and neurodegeneration
  2204. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease
  2205. The critical role of epigallocatechin gallate in regulating mitochondrial metabolism
  2206. Biased signalling of Dual GLP-1R/GCGR agonists
  2207. NUTRITION-RELATED CONTINUING EDUCATION OPEN-BOOK COURSES
  2208. Nutritional analysis ofspirulina spto promote as superfood candidate
  2209. Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway
  2210. Pharmacokinetic and Pharmacodynamic Interactions between Simvastatin and Gardeniae Fructus in Healthy and High-fat High-cholesterol Diet Induced …
  2211. The impact of metformin and aspirin on T-cell mediated inflammation: A systematic review of in vitro and in vivo findings
  2212. NAD+ metabolism as a target for metabolic health: have we found the silver bullet?
  2213. Nicotinamide riboside augments the human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures in aged subjects: a …
  2214. Influence of paternal consumption of a high-fat/high-sugar diet and/or orange juice during preconception on C57BL/6 female mice offspring breast cancer risk
  2215. A futile battle? Protein quality control and the stress of aging
  2216. The Best Possible You: A unique nutritional guide to healing your body
  2217. Nature’s armamentarium against malaria: antimalarials and their semisynthetic derivatives
  2218. Pharmacological and therapeutic aspects of plants from the genus Ferula: a comprehensive review
  2219. Sirtuins in mitochondrial stress: Indispensable helpers behind the scenes
  2220. A polysaccharide extract from the medicinal plant Maidong inhibits the IKK–NF-κB pathway and IL-1β–induced islet inflammation and increases insulin …
  2221. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson’s disease
  2222. Granulosa-lutein cell sirtuin gene expression profiles differ between normal donors and infertile women
  2223. Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism
  2224. Integrated Analysis of Transcriptomics and Metabolomics in Blunt Snout Bream (Megalobrama amblycephala)
  2225. Introductory review on sirtuins in biology, aging, and disease
  2226. Toward the Understanding of the Metabolic Regulation of Sirtuins
  2227. Brown and brite: the fat soldiers in the anti-obesity fight
  2228. Effects of the supplementation of distillers’ grape residues on ruminal degradability, whole tract digestibility and nitrogen metabolism in sheep
  2229. The roles of sirtuin family proteins in cancer progression
  2230. Molecular regulation of nutrient sensing and immunometabolism by calorie restriction
  2231. Glucose metabolism in CD4 and CD8 T cells
  2232. MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
  2233. In vivo protective effect of adipsin-deficiency on spontaneous knee osteoarthritis in aging mice
  2234. The Effect of Mandarin Juice on Rats on High Fat Diet Plus Cholesterol
  2235. Metformin effects on vaspin levels and other parameters in Iraqi polycystic ovarian women.
  2236. Elucidating the Pharmacokinetics and Pharmacodynamics of Oxidative Phosphorylation Uncouplers for the Treatment of Obesity
  2237. Adaptogens in chemobrain (Part III): Antitoxic effects of plant extracts towards cancer chemotherapy-induced toxicity-transcriptome-wide microarray analysis of …
  2238. Evaluation of anti-hepatotoxic potential of Cassia javanica (L.) methanol extract against paracetamol-induced liver damage in Wistar albino rats
  2239. Spirulina microalgae improves memory deficit induced by scopolamine in male pup rats: Role of oxidative stress
  2240. The role of acetyl-coA carboxylase2 in head and neck squamous cell carcinoma
  2241. An Alternative Potential Natural Genetic Resource: Sea Buckthorn [Elaeagnus rhamnoides (syn.: Hippophae rhamnoides)]
  2242. Synthesis of chiral sphingolipids and their stereochemical effects on induction of neurite outgrowth and sphingomyelin synthase activity
  2243. The good, the bad, and the ugly of ROS: new insights on aging and aging-related diseases from eukaryotic and prokaryotic model organisms
  2244. TUMOR PROMOTING FUNCTIONS FOR THE METABOLIC REGULATOR SIRT5
  2245. Does intestinal dysbiosis contribute to an aberrant inflammatory response to severe acute respiratory syndrome coronavirus 2 in frail patients?
  2246. The mitochondrial metabolic checkpoint in stem cell aging and rejuvenation
  2247. The choline requirement of juvenile yellowtail kingfish (Seriola lalandi) and the interactive effects of choline and water temperature on nutrient assimilation
  2248. Physiological Effects of Isocaloric and Mineral Deficient Maternal Mouse Diets on Offspring Growth and Body Composition
  2249. Increasing NAD+ levels through nicotinamide riboside activates in vivo brown adipose tissue in mice but not in humans
  2250. Anti‑tumour effects of polysaccharide extracted from Acanthopanax senticosus and cell‑mediated immunity
  2251. Metabolic tracing of NAD+ precursors using strategically labelled isotopes of NMN
  2252. Effects of epigallocatechin-3-gallate (EGCG) on a scleroderma model of fibrosis
  2253. Bone marrow-derived mesenchymal stem cells protect islet grafts against endoplasmic reticulum stress-induced apoptosis during the early stage after transplantation
  2254. Metformin increases proliferative activity and viability of multipotent stromal stem cells isolated from adipose tissue derived from horses with equine metabolic …
  2255. Nutrient sensing, the oxidative stress response, and stem cell aging
  2256. Impacts of obesity, maternal obesity and nicotinamide mononucleotide supplementation on sperm quality in mice
  2257. The role of nicotinamide adenine dinucleotide in the pathogenesis of rheumatoid arthritis: potential implications for treatment
  2258. Revisiting histone deacetylases in human tumorigenesis: The paradigm of urothelial bladder cancer
  2259. A polyphenol-enriched supplement exerts potent epigenetic-protective activity in a cell-based model of brain ischemia
  2260. Improving metabolic health via dietary and pharmacologic modulation of stress response pathways
  2261. Adaptogens in chemobrain (part IV): Adaptogenic plants prevent the chemotherapeutics-induced imbalance of redox homeostasis by modulation of expression …
  2262. Suhuai suckling piglet ionomic-metabolome responses to different dietary copper level in antibiotic free creep feed
  2263. The quality of leguminous vegetables as influenced by preharvest factors
  2264. Alcohol induces mitochondrial fragmentation and stress responses to maintain normal muscle function in Caenorhabditis elegans
  2265. Mitochondria as 10
  2266. Advantages and limitations of the neonatal immune system
  2267. Proteomic characterization of the heart and skeletal muscle reveals widespread Arginine ADP-ribosylation by the ectopic ADP-ribosyltransferase ARTC1
  2268. Mitochondria as a Key Player in Aging
  2269. Arginine methylation of SIRT 7 couples glucose sensing with mitochondria biogenesis
  2270. EFFECT OF DIETARY ENERGY LEVELS WITH OR WITHOUT SELENIUM AND CHOLINE SUPPLEMENTATION ON PERFORMANCE OF BROILER CHICKENS
  2271. Novel Mitochondrial Translation Optimizer-1 Mutations as a Cause of Hereditary Optic Neuropathy
  2272. Extraction of nanochitin from marine resources and fabrication of polymer nanocomposites: recent advances
  2273. A randomized trial on the effects of CitrusiM®(Citrus sinensis (L.) Osbeck dried extract) on body composition
  2274. A study of pro-technological and spoilage yeasts in the food industry
  2275. Effect of betaine supplementation on quantity and quality of colostrum and on circulating blood metabolites in Sanjabi pregnant ewes
  2276. SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer
  2277. The mitohormetic response as part of the cytoprotection mechanism of berberine: Berberine induces mitohormesis and mechanisms
  2278. SIRT7 slows down stem cell aging by preserving heterochromatin: a perspective on the new discovery
  2279. Kidney Injury Molecule-1 Mediated Phagocytosis and Its Therapeutic Application in Ameliorating Renal Transplant Ischemia Reperfusion Injury
  2280. Enhancement of niacin availability in the ileocolonic region by microencapsulation and coating
  2281. Burn-Induced Muscle Wasting: Changes in Muscle Progenitor Cells
  2282. INVESTIGATING THE ROLE OF NICOTINIC ACID PHOSPHORIBOSYL TRANSFERASE IN CANCER
  2283. Role of homocysteine metabolism in animal reproduction: A review
  2284. Harmful and Beneficial Role of ROS 2017
  2285. Antioxidant effect of Epigallocatechin-3-gallate in a bleomycin-induced scleroderma model
  2286. PGC-1β modulates statin-associated myotoxicity in mice
  2287. Health-promoting properties of bioactive compounds of tea and the influence of method of infusion preparation and time on their contenth®
  2288. Epigenomic profiling of primary hepatocellular carcinoma reveals super-enhancer-associated chromatin regulator network
  2289. Micronutrient supplementation to improve the impact of paternal obesity on subsequent generations
  2290. Expression of hsa_circ_0007240 in peripheral blood leucocytes and correlated with inflammatory factor in patients with type 2 diabetes mellitus.
  2291. Brown adipose tissue ameliorates autoimmune arthritis via inhibition of Th17 cells
  2292. Orange (lat. Cītrus× sinēnsis)
  2293. NAD+ precursor increases aerobic performance in mice
  2294. Effects of overexpression of nicotinamide phosphoribosyltransferase in mouse embryonic fibroblast cells on oxidative and endoplasmic reticulum stress …
  2295. Changes in weight and substrate oxidation in overweight adults following isomaltulose intake during a 12-week weight loss intervention: a randomized, double-blind …
  2296. Histological Study on the Protective Effect of Atomoxetine against Olanzapine Induced Weight Gain in Male Albino Rats
  2297. Irvingia gabonensis: Phytochemical Constituents, Bioactive Compounds, Traditional and Medicinal Uses
  2298. Water-Based Extraction of Bioactive Principles from Hawthorn, Blackcurrant Leaves and Chrysanthellum Americanum: from Experimental Laboratory Research to …
  2299. Nicotinamide pathway-dependent Sirt1 activation restores calcium homeostasis to achieve neuroprotection in spinocerebellar ataxia type 7
  2300. A Mitochondrial UPR Negative Feedback Loop Limits Longevity and Is Exploited During Infection
  2301. SIRT 7 activates quiescent hair follicle stem cells to ensure hair growth in mice
  2302. Effect of high dietary sugar and metformin in a mouse model of Alzheimer’s disease
  2303. SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders
  2304. Sirt7 acts as a novel regulator of chromatin dynamics through modulation of the Sirt1/Suv39H1 axis: Possible role in cancer
  2305. Sirtuins’ deregulation in bladder cancer: SIRT7 is implicated in tumor progression through epithelial to mesenchymal transition promotion
  2306. Effect of betaine on circulating homocysteine, antioxidant enzymes, and lipid peroxidation in pregnant Sanjabi ewes
  2307. Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas
  2308. SIRT7 deacetylates STRAP to regulate p53 activity and stability
  2309. Lynch syndrome-related clear cell carcinoma of the cervix: a case report
  2310. Influence of phytochemical compounds of red orange juice on reduction of abdominal fat/INFLUENCIA DOS COMPOSTOS FITOQUIMICOS DO SUCO DE LARANJA …
  2311. The mitochondrial unfolded protein response: a hinge between healthy and pathological aging
  2312. Progress in Phytochemical and Bioactivities of Coffea arabica L.
  2313. Molecular perspectives of mitochondrial adaptations and their role in cardiac proteostasis
  2314. Associations between Soy Intake and Disease Severity in Cirrhotic Patients: Results from a Cross-Sectional Study
  2315. Development and evaluation of novel biodegradable chitosan based metformin intrapocket dental film for the management of periodontitis and alveolar bone loss in a …
  2316. The contribution of bioactive peptides of whey to quality of food products
  2317. Identification of dysregulated microRNA networks in schwann cell-like cultures exposed to immune challenge: Potential crosstalk with the protective VIP/PACAP …
  2318. AMINO ACID PROFILES OF FIVE COMMONLY CONSUMED INSECTS IN SOUTHWESTERN NIGERIA.
  2319. Expression of Halo-hFGF18 and study of its effect on differentiation of ATDC5 cells
  2320. Mechanisms of GBA1 related PD in hiPSC derived neurons
  2321. The new plant raw materials in the European Pharmacopoeia. Part 8. Camellia sinensis (L.) Kuntze (Chinese tea) – the source of catechin – alkaloid raw …
  2322. A Chemoproteomic Technique for the Identification of Proteins Regulated by Coenzyme A
  2323. Bioactive Potential of Nonconventional Edible Wild Mushroom Amanita
  2324. Importance of NAD+ and Boosting Strategies via Targeting NAD+ Pathway Genes
  2325. Effects of light intensity on the growth, photosynthetic characteristics, and secondary metabolites of Eleutherococcus senticosus Harms.
  2326. Biosynthesis and degradation of glycine betaine and its potential to control plant growth and development
  2327. The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis.
  2328. Drink?: The New Science of Alcohol and Health
  2329. Ultrastructural Analysis Of Proteins Implicated in Synaptic Vesicle Docking and Priming in C. elegans
  2330. Availability and nutritive value of Spirulina (Arthrospira fusiformis) from Arenguade and Chitu Lakes of Rift Valley of Ethiopia and Farmers’ perception about its …
  2331. Diet and longevity: The effects of traditional eating habits on human lifespan extension
  2332. Motor skills in children with primary headache: A pilot case-control study
  2333. Influence of Age and Feeding Length on Phytase Efficacy in Broiler Chickens
  2334. Innovation in Public Health: a behavioral and design sciences approach
  2335. Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability
  2336. Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease
  2337. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet
  2338. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD–Reconciling the present with the past
  2339. Advanced lipodystrophy reverses fatty liver in mice lacking adipocyte hormone-sensitive lipase
  2340. Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease
  2341. Telmisartan and candesartan promote browning of white adipose tissue and reverse fatty liver changes in high fat diet fed male albino rats
  2342. High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition
  2343. Recent Updates in the Prevention of Nonalcoholic fatty liver Disease
  2344. Lipid balance must be just right to prevent development of severe liver damage
  2345. Fu instant tea ameliorates fatty liver by improving microbiota dysbiosis and elevating short-chain fatty acids in the intestine of mice fed a high-fat diet
  2346. fatty liver disease in living liver donors: a single‐institute experience of 220 donors
  2347. Polyphenols in the prevention and treatment of non-alcoholic fatty liver disease: An update of preclinical and clinical studies
  2348. Plant-based foods and their bioactive compounds on fatty liver disease: Effects, mechanisms, and clinical application
  2349. Beneficial effects of plant-derived natural products on non-alcoholic fatty liver disease
  2350. Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development
  2351. NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin
  2352. Effects of different green teas on obesity and non-alcoholic fatty liver disease induced by a high-fat diet in mice
  2353. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
  2354. Adherence to mediterranean diet and NAFLD in patients with metabolic syndrome: The FLIPAN study
  2355. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
  2356. Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink
  2357. The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis
  2358. Methanolic Extract of Lysimachia Candida Lindl. prevents High-Fat High-Fructose-Induced fatty liver in Rats: Understanding the Molecular Mechanism …
  2359. Genistein protects against hyperglycemia and fatty liver disease in diet-induced prediabetes mice via activating hepatic insulin signaling pathway
  2360. Plasma alkylresorcinol metabolite, a biomarker for whole-grain intake, is inversely associated with risk of nonalcoholic fatty liver disease in a case-control study of …
  2361. Epidemiology and lifestyle survey of non-alcoholic fatty liver disease in school-age children and adolescents in Shenyang, Liaoning
  2362. Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic fatty liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat …
  2363. Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease
  2364. A Transcriptomic Response to Lactiplantibacillus plantarum-KCC48 against High-Fat Diet-Induced fatty liver Diseases in Mice
  2365. Protective effects of polysaccharide from Artocarpus heterophyllus Lam.(jackfruit) pulp on non-alcoholic fatty liver disease in high-fat diet rats via PPAR and …
  2366. α, β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling …
  2367. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways
  2368. Peroxisome proliferator-activated receptor α has a protective effect on fatty liver caused by excessive sucrose intake
  2369. Nonalcoholic fatty liver disease (NAFLD). Mitochondria as players and targets of therapies?
  2370. Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
  2371. Biological Role and Related Natural Products of SIRT1 in Nonalcoholic fatty liver
  2372. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1
  2373. Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice
  2374. Effects of curcumin on non-alcoholic fatty liver disease: a scientific metrogy study
  2375. The Clock‐NAD+‐Sirtuin connection in nonalcoholic fatty liver disease
  2376. The hepatic integrated stress response suppresses the somatotroph axis to control liver damage in nonalcoholic fatty liver disease
  2377. Preventive effects of black soybean polyphenols on non-alcoholic fatty liver disease in three different mouse models
  2378. Creatine supplementation protects against diet-induced non-alcoholic fatty liver but exacerbates alcoholic fatty liver
  2379. Nonalcoholic fatty liver disease and the gut-liver axis: Exploring an undernutrition perspective
  2380. Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease
  2381. Free fatty acid receptors as mediators and therapeutic targets in liver disease
  2382. The role of gut–liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC
  2383. Intestinal Barrier Function in the Pathogenesis of Nonalcoholic fatty liver Disease
  2384. Effects of chitosan oligosaccharide on production performance, egg quality and ovarian function in laying hens with fatty liver syndrome
  2385. The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
  2386. Protocols for mitochondria as the target of pharmacological therapy in the context of nonalcoholic fatty liver disease (NAFLD)
  2387. Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD): Insights into the role of oxidative stress and …
  2388. Erα-dependent regulation of adropin predicts sex differences in liver homeostasis during high-fat diet
  2389. Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
  2390. CBD Alleviates liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway
  2391. Thiamethoxam induces nonalcoholic fatty liver disease in mice via methionine metabolism disturb via nicotinamide N-methyltransferase overexpression
  2392. Litchi-derived polyphenol alleviates liver steatosis and gut dysbiosis in patients with non-alcoholic fatty liver disease: a randomized double-blinded, placebo …
  2393. The development of the Metabolic-associated fatty liver Disease during pharmacotherapy of mental disorders-a review
  2394. Salubrious effects of green tea catechins on fatty liver disease: A systematic review
  2395. Chlorogenic acid improves NAFLD by regulating gut microbiota and GLP-1
  2396. The gut-liver axis as a target of liver disease management
  2397. Development and initial validation of the nonalcoholic fatty liver disease self‐management questionnaire
  2398. Sequentially fermented dealcoholized apple juice intervenes fatty liver induced by high-fat diets via modulation of intestinal flora and gene pathways
  2399. Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction
  2400. A global research priority agenda to advance public health responses to fatty liver disease
  2401. Perillartine protects against metabolic associated fatty liver in high-fat diet-induced obese mice
  2402. Co-treatment with cefotaxime and high-fructose diet inducing nonalcoholic fatty liver disease and gut microbial dysbiosis in mice
  2403. Prevalence of Non-Alcoholic fatty liver Disease in Urban Adult Population in a Tertiary Care Center, Chennai
  2404. Amelioratory effect of resistant starch on non-alcoholic fatty liver disease via the gut-liver axis
  2405. Coffee modulates insulin-hepatocyte nuclear factor-4α-Cyp7b1 pathway and reduces oxysterol-driven liver toxicity in a nonalcoholic fatty liver disease mouse model
  2406. Mitochondria-targeted anti-oxidant AntiOxCIN4 improved liver steatosis in Western diet-fed mice by preventing lipid accumulation due to upregulation of fatty …
  2407. MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila
  2408. Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review
  2409. Non-alcoholic fatty liver disease and liver fibrosis during aging
  2410. Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis
  2411. Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease …
  2412. Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
  2413. Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives
  2414. Effects of long-term DHA supplementation and physical exercise on non-alcoholic fatty liver development in obese aged female mice
  2415. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae
  2416. The role of FGF21 and its analogs on liver associated diseases
  2417. Target deconvolution of fenofibrate in nonalcoholic fatty liver disease using bioinformatics analysis
  2418. Epigallocatechin-3-gallate dampens non-alcoholic fatty liver by modulating liver function, lipid profile, and macrophage polarization
  2419. The Hepatic Integrated Stress Response Suppresses the Somatotroph Axis to Control liver Damage in Nonalcoholic fatty liver Disease
  2420. Adipose lipolysis is important for ethanol to induce fatty liver in the National Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge ethanol …
  2421. Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation
  2422. Reversal of Diabesity: Normalization of Insulin Release Curve in Association with Reversal of Non-Alcoholic fatty liver Disease
  2423. Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
  2424. Correlation between shift work and non-alcoholic fatty liver disease among male workers in the steel manufacturing company of Korea: a cross-sectional study
  2425. Polylactose exhibits prebiotic activity and reduces adiposity and nonalcoholic fatty liver disease in rats fed a high-fat diet
  2426. Effect of Jiangan‐Jiangzhi Pill on Gut Microbiota and Chronic Inflammatory Response in Rats with Non‐Alcoholic fatty liver
  2427. Metabolism and antioxidation regulation of total flavanones from Sedum sarmentosum Bunge against high-fat diet-induced fatty liver disease in Nile tilapia …
  2428. Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide+/Sirtuin …
  2429. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD
  2430. Intervention effects of four exercise modalities on nonalcoholic fatty liver disease: a systematic review and Bayesian network meta-analysis.
  2431. Innate and adaptive immunity alterations in metabolic associated fatty liver disease and its implication in COVID-19 severity
  2432. Defect in Ser312 phosphorylation of Tp53 dysregulates lipid metabolism for fatty accumulation and fatty liver susceptibility: Revealed by lipidomics
  2433. Effects of betaine on non-alcoholic liver disease
  2434. Non-alcoholic fatty liver disease and gut microbial dysbiosis-underlying mechanisms and gut microbiota mediated treatment strategies
  2435. Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice
  2436. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast
  2437. Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
  2438. LCHP Diet Enriched with Cholesterol Promotes Non-Alcoholic fatty liver Disease in Wistar Rats
  2439. liver protective effect of fenofibrate in NASH/NAFLD animal models
  2440. Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
  2441. fatty liver? Microbiome sphingolipids to the rescue
  2442. ALLEVIATION HARMFUL EFFECTS OF NON-ALCOHOLIC fatty liver DISEASE WITH Phyllanthus niruri EXTRACT IN ALBINO RATS.
  2443. Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
  2444. Enrichment efficiency of lutein in eggs and its function in improving fatty liver hemorrhagic syndrome in aged laying hens
  2445. Identification of lipid regulatory genes modulated by polyherbal formulation in chicken liver tissues using transcriptome analysis
  2446. Supplementation with a specific combination of metabolic cofactors ameliorates non-alcoholic fatty liver disease, hepatic fibrosis, and insulin resistance in mice
  2447. Educational Intervention in Promoting fatty liver Preventive Behaviors in Women: Using the Protection Motivation Theory
  2448. Dietary Acid Load (DAL), Glycated Hemoglobin A1c (HbA1c), and Metabolic Syndrome (MeS) Mediate the Association of the Adherence to the Dietary …
  2449. Mitochondrial dysfunction and epigenetics underlying the link between early-life nutrition and non-alcoholic fatty liver disease
  2450. Hepatic mediators of lipid metabolism and ketogenesis: focus on fatty liver and diabetes
  2451. Study of cellular senescence and vitamin D deficiency in nonalcoholic fatty liver disease and the potential protective effect of vitamin D supplementation
  2452. The effect of metformin on aminotransferase levels, metabolic parameters and body mass index in nonalcoholic fatty liver disease patients: a metaanalysis
  2453. Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review
  2454. Literature Review on the Use of Herbal Extracts in the Treatment of Non-Alcoholic fatty liver Disease
  2455. Screening of MicroRNAs with potential systemic effects released from goose fatty liver
  2456. Management of liver diseases: Current perspectives
  2457. Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic …
  2458. Periodontal treatment and usual care for nonalcoholic fatty liver disease: A multicenter, randomized controlled trial
  2459. Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study
  2460. EXTENT OF KNOWLEDGE ABOUT CAUSES AND COMPLICATIONS OF fatty liver DISEASE AMONG THE POPULATION IN TABUK CITY, SAUDI ARABIA
  2461. Integrated analysis of the methylome and transcriptome of chickens with fatty liver hemorrhagic syndrome
  2462. Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance
  2463. Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
  2464. Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease
  2465. Dealing fatty liver through HHH-‘Homoeopathy & Hepatic Health’Care
  2466. From Non-Alcoholic fatty liver to Hepatocellular Carcinoma: A Story of (Mal) Adapted Mitochondria
  2467. Targeting macrophagic 17β-Hsd7 by fenretinide for the treatment of nonalcoholic fatty liver disease
  2468. Therapeutic Potential of Artichoke in the Treatment of fatty liver: A Systematic Review and Meta-Analysis
  2469. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation
  2470. Heat-Killed Enterococcus faecalis Inhibit FL83B Hepatic Lipid Accumulation and High Fat Diet-Induced fatty liver Damage in Rats by Activating Lipolysis …
  2471. Abdominal magnetic resonance imaging assessment and quantification of pancreatic and liver adipose tissues in obesity before and after laparoscopic sleeve …
  2472. Natural Products for the Treatment of Non-Alcoholic fatty liver Disease: A Comprehensive Review
  2473. GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver disease
  2474. Different expressions of clock genes in fatty liver induced by high-sucrose and high-fat diets
  2475. Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition
  2476. Traditional Chinese medicines and natural products targeting immune cells in the treatment of metabolic-related fatty liver disease
  2477. High Extra Virgin Olive Oil Consumption Is Linked to a Lower Prevalence of NAFLD with a Prominent Effect in Obese Subjects: Results from the MICOL Study
  2478. Current Advances in the Regulatory Effects of Bioactive Compounds from Dietary Resources on Nonalcoholic fatty liver Disease: Role of Autophagy
  2479. Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats
  2480. Quinoa Ameliorates Hepatic Steatosis, Oxidative Stress, Inflammation and Regulates the Gut Microbiota in Nonalcoholic fatty liver Disease Rats
  2481. Atherogenic Index of Plasma (AIP) and Its Association with fatty liver in Obese Adolescents
  2482. Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic fatty liver Disease: Role of Metformin
  2483. A new activator of esterase D decreases blood cholesterol level through ESD/JAB1/ABCA1 pathway
  2484. Exploring the antioxidant effects of Aloe vera: Potential role in controlling liver function and lipid profile in high fat and fructose diet (HFFD) fed mice
  2485. Contemporary directions in fatty liver disease in light of low-carbohydrate approach: a review by public health India
  2486. Is there enough choline for children in food aid?
  2487. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
  2488. An adenosine derivative prevents the alterations observed in metabolic syndrome in a rat model induced by a rich high-fat diet and sucrose supplementation
  2489. High-fructose diet-induced hepatic expression of the Scd1 gene is associated with increased acetylation of histones H3 and H4 and the binding of ChREBP at the …
  2490. The effect of 12 week-maximum fat oxidation (FATmax) intensity exercise on microvascular function in obese patients with nonalcoholic fatty liver disease and its …
  2491. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1
  2492. Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
  2493. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
  2494. Management of Cardiometabolic Complications in Patients with Nonalcoholic fatty liver Disease: A Review of the Literature With Recommendations
  2495. Soybean β-conglycinin: structure characteristic, allergenicity, plasma lipid-controlling, prevention of obesity and non-alcoholic fatty liver disease
  2496. AdipoRon alleviates fatty acid–induced lipid accumulation and mitochondrial dysfunction in bovine hepatocytes by promoting autophagy
  2497. Dietary polyphenols to combat nonalcoholic fatty liver disease via the gut–brain–liver axis: a review of possible mechanisms
  2498. Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic
  2499. The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease
  2500. Nuciferine prevents hepatic steatosis associated with improving intestinal mucosal integrity, mucus-related microbiota and inhibiting TLR4/MyD88/NF-κB …
  2501. Creatine Supplementation to Improve Sarcopenia in Chronic liver Disease: Facts and Perspectives
  2502. Clinical efficacy of Qingre Quzhuo capsule in the treatment of non-alcoholic fatty liver disease
  2503. Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
  2504. Effect of dietary glycine supplementation on productive performance, egg quality, stress response, and fatty liver incidence in laying hens raised under heat …
  2505. Coffee modulates insulin-HNF-4alpha-Cyp7b1 pathway and reduces oxysterol driven liver toxicity in a NAFLD mouse model
  2506. The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models …
  2507. Impact of fenofibrate on NAFLD/NASH: A genetic perspective
  2508. High-carbohydrate diet-induced metabolic disorders in Gerbillus tarabuli (a new model of non-alcoholic fatty–liver disease). Protective effects of 20-hydroxyecdysone
  2509. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms
  2510. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway
  2511. Momordica cochinchinensis Aril Ameliorates Diet-Induced Metabolic Dysfunction and Non-Alcoholic fatty liver by Modulating Gut Microbiota
  2512. Taraxasterol alleviates fatty acid-induced lipid deposition in calf hepatocytes by decreasing ROS production and endoplasmic reticulum stress
  2513. Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of …
  2514. The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
  2515. In Silico and In Vitro Analyses of PNPLA3 rs738409 C> G Polymorphism in Patients With Non-alcoholic fatty liver Disease
  2516. Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease
  2517. Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis–like phenotypes
  2518. Natural recovery by the liver and other organs after chronic alcohol use
  2519. Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue
  2520. QSPR Analysis of Some Phenolic Compounds Present in Moringa Oleifera
  2521. Coffee restores expression of lncRNAs involved in steatosis and fibrosis in a mouse model of NAFLD
  2522. Metabolic profiling of emodin drug‐induced liver injury and silybin treatment in rats using ultra‐performance liquid chromatography‐quadrupole‐time‐of‐flight‐mass …
  2523. A novel noninvasive diagnostic model of HBV-related inflammation in chronic hepatitis B virus infection patients with concurrent nonalcoholic fatty liver …
  2524. Therapeutic Potential of Herbal Medicine against Non-alcoholic fatty liver Disease
  2525. Nutraceuticals for Non-alcoholic fatty liver Disease
  2526. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic fatty liver Disease Resolution in Bariatric Surgery Patients
  2527. Hypolipidemic effects of soy protein and isoflavones in the prevention of non-alcoholic fatty liver disease-a review
  2528. Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
  2529. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
  2530. Identification, functional characterization and therapeutic implication of Akkermansia muciniphila in non-alcoholic fatty liver disease-induced hepatocellular carcinoma
  2531. Regulatory effects of Lactobacillus fermented black barley on intestinal microbiota of NAFLD rats
  2532. Hepatoprotection of Cinnamomum burmannii ethanolic extract against high-fat and cholesterol diet in Sprague–Dawley rats (Rattus norvegicus)
  2533. Lotus seed resistant starch ameliorates high-fat diet induced hyperlipidemia by fatty acid degradation and glycerolipid metabolism pathways in mouse liver
  2534. Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives
  2535. Spirulina liquid extract prevents metabolic disturbances and improves liver sphingolipids profile in hamster fed a high-fat diet
  2536. liver fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic fatty liver Disease
  2537. Lactylation Analysis in Nonalcoholic fatty liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery
  2538. Metformin protects against ethanol-induced liver triglyceride accumulation by the LKB1/AMPK/ACC pathway
  2539. Carbon Dots as Potential Therapeutic Agents for Treating Non-Alcoholic fatty liver Disease and Associated Inflammatory Bone Loss
  2540. Does vitamin D replacement therapy cause a regression in fatty liver disease? A case control study of comparison of vitamin D and other common therapy modalities
  2541. Association of Type 2 Diabetes Mellitus with fatty liver
  2542. The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
  2543. Nicotinamide N-methyltransferase and liver diseases
  2544. fatty liver prediction: a multivariable linear regression model based on transient elastography using routine biochemical indicators and waist circumference
  2545. The effect of melatonin, metformin and ursodeoxycholic acid on non-alcoholic fatty liver disease: A randomized, double-blinded controlled trial
  2546. The role of Hmgcs2-mediated ketogenesis in non-alcoholic fatty liver disease development and treatment
  2547. S-adenosylmethionine upregulates the angiotensin receptor-binding protein ATRAP via the methylation of HuR in NAFLD
  2548. Salidroside Alleviates Lipid Metabolism Disorder and Inflammatory Response, and Promotes Hepatocyte Proliferation in fatty liver-Hemorrhagic Syndrome of Laying …
  2549. Cyclo (His-Pro): A further step in the management of steatohepatitis
  2550. Potential Beneficial Effect of Rifaximin in the Prevention of Hepatocellular Carcinoma through the Modulation of the Microbiota in an Experimental Model of Non …
  2551. FGF21: a novel regulator of glucose and lipid metabolism and whole-body energy balance
  2552. An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides
  2553. Analysis of the detection rate and related factors of fatty liver disease in physical examination of healthy population in Chengdu district
  2554. Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
  2555. Effects of obesity and 10 weeks metformin treatment on liver steatosis
  2556. Histopathological analysis of the liver in hypercholesterolemia rats treated with Dillenia serrata fruits
  2557. Maternal polyunsaturated fatty acid concentrations during pregnancy and childhood liver fat accumulation
  2558. Evaluation of the effect of red turmeric on inhibiting liver cancer cells
  2559. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic fatty liver Disease
  2560. Innate and Adaptive Immunity Alterations in Metabolic Associated fatty liver Disease and Its Implication in COVID-19 Severity
  2561. Environmental exposure to low-dose perfluorohexanesulfonate promotes obesity and non-alcoholic fatty liver disease in mice fed a high-fat diet
  2562. Nutraceutical and Dietary Measures with Potential for Preventing/Controlling Non-Alcoholic fatty liver Disease and Its Complications
  2563. Temporal dynamics and nutritional targeting of multi-organ metabolic dysfunctions in non-alcoholic fatty liver disease
  2564. A designed self-microemulsion delivery system for dihydromyricetin and its dietary intervention effect on high-fat-diet fed mice
  2565. Investigating the antioxidant effects of Aloe vera: Possible role in regulating lipid profile and liver function in high fat and fructose diet (HFFD) fed mice
  2566. Green Tea and Java Pepper Mixture prevents Obesity by Increasing Energy Expenditure and Modulating Hepatic AMPK/MicroRNA-34a/370 Pathway in High-Fat Diet …
  2567. Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice
  2568. Effects of Keemun and dianhong black tea in alleviating excess lipid accumulation in the liver of obese mice: A comparative study
  2569. FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism
  2570. Combination of a Glucagon-Like Peptide 1 Analog and a Sodium-Glucose Cotransporter 2 Inhibitor Improves Lipid Metabolism Compared to the Monotherapies in …
  2571. Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
  2572. Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis
  2573. Acetyl-11-Keto-Beta-Boswellic Acid Has Therapeutic Benefits for NAFLD Rat Models That Were Given a High Fructose Diet by Ameliorating Hepatic Inflammation and …
  2574. Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet–induced obesity in rats
  2575. Nicotinamide riboside supplementation exerts an anti–obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity …
  2576. fatty liver disease in overweight and Obese Iranian Children: Comprehensive systematic review and meta-analysis
  2577. Deficiency of SREBP1c modulates autophagy mediated lipid droplet catabolism during oleic acid induced steatosis
  2578. Understanding the role of probiotics as a possible treatment strategy for alcoholism induced liver dysfunction
  2579. The relationship of Megamonas species with nonalcoholic fatty liver disease in children and adolescents revealed by metagenomics of gut microbiota
  2580. Endoplasmic reticulum stress in liver diseases
  2581. Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
  2582. Coffee: More Than Just Your Morning Pick-Me-Up
  2583. Effect of dietary and lifestyle interventions on the amelioration of NAFLD in patients with metabolic syndrome: The FLIPAN study
  2584. Green tea and selenium-enriched green tea ameliorates non-alcoholic fatty liver disease through peripheral 5-hydroxytryptamine signals in high-fat diet-fed mice
  2585. Role of endoplasmic reticulum stress in hepatic glucose and lipid metabolism and therapeutic strategies for metabolic liver disease
  2586. Crucial role of T cells in NAFLD-related disease: A review and prospect
  2587. Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic liver Disease (MASLD)
  2588. Therapeutic potential of palm oil vitamin E-derived tocotrienols in inflammation and chronic diseases: Evidence from preclinical and clinical studies
  2589. Hepatic steatosis, rather than underlying obesity, increases the risk of infection and hospitalization for COVID-19
  2590. Integrated transcriptomic and translatomic inquiry of the role of betaine on lipid metabolic dysregulation induced by a high-fat diet
  2591. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling
  2592. α, ß-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism
  2593. Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation
  2594. Exercise Training and Probiotic Lacticaseibacillus rhamnosus GG Reduce Tetracycline-Induced liver Oxidative Stress and Inflammation in Rats with Hepatic …
  2595. Genetic Ablation of C/EBPα-p300 Pathway Blocks Development of Obese Pregnancy Associated liver Disorders in Offspring
  2596. The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
  2597. Beneficial effects of betaine: A comprehensive review
  2598. Protein Kinase A (PKA) in Health and Disease: An integrated approach from disease predisposition to the design of new treatments around a key enzyme
  2599. Chop/Ddit3 depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice
  2600. NAFLD, insulin resistance, and diabetes mellitus type 2
  2601. Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3 …
  2602. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of …
  2603. Protective effects of voluntary exercise on hepatic fat accumulation induced by dietary restriction in Zucker fatty rats
  2604. Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet
  2605. liver complications of total parenteral nutrition: the latest therapeutic strategies
  2606. A Metabolic Enhancer Protects against Diet-Induced Obesity and liver Steatosis and Corrects a Pro-Atherogenic Serum Profile in Mice
  2607. Gut-liver axis: Pathophysiological concepts and clinical implications
  2608. Almond protects the liver in coronary artery disease: A randomized controlled clinical trial
  2609. Black and Yellow Soybean Consumption prevents High-Fat Diet-Induced Obesity by Regulating Lipid Metabolism in C57BL/6 Mice
  2610. Identification of Dacinostat as a potential anti-obesity compound through transcriptional activation of adipose thermogenesis in mice
  2611. Nonalcoholic fatty liver Disease in children
  2612. The beneficial effects of Lactobacillus brevis FZU0713-fermented Laminaria japonica on lipid metabolism and intestinal microbiota in hyperlipidemic rats fed with a …
  2613. Texas Dairy Matters
  2614. Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis
  2615. Nutritional aspects, bioactive phytochemicals and biomedical traits of Opuntia spp.: current trends and applications
  2616. Metformin Ameliorates Ethanol-Induced liver Triglyceride Accumulation by LKB1/AMPK/ACC Pathway
  2617. Creatine ameliorates high-fat diet-induced obesity by regulation of lipolysis and lipophagy in brown adipose tissue and liver
  2618. The lactate receptor GPR81 mediates hepatic lipid metabolism and the therapeutic effect of metformin on experimental NAFLDs
  2619. Self-Management and Associated Factors among Patients with Non-Alcoholic fatty liver Disease: A Cross-Sectional Study
  2620. The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice
  2621. It is high time physicians thought of natural products for alleviating NAFLD. Is there sufficient evidence to use them?
  2622. The beneficial metabolic actions of prolactin
  2623. Short-Term Effect of Aerobic Exercise and High-Fat Diet and Consumption of Curcumin Extract on Leptin Gene Expression in liver Tissue in Male Rats.
  2624. The Role of Zonulin as a Prognostic Biomarker in liver Diseases: A Systematic Review
  2625. Hepatic transcriptome profiles reveal the hepatoprotective effects of dietary quercetin and sodium quercetin-5′-sulfonates supplementation in hybrid grouper …
  2626. Rice bran fermented with kimchi-derived lactic acid bacteria prevents metabolic complications in mice on a high-fat and-cholesterol diet
  2627. Mechanism of action of traditional Chinese medicine in treatment of nonalcoholic fatty liver disease
  2628. SIRT5 rs12216101 T> G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
  2629. A new in vivo zebrafish bioassay evaluating liver steatosis identifies DDE as a steatogenic endocrine disruptor, partly through SCD1 regulation
  2630. Reprogramming of hepatic metabolism and microenvironment in nonalcoholic steatohepatitis
  2631. Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
  2632. Duodenal-jejunal bypass maintains hepatic S-adenosylmethionine/S-homocysteine ratio in diet-induced obese rats
  2633. The beneficial additive effect of silymarin in metformin therapy of liver steatosis in a pre-diabetic model
  2634. Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study
  2635. Role of Probiotics and Gut microbiota in liver Diseases
  2636. The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD/CCl4-induced liver injury
  2637. Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
  2638. Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPARα
  2639. De Novo Lipogenesis Inhibitors
  2640. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2
  2641. Antisense oligonucleotide is a promising intervention for liver diseases
  2642. Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced …
  2643. EGCG and catechin relative to green tea extract differentially modulate the gut microbial metabolome and liver metabolome to prevent obesity in mice fed a high-fat …
  2644. The Effect of Two Types of Continuous and Interval Training on fatty liver Markers in Women with Type 2 Diabetes
  2645. The effect of propolis addition to the laying-hen diet on performance, serum lipid profile and liver fat rate
  2646. Large yellow tea extract ameliorates metabolic syndrome by suppressing lipogenesis through SIRT6/SREBP1 pathway and modulating microbiota in leptin …
  2647. Potential mechanisms underlying the ameliorative effect of Lactobacillus paracasei FZU103 on the lipid metabolism in hyperlipidemic mice fed a high-fat diet
  2648. Antioxidant hepatic lipid metabolism can be promoted by orally administered inorganic nanoparticles
  2649. Yuzu, Citrus junos, peels extract ameliorated hepatic steatosis induced by chloretone in rats
  2650. Methanolic Extract of
  2651. Discovery of farnesoid X receptor and its role in bile acid metabolism
  2652. Anti-obesity potential of heat-killed Lactiplantibacillus plantarum K8 in 3T3-L1 cells and high-fat diet mice
  2653. Musclin attenuates lipid deposition in hepatocytes through SIRT7/autophagy-mediated suppression of ER stress
  2654. Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase
  2655. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
  2656. Metformin Alleviates steatohepatitis in diet-induced obese mice in a SIRT1-dependent way
  2657. Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice
  2658. IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study
  2659. Roles of CCR2 and CCR5 for hepatic macrophage polarization in mice with liver parenchymal cell-specific NEMO deletion
  2660. Epigenetic Histone Methylation of PPARγ and CPT1A Signaling Contributes to Betahistine Preventing Olanzapine-Induced Dyslipidemia
  2661. Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice
  2662. MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis Corrigendum in/10.3892/etm. 2022.11390
  2663. Dietary choline intake is necessary to prevent systems‐wide organ pathology and reduce Alzheimer’s disease hallmarks
  2664. Recent advances on FXR-targeting therapeutics
  2665. Dietary fatty acids and CD36-mediated cholesterol homeostasis: potential mechanisms
  2666. Investigating the Impact of Eight Weeks of Aerobic Training on liver Enzymes and Hematological Profile in Children with Leukemia
  2667. Effect of High-Intensity Interval Training with Portulaca oleracea Supplementation on liver LXα and PPARγ Receptors in Rats with Nonalcoholic fatty liver Disease
  2668. Disruptions in Hepatic One Carbon Metabolism and the Gut Microbiome during the Progression of Non-alcoholic fatty liver Disease
  2669. Empagliflozin treatment attenuates hepatic steatosis by promoting white adipose expansion in obese TallyHo mice
  2670. The association of sleep duration, sleep quality and liver function in Taiwan
  2671. Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat
  2672. Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis
  2673. The Effect of Propolis Addition Into Laying Hen Diet on Performance, Serum Lipid Profile and liver Fat Rate
  2674. SIRT2 deficiency exacerbates hepatic steatosis via a putative role of the ER stress pathway
  2675. Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling
  2676. Tartary Buckwheat Flavonoids Relieve Non-alcoholic fatty liver Disease by Inhibiting Lipid Accumulation, Inflammation, and Regulating Intestinal Flora
  2677. Disease and Diagnosis
  2678. Captopril and spironolactone can attenuate diabetic nephropathy in wistar rats by targeting ABCA1 and microRNA-33
  2679. NAFLD or MAFLD diagnoses and cardiovascular diseases: From epidemiology to drug approaches
  2680. Antioxidant effects of Se-glutathione peroxidase in alcoholic liver disease
  2681. Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial
  2682. Loss of hepatic phosphoenolpyruvate carboxykinase 1 dysregulates metabolic responses to acute exercise but enhances adaptations to exercise training in mice
  2683. The metabolic, protective, and immune functions of Akkermansia muciniphila
  2684. Systemic multiomics evaluation of the therapeutic effect of Bacteroides species on liver cirrhosis in male mice
  2685. Pu’er raw tea extract alleviates lipid deposition in both LO2 cells and Caenorhabditis elegans
  2686. Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential
  2687. Novel Effect of p-Coumaric Acid on Hepatic Lipolysis: Inhibition of Hepatic Lipid-Droplets
  2688. Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules
  2689. Beneficial Effects of Standardized Extracts from Wastes of Red Oranges and Olive Leaves
  2690. Genistein activated SIRT1-AMPK signaling pathway mediated by ERβ-FOXO1-Nampt to reduce fat accumulation in chicken hepatocytes
  2691. Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design
  2692. Study on mechanism of action of total flavonoids from Cortex Juglandis Mandshuricae against alcoholic liver disease based on “gut-liver axis”
  2693. (Pro) renin receptor inhibition attenuated liver steatosis, inflammation, and fibrosis in mice with steatohepatitis
  2694. Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
  2695. Qushi Huayu decoction attenuated hepatic lipid accumulation via JAK2/STAT3/CPT-1A-related fatty acid β-oxidation in mice with non-alcoholic steatohepatitis
  2696. Weight Loss Improves liver Dysfunction and Dipstick Proteinuria in Obesity: The Japan Specific Health Checkups Study
  2697. Effect of spirulina on lipid Profile, glucose and malondialdehyde levels in type 2 diabetic patients
  2698. Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD+ bioavailability protecting against steatohepatitis
  2699. Optimal dietary intake composition of choline and betaine is associated with minimized visceral obesity-related hepatic steatosis in a case-control study
  2700. Phosphatidylethanolamine N-methyltransferase: from Functions to Diseases
  2701. Overexpression of salusin‑α upregulates AdipoR2 and activates the PPARα/ApoA5/SREBP‑1c pathway to inhibit lipid synthesis in HepG2 cells
  2702. Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cells
  2703. The effects of maternal polyphenol intake during lactation on lipid metabolism in adult rat offspring
  2704. The role and regulation of apoptosis signal-regulated kinase 1 in liver disease
  2705. Choline supplementation to transition cows: A healthier launch of her lactation
  2706. The alterations in and the role of the Th17/Treg balance in metabolic diseases
  2707. Dysregulation of Lipid and Glucose Homeostasis in Hepatocyte-Specific SLC25A34 Knockout Mice
  2708. Preventive Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are Related to the Regulation of Hepatic Lipid Metabolism, Autophagy, and …
  2709. Preventive effect of apple polyphenol extract on high-fat diet-induced hepatic steatosis in mice through alleviating endoplasmic reticulum stress
  2710. BPA and its alternatives BPF and BPAF exaggerate hepatic lipid metabolism disorders in male mice fed a high fat diet
  2711. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data
  2712. Anti-Obesity Effects of Polymethoxyflavone-Rich Fraction from Jinkyool (Citrus sunki Hort. ex Tanaka) Leaf on Obese Mice Induced by High-Fat Diet
  2713. Effects of amino acids supplementation on lipid and glucose metabolism in HepG2 cells
  2714. Targeted Proteomics for Monitoring One-Carbon Metabolism in liver Diseases
  2715. Investigation of Related Impurities in Metadoxine by a Reversed Phase High Performance Liquid Chromatography Technique
  2716. The glycine betaine role in neurodegenerative, cardiovascular, hepatic, and renal diseases: Insights into disease and dysfunction networks
  2717. Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?
  2718. Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6+ natural killer T cells
  2719. Sleeve Gastrectomy Improves High-Fat Diet–Associated Hepatic Steatosis Independent of the Glucagon-like-Petpide-1 Receptor in Rats
  2720. Pediococcus acidilactici FZU106 alleviates high-fat diet-induced lipid metabolism disorder in association with the modulation of intestinal microbiota in …
  2721. Camel whey protein improves diabetic liver injury by targeting ACMSD and promoting de novo NAD+ synthesis
  2722. Novel Curcumin Analogue L6H4 in Treating liver Fibrosis and Type 2 Diabetes
  2723. Amuc attenuates high-fat diet-induced metabolic disorders linked to the regulation of fatty acid metabolism, bile acid metabolism, and the gut microbiota in mice
  2724. An insight into multifunctional tool box: Akkermansia muciniphila provides dynamic benefits to the human gut
  2725. SIRT7: a sentinel of genome stability
  2726. Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride
  2727. Protective effect of probiotic and prebiotic fermented milk containing Lactobacillus fermentum against obesity‐induced hepatic steatosis and inflammation
  2728. Nicotinamide riboside supplementation to suckling male mice improves lipid and energy metabolism in skeletal muscle and liver in adulthood
  2729. Nutrients against adipogenesis: aim to cheating age or weight reduction
  2730. Multitasking bamboo leaf-derived compounds in prevention of infectious, inflammatory, atherosclerotic, metabolic, and neuropsychiatric diseases
  2731. Central acting Hsp10 regulates mitochondrial function, fatty acid metabolism, and insulin sensitivity in the hypothalamus
  2732. Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated γδT17 cell and macrophage polarization
  2733. Metabolic alterations of the gut–liver axis induced by cholic acid contribute to hepatic steatosis in rats
  2734. Dietary combination of fish oil and soy β-conglycinin inhibits fat accumulation and reduces blood glucose levels by altering gut microbiome composition in diabetic …
  2735. Comparative effects of alive and pasteurized Akkermansia muciniphila on normal diet-fed mice
  2736. Metabolic messengers: FGF21
  2737. SAHA induces white fat browning and rectifies metabolic dysfunctions via activation of ZFPs
  2738. Implications of trimethylamine N-oxide (TMAO) and betaine in human health: beyond being osmoprotective compounds
  2739. Beyond Thermal Sensation: Roles of Transient Receptor Potential Vanilloid Subfamily Member 1 and Spicy Food in Cardiometabolic Diseases
  2740. Both prolonged high-fat diet consumption and calorie restriction boost hepatic NAD+ metabolism in mice
  2741. Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease
  2742. Efficacy and safety of prolonged water fasting: a narrative review of human trials
  2743. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage
  2744. CD38 Inhibition Protects Fructose-Induced Toxicity in Primary Hepatocytes
  2745. Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A …
  2746. The Roles of Myeloid Cells in Aging-related liver Diseases
  2747. Production Diseases and Its Management in Dairy Animals
  2748. Pathological crosstalk between oxidized LDL and ER stress in human diseases: a comprehensive review
  2749. Gut microbiota induced by pterostilbene and resveratrol in high-fat-high-fructose fed rats: putative role in steatohepatitis onset
  2750. Assessment of causal relationships between omega-3 and omega-6 polyunsaturated fatty acids in bipolar disorder: a 2-sample bidirectional mendelian randomization …
  2751. Theabrownin isolated from Pu‐erh tea regulates Bacteroidetes to improve metabolic syndrome of rats induced by high‐fat, high‐sugar and high‐salt diet
  2752. Coffee and lower risk of type 2 diabetes: Arguments for a causal relationship
  2753. The role of the tryptophan-NAD+ pathway in a mouse model of severe malnutrition induced liver dysfunction
  2754. Novel therapeutic targets in liver fibrosis
  2755. Effects of Torreya Grandis Kernel and Sciadonic Acid on Lipid Profile in Hyperlipidemic Experimental Model
  2756. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders
  2757. Distinct Types of Cell Death and Implications in liver Diseases: An Overview of Mechanisms and Application
  2758. GPR52 accelerates fatty acid biosynthesis in a ligand-dependent manner in hepatocytes and in response to excessive fat intake in mice
  2759. The Roles of Nutrients in Fruits in the Prevention and Intervention of Obesity
  2760. Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation
  2761. Potential Antihyperlipidemia Effect of Lactoferrin in Hyperlipidemia-Induced Male Sprague–Dawley Rats
  2762. Dietary supplementation of exogenous probiotics reduces excessive liver lipid deposition in Chinese perch (Siniperca chuatsi)
  2763. Performance, egg quality, and yolk antioxidant capacity of the laying quail in response to dietary choline levels
  2764. Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis
  2765. Growth performance, physiological parameters, and transcript levels of lipid metabolism-related genes in hybrid yellow catfish (Tachysurus fulvidraco♀× …
  2766. Trans-anethole pretreatment ameliorates hepatic ischemia–reperfusion injury via regulation of soluble epoxide hydrolase
  2767. Long-Term Supplementation of Ozonated Sunflower Oil Improves Dyslipidemia and Hepatic Inflammation in Hyperlipidemic Zebrafish: Suppression of …
  2768. Effect of Some Levels from Ziziphus Spina-christi Leaves and Choline on Acute liver Disease in Rats
  2769. Effects of fermented extracts of Wuniuzao dark loose tea on hepatic SREBPs pathway and gut microbiota disorder in obese mice
  2770. Grape seed extract supplementation modulates hepatic lipid metabolism in rats. Implication of PPARβ/δ
  2771. Effects of dietary supplementation of trans-anethole on the intestinal antioxidant status, immune function, and liver lipid metabolism in broilers
  2772. Lysine β-hydroxybutyrylation promotes lipid accumulation in alcoholic liver disease
  2773. Effects of Metabolic Therapy of Non-Alcoholic fatty liver Using Decanoic Acid-based Ketogenic Diet in Animal Models
  2774. GRIM19 impedes obesity by regulating inflammatory white fat browning and promoting Th17/Treg balance
  2775. Effect of mixture of Artemisia argyi and Houttuynia cordata Thunb extracts on growth performance, antioxidant activity, serum and hepatic lipid levels, and gut bacteria …
  2776. Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
  2777. Hepatic PTEN signaling regulates systemic metabolic homeostasis through hepatokines-mediated liver-to-Peripheral organs crosstalk
  2778. Chemical constituents and medicinal properties of Allium species
  2779. Macrophage specific restoration of the Nrf2 gene in whole-body knockout mice ameliorates steatohepatitis induced by lipopolysaccharide from …
  2780. Traditional Mongolian medicine (HHQG) attenuates CCl4-induced acute liver injury through inhibiting monocyte/macrophage infiltration via the p-P38/p-JNK pathway
  2781. Purple grumixama anthocyanins (Eugenia brasiliensis Lam.) attenuate obesity and insulin resistance in high-fat diet mice
  2782. Chronic lead exposure exacerbates hepatic glucolipid metabolism disorder and gut microbiota dysbiosis in high-fat-diet mice
  2783. Ameliorative effects of Orlistat and metformin either alone or in combination on liver functions, structure, immunoreactivity and antioxidant enzymes in …
  2784. Macrophage-Targeted Oligonucleotide Therapeutics to Downregulate Inflammatory Cytokines in Non-Alcoholic Steatohepatitis
  2785. Short-term physical exercise controls age-related hyperinsulinemia and improves hepatic metabolism in aged rodents
  2786. Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity
  2787. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications
  2788. Effect of Siberian Ginseng Water Extract as a Dietary Additive on Growth Performance, Blood Biochemical Indexes, Lipid Metabolism, and Expression of PPARs …
  2789. The crucial role and mechanism of insulin resistance in metabolic disease
  2790. Differences in iron balance observed with dietary cholic acid supplementation and marginal iron deficiency in rats
  2791. The Effects of Different Feeding Regimes on Body Composition, Gut Microbial Population, and Susceptibility to Pathogenic Infection in Largemouth Bass
  2792. Dietary betaine mitigates hepatic steatosis and inflammation induced by a high-fat-diet by modulating the Sirt1/Srebp-1/Pparɑ pathway in juvenile black …
  2793. Reduction of obesity and hepatic adiposity in high-fat diet-induced rats by besunyen slimming tea
  2794. The anti-diabetic potential of betaine. Mechanisms of action in rodent models of type 2 diabetes
  2795. Nicotinamide riboside, an NAD+ precursor, attenuates inflammation and oxidative stress by activating sirtuin 1 in alcohol-stimulated macrophages
  2796. Role of Adipose Lipolysis in Development of Alcoholic liver Disease
  2797. Effects of xylooligosaccharides on lipid metabolism, inflammation, and gut microbiota in C57BL/6J mice fed a high-fat diet
  2798. Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a …
  2799. Comparison of Policosanols via Incorporation into Reconstituted High-Density Lipoproteins: Cuban Policosanol (Raydel®) Exerts the Highest Antioxidant …
  2800. Oat fiber modulates hepatic circadian clock via promoting gut microbiota-derived short chain fatty acids
  2801. Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut …
  2802. Which obesity index is the most useful marker for predicting hepatic steatosis in children and adolescents with obesity? A cross-sectional study using quantitative …
  2803. Gallic acid and metformin co-administration reduce oxidative stress, apoptosis and inflammation via Fas/caspase-3 and NF-κB signaling pathways in …
  2804. Nicotinamide reprograms adipose cellular metabolism and increases mitochondrial biogenesis to ameliorate obesity
  2805. Antenatal corticosteroid therapy modulates hepatic AMPK phosphorylation and maternal lipid metabolism in early lactating rats
  2806. Propionate alleviates palmitic acid–induced endoplasmic reticulum stress by enhancing autophagy in calf hepatic cells
  2807. A comprehensive review of Sirtuins: With a major focus on redox homeostasis and metabolism
  2808. The Ameliorating Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are SIRT1-Dependent: Evidence from Hepatic-Specific SIRT1 …
  2809. Green Tea and Decaffeinated Light Roasted Green Coffee Extract Combination Improved Cardiac Insulin Resistance through Free fatty Acids and …
  2810. Differential expression of gluconeogenic enzymes in early- and late-stage diabetes: the effect of Citrullus colocynthis (L.) Schrad. Seed extract on …
  2811. Herbal medicines for the treatment of nonalcoholic steatohepatitis
  2812. Radix Saposhnikoviae enhancing Huangqi Chifeng Decoction improves lipid metabolism in AS mice
  2813. Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes
  2814. SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside
  2815. Metabolic Disease, NAD Metabolism, Nicotinamide Riboside, and the Gut Microbiome: Connecting the Dots from the Gut to Physiology
  2816. Cr (VI) induces abnormalities in glucose and lipid metabolism through ROS/Nrf2 signaling
  2817. Akkermansia Muciniphila Suppressing Nonalcoholic Steatohepatitis Associated Tumorigenesis Through Natural Killer T Cells
  2818. Coffee consumption prevents obesity-related comorbidities and attenuates brown adipose tissue whitening in high-fat diet-fed mice
  2819. Prolonged Use of Carnitine-Orotate Complex (Godex®) Is Associated with Improved Mortality: A Nationwide Cohort Study
  2820. Monitoring and improving the metabolic health of dairy cows during the transition period
  2821. Potential Antihyperlipidemia Effect of Lactoferrin in Hyperlipidemia-Induced Male Sprague–Dawley Rats
  2822. Rosiglitazone reverses Inflammation in Epididymal White Adipose Tissue in Hormone-Sensitive Lipase-Knockout Mice
  2823. Sustained oral intake of nano-iron oxide perturbs the gut-liver axis
  2824. From Bedside to Boardroom: advancing liver health for a hepatitis free future…….
  2825. Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD/STZ-induced diabetic mice
  2826. Mitochondrial regulation in stem cells
  2827. Hepatic lipid metabolomics in response to heat stress in local broiler chickens breed (Huaixiang chickens)
  2828. Bifidobacterium longum R0175 protects mice against APAP-induced liver injury by modulating the Nrf2 pathway
  2829. Adipose tissue lipid metabolism: lipolysis
  2830. β-Cell dysfunction, hepatic lipid metabolism, and cardiovascular health in type 2 diabetes: new directions of research and novel therapeutic strategies
  2831. The Roles of Natural Alkaloids and Polyphenols in Lipid Metabolism: Therapeutic Implications and Potential Targets in Metabolic Diseases
  2832. ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury
  2833. Wolfberry enhanced the abundance of Akkermansia muciniphila by YAP1 in mice with acetaminophen‐induced liver injury
  2834. Therapeutic effects and safe uses of plant-derived polyphenolic compounds in cardiovascular diseases: a review
  2835. Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation
  2836. Probiotics and their beneficial effects on alcohol-induced liver injury in a rat model: the role of fecal microbiota
  2837. Role and interaction of bacterial sphingolipids in human health
  2838. Biochemical Hypolipidemic Action of Some Herbs and Medicinal Plants.
  2839. A water soluble extract of radish greens ameliorates high fat diet-induced obesity in mice and inhibits adipogenesis in preadipocytes
  2840. Nutritional management of livestock during scarcity
  2841. Kefir peptides ameliorate osteoporosis in AKR1A1 knockout mice with vitamin C deficiency by promoting osteoblastogenesis and inhibiting …
  2842. Dietary n-3 PUFA enhances DMI in transition cows by regulating taste transduction gene expression in liver associated with rumen microbial alteration
  2843. Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice
  2844. Intestinal MYC modulates obesity-related metabolic dysfunction
  2845. Akkermansia muciniphila Ameliorates Alcoholic liver Disease in Experimental Mice by Regulating Serum Metabolism and Improving Gut Dysbiosis
  2846. Substituting dietary fishmeal with soybean meal isolate influences hepatic lipid metabolism and gut microbiota in spotted seabass (Lateolabrax maculatus)
  2847. Physicochemical Characteristics and Functional Properties of Seed Oil from Four Different Cultivars of S. Wilsoniana
  2848. An Energy-Restricted Diet Including Yogurt, Fruit, and Vegetables Alleviates High-Fat Diet–Induced Metabolic Syndrome in Mice by Modulating the Gut Microbiota
  2849. NAD+ and its possible role in gut microbiota: Insights on the mechanisms by which gut microbes influence host metabolism
  2850. Time-of-day defines NAD+ efficacy to treat diet-induced metabolic disease by synchronizing the hepatic clock in mice
  2851. Impact of feeding probiotics on blood parameters, tail fat metabolites, and volatile flavor components of Sunit sheep
  2852. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
  2853. Metabolic action of metformin
  2854. Medicinal Plants
  2855. Metformin alleviates HFD-induced oxidative stress in hepatocyte via activating SIRT6/PGC-1α/ENDOG signaling
  2856. Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
  2857. Zinc deficiency alters metabolism-related organ crosstalk via changing insulin levels
  2858. The role of cereal soluble fiber in the beneficial modulation of glycometabolic gastrointestinal hormones
  2859. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions
  2860. ADVANTAGES OF METFORMIN FOR A DIVERSITY OF DISEASES
  2861. Multi-omics reveals 2-bromo-4, 6-dinitroaniline (BDNA)-induced hepatotoxicity and the role of the gut-liver axis in rats
  2862. Creatine Supplementation Potentiates Exercise Protective Effects against Doxorubicin-Induced Hepatotoxicity in Mice
  2863. MYC in liver cancer: mechanisms and targeted therapy opportunities
  2864. Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
  2865. Functional Diversity of SIRT7 Across Cellular Compartments: Insights and Perspectives
  2866. Adipose tissue aging: Mechanisms and therapeutic implications
  2867. Impact of dry-off and lyophilized Aloe arborescens supplementation on plasma metabolome of dairy cows
  2868. Obesity and male reproduction: Do sirtuins play a role?
  2869. Anti-Obesity Potential of Sargassum horneri and Ulva australis Extracts: Study In Vitro and In Vivo
  2870. Effects of Totum-63 on glucose homeostasis and postprandial glycemia: a translational study
  2871. Evaluation of the effect of red turmeric on inhibiting live cancer cells
  2872. From dietary cholesterol to blood cholesterol, physiological lipid fluxes, and cholesterol homeostasis
  2873. The Ameliorating Effect of Chloroform and Aqueous Ethanol Extracts from Pleurotus tuber reguim (Fr.) Sing.(Pleurotaceae) sclerotia on Triton-X Induced …
  2874. Sexually dimorphic hepatic mitochondrial adaptations to exercise: a mini-review
  2875. FAS and SREBP-1c Inhibition via AMPK Activation in HepG2 Cells by Biovip, Tox-off, and Traphanoside GO1 from Glinus oppositifolius
  2876. Supplementation with a New Standardized Extract of Green and Black Tea Exerts Antiadipogenic Effects and prevents Insulin Resistance in Mice with …
  2877. Hypoprolactinemia. Does it matter? Redefining the hypopituitarism and return from a mumpsimus: “Absence of proof is not the proof of absence”
  2878. In Vivo Study Of Phospholipid Naringenin Complex In Diabetes Treatment
  2879. Unique adaptations in neonatal hepatic transcriptome, nutrient signaling, and one-carbon metabolism in response to feeding ethyl cellulose rumen-protected …
  2880. Betaine suppresses hepatic steatosis: Inhibition of FoxO6 and PPARγ interaction
  2881. Nicotinamide riboside enhances in vitro beta-adrenergic brown adipose tissue activity in humans
  2882. Two methods for assessment of choline status in a randomized crossover study with varying dietary choline intake in people: Isotope dilution MS of plasma and in vivo …
  2883. Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2, 4‐dinitrophenol delivery to steatotic human livers
  2884. Metabolic Complications of Glucocorticoids–Prevention by Metformin
  2885. Effects of dietary supplementation of primaLac, inulin, and biomin imbo on growth performance, antioxidant, and innate immune responses of common carp …
  2886. A Study on the Effects of Turmeric Intake after Weight Training on Blood Alcohol Concentration
  2887. Dietary and exercise interventions for metabolic health in perimenopausal women in Beijing
  2888. Time-of-day defines the efficacy of NAD+ to treat diet-induced metabolic disease by adjusting oscillations of the hepatic circadian clock
  2889. Subclinical ketosis in dairy herds: impact of early diagnosis and treatment
  2890. Adiponectin deficiency leads to hepatic steatosis and contributes to the development of Gestational Diabetes Mellitus
  2891. Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: a metabolic mechanism perspective
  2892. The potential of the Mediterranean diet to improve mitochondrial function in experimental models of obesity and metabolic syndrome
  2893. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice
  2894. Gut microbiota-metabolic axis insight into the hyperlipidemic effect of lotus seed resistant starch in hyperlipidemic mice
  2895. The mitochondrial multi-omic response to exercise training across tissues
  2896. Pasteurized Akkermansia muciniphila Reduces Fat Accumulation via nhr-49-Mediated Nuclear Hormone Signaling Pathway in Caenorhabditis elegans
  2897. Dietary lysophospholipids improves growth performance and hepatic lipid metabolism of largemouth bass (Micropterus salmoides)
  2898. Cholesterol-lowering effect of bile salt hydrolase from a Lactobacillus johnsonii strain mediated by FXR pathway regulation
  2899. Hypoglycaemic and hypolipidemic effects of unripe apple extract in a murine diabetic model
  2900. NAD+-Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in …
  2901. In Vitro and In Ovo Evaluation of the Potential Hepatoprotective Effect of Metformin
  2902. Lipidomics Indicates the Hepatotoxicity Effects of EtOAc Extract of Rhizoma Paridis
  2903. Elucidating the Effects of Dietary Choline Deficiency on the Hippocampal and Plasma Proteomes of Non-Transgenic and 3xTg-AD Mice
  2904. Protective Effects of Phytic Acid on CCl4-Induced liver Fibrosis in Mice
  2905. Protective effect of aqueous leaf extracts of Chromolaena odorata and Tridax procumbens on doxorubicin-induced hepatotoxicity in Wistar rats
  2906. The effects of spirulina under high-intensity interval training on levels of nesfatin-1, omentin-1, and lipid profiles in overweight and obese females: A …
  2907. Hawthorn pectin: Extraction, function and utilization
  2908. Gut microbiota markers associated with obesity and overweight in Italian adults
  2909. Metabolome combined with gut microbiome revealed the lipid-lowering mechanism of Xuezhiping capsule on hyperlipidemic hamster induced by high fat diet
  2910. Choline Supplementation in Pregnancy: Current Evidence and Implications
  2911. Effects of Hericium erinaceus polypeptide on lowering blood lipids of mice with hyperlipidemia induced by a high-fat diet
  2912. An antisteatosis response regulated by oleic acid through lipid droplet–mediated ERAD enhancement
  2913. Effect of essential fatty acids and conjugated linoleic acid on the adaptive physiology of dairy cows during the transition period
  2914. The Role of NAD+ in Rejuvenating Human Body
  2915. l-Theanine Activates the Browning of White Adipose Tissue Through the AMPK/α-Ketoglutarate/Prdm16 Axis and Ameliorates Diet-Induced Obesity in Mice
  2916. Exploring Fenofibrate Formulations for the Treatment of Lipid Disorders: Past, Present, and Future
  2917. peer review: awaiting peer review
  2918. Identification of Paracentrone in Fucoxanthin‐Fed Mice and Anti‐Inflammatory Effect against Lipopolysaccharide‐Stimulated Macrophages and Adipocytes
  2919. A clinical perspective of the multifaceted mechanism of metformin in Diabetes, infections, cognitive dysfunction, and cancer
  2920. Metformin in aging and aging-related diseases: Clinical applications and relevant mechanisms
  2921. The monoacylglycerol acyltransferase pathway contributes to triacylglycerol synthesis in HepG2 cells
  2922. Effects of metformin on fibroblast growth factor 21 in patients with type 2 diabetes mellitus: faraway but so close
  2923. Dihydromyricetin alleviates high glucose-induced oxidative stress and apoptosis in human retinal pigment epithelial cells by downregulating miR-34a expression
  2924. Role of microRNA-125b in the development and progression of various chronic liver diseases
  2925. Effect of microalgae arthrospira on biomarkers of glycemic control and glucose metabolism: a systematic review and meta-analysis
  2926. Nad+ precursors nicotinamide mononucleotide (nmn) and nicotinamide riboside (nr): Potential dietary contribution to health
  2927. Su1515: EFFECT OF VEDOLIZUMAB ON HEALTH-RELATED QUALITY OF LIFE AND 1-YEAR EFFECTIVENESS IN COMPARISON TO ANTI-TNF THERAPY …
  2928. Relationship between the chemical composition and the biological functions of coffee
  2929. An overview of alkylresorcinols biological properties and effects
  2930. Esaxerenone, a selective mineralocorticoid receptor blocker, improves insulin sensitivity in mice consuming high-fat diet
  2931. Spirulina reduces diet-induced obesity through downregulation of lipogenic genes expression in Psammomys obesus
  2932. NUTRITIONAL AND MEDICINAL VALUES OF SETARIA ITALICA SEEDS-AN EVIDENCE-BASED REVIEW
  2933. Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans
  2934. Akkermansia muciniphila: a probiotic with great potential
  2935. Steroidal Saponins as Antioxidant and Alleviator of CCl4-Induced Oxidative Damage in Albino Rats
  2936. Dihydromyricetin ameliorated MCD mice by regulating the composition of serous lipids, bile acids and ileal microflora
  2937. Human Health Risk of Glyphosate Residues in Rice (Oryza sativa) and Beans (Phaseolus vulgaris) In Gombe State, Nigeria in an Era of COVID-19 Pandemic
  2938. Roux-en-Y gastric bypass-induced perturbative changes in microbial communities and metabolic pathways in rats
  2939. Aliskiren and Fenofibrate Constrict liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression
  2940. Caloric restriction overcomes pre-diabetic and hypertension induced by high fat diet and renal artery stenosis
  2941. Metformin can mitigate skeletal dysplasia caused by Pck2 deficiency
  2942. Effect of protected production and unprotected betaine on the plasma parameters of Holstein dairy cattle
  2943. A Method to Monitor the NAD+ Metabolome—From Mechanistic to Clinical Applications
  2944. Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis
  2945. Pyrazolone derivative C29 protects against HFD-induced obesity in mice via activation of AMPK in adipose tissue
  2946. Metformin Improves the Prerequisites for FGF21 Signaling in Patients with Type 2 Diabetes
  2947. Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
  2948. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers
  2949. Effects of an Extruded Flaxseed Supplement on Plasma Haptoglobin, Non-esterified fatty Acids, Beta-hydroxybutyrate, and Complete Blood Count in Transition …
  2950. The effect of coffee consumption on glucose homeostasis and redox-inflammatory responses in high-fat diet-induced obese rats
  2951. The bio-persistence of reversible inflammatory, histological changes and metabolic profile alterations in rat livers after silver/gold nanorod administration
  2952. Adipogenesis as a potential anti-obesity target: A review of pharmacological treatment and natural products
  2953. The nutritional functions of dietary sphingomyelin and its applications in food
  2954. Molecular mechanism of the role of Mare Nectaris in the Feng-Flavor Baijiu aging
  2955. Antihyperlipidemic Activity and Phytochemical Screening of Chromatography Fractions from the Chloroform Extract of the Sclerotia of the Edible Mushroom …
  2956. Pediococcus acidilactici pA1c® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating …
  2957. Bisphenol F induces liver-gut alteration in zebrafish
  2958. Impact of dietary supplementation of choline on blood biochemistry indices and lipid profile of broiler chickens (Cobb 500)
  2959. High‐quality ice plant reference genome analysis provides insights into genome evolution and allows exploration of genes involved in the transition from C3 …
  2960. Anti-obesity effects of metformin: A scoping review evaluating the feasibility of brown adipose tissue as a therapeutic target
  2961. Therapeutic and Adverse Effects of Metformin in Diabetes: A Review Article.(2023)
  2962. The Therapeutic Potential of Targeting Hepatic MCT1 in Non-Alcoholic Steatohepatitis
  2963. The Effect of High Temperature on Poultry and Effective Factors on Reducing the Adverse Effects of Heat Stress: A Review
  2964. The impact of catechins included in high fat diet on AMP-dependent protein kinase in apoE knock-out mice
  2965. Effects of temperature-humidity index on blood metabolites of German dairy cows and their female calves
  2966. Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese liver Steatosis Zucker Rat Model
  2967. The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure—the current facts and evidence
  2968. High-fat diet promotes the effect of fructo-oligosaccharides on the colonic luminal environment, including alkaline phosphatase activity in rats
  2969. Effect of citrus flavanones on diabetes: A systematic review
  2970. Effect Of Extract Breadfruit Leaf (Artocarpus altilis (Park.) Fosberg) Toward Tumor Necrosis Factor (TNF-α) In Obese Rat (Rattu norvegicus) With Insulin Resistance
  2971. High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
  2972. SIRT7 in the aging process
  2973. Parenteral Nutrition in Neonates
  2974. Transdermal Delivery of Metformin Using Dissolving Microneedles and Iontophoresis Patches for Browning Subcutaneous Adipose Tissue
  2975. Negative correlation between neuregulin-4 and IL-9 serum levels in patients with coronary artery disease
  2976. A novel multi-ingredient supplement activates a browning program in white adipose tissue and mitigates weight gain in high-fat diet-fed mice
  2977. Phospholipids from marine source: Extractions and forthcoming industrial applications
  2978. Effects of the Dietary Inclusion of Allium mongolicum Regel Extract on Serum Index and Meat Quality in Small-Tailed Han Sheep
  2979. Maternal Calorie Restriction Induces a Transcriptional Cytoprotective Response in Embryonic liver Partially Dependent on Nrf2
  2980. Therapeutic potential of green tea catechins-A magical herb
  2981. A comprehensive analysis into the therapeutic application of natural products as SIRT6 modulators in Alzheimer’s disease, aging, cancer, inflammation, and diabetes
  2982. Renal Metabolome in Obese Mice Treated with Empagliflozin Suggests a Reduction in Cellular Respiration
  2983. Capsaicinoids–Properties and Mechanisms of Pro-health Action
  2984. Impact of dietary betaine and metabolizable energy levels on profiles of proteins and lipids, bioenergetics, peroxidation and quality of meat in Japanese quail
  2985. The Effects of Vasointestinal Peptide and Naringenin on Rotenone-Induced Experimental Model of Parkinson’s Disease
  2986. Native and engineered probiotics: promising agents against related systemic and intestinal diseases
  2987. AMPK activators for the prevention and treatment of neurodegenerative diseases
  2988. NAD+ Precursors: A Questionable Redundancy
  2989. Effect of a freeze-dried coffee solution in a high-fat diet-induced obesity model in rats: Impact on inflammatory response, lipid profile, and gut microbiota
  2990. Low abundance of Akkermansia muciniphila and low consumption of polyphenols associated with metabolic disorders in child population
  2991. Interactive effects of water salinity and dietary methionine levels on growth performance, whole-body composition, plasma parameters, and expression of major …
  2992. Effects of Elephantopus scaber extract on growth, proximate composition, immunity, intestinal microbiota and resistance of the GIFT strain of Nile tilapia Oreochromis …
  2993. Health Beneficial Properties of Spirulina in Preventing Non-Communicable Diseases-The Green Metabolic Regulator from the Sea
  2994. Obesity in the Pathophysiology of Diabetes
  2995. Bamboo leaf: A review of traditional medicinal property, phytochemistry, pharmacology, and purification technology
  2996. Genome-wide association study and high-quality gene mining related to soybean protein and fat
  2997. Chemical Composition and Biological Properties of Zingiber zerumbet (L.) Roscoe ex Sm.
  2998. The symbiotic effect of a new nutraceutical with yeast β-glucan, prebiotics, minerals, and silybum marianum (Silymarin) for recovering metabolic homeostasis …
  2999. Development of Citrus-Based Functional Jelly and an Investigation of Its Anti-Obesity and Antioxidant Properties
  3000. SIRT7: the seventh key to unlocking the mystery of aging
  3001. Key signaling pathways in aging and potential interventions for healthy aging
  3002. The dysfunction of hormone-sensitive lipase induces lipid deposition and reprogramming of nutrient metabolism in fish
  3003. Akkermansia muciniphila and gut immune system: A good friendship that attenuates inflammatory bowel disease, obesity, and diabetes
  3004. Effects of stevia extract on production performance, serum biochemistry, antioxidant capacity, and gut health of laying hens
  3005. Histology and metabonomics reveal the toxic effects of kresoxim-methyl on adult zebrafish
  3006. Pediococcus acidilactici pA1c® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal …
  3007. Adverse cardiac remodeling augments adipose tissue ß-adrenergic signaling and lipolysis counteracting diet-induced obesity
  3008. Artemisia annua L.(Sweet wormwood) leaf extract attenuates high-fat diet-induced testicular dysfunctions and improves spermatogenesis in obese rats
  3009. Investigating Physiopathological Roles for Sirtuins in a Mouse Model
  3010. Gut microbiome lipid metabolism and its impact on host physiology
  3011. Role of NAD+ in regulating cellular and metabolic signaling pathways
  3012. Contribution of monocarboxylate transporter 12 to blood supply of creatine on the sinusoidal membrane of the hepatocytes
  3013. Dose-response relationship between dietary choline and serum lipid profile, energy expenditure, and respiratory quotient in overweight adult cats fed at maintenance …
  3014. Nad+ Precursors and intestinal inflammation: therapeutic insights involving gut microbiota
  3015. Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome
  3016. Flaxseed Bioactive Compounds: Chemical composition, functional properties, food applications and health benefits-related gut microbes
  3017. Dietary supplementation with nicotinamide riboside improves fetal growth under hypoglycemia
  3018. Key Stratification of Microbiota Taxa and Metabolites in the Host Metabolic Health–Disease Balance
  3019. Trimethyl glycine (TMG) influences on blood biochemistry and organ indices of heat stressed growing rabbits
  3020. How smell regulates metabolism: The role of ectopically expressed olfactory receptors in lipid and glucose homeostasis
  3021. Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators
  3022. Modulation of insulin resistance by renin angiotensin system inhibitors: Implications for cardiovascular prevention
  3023. The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
  3024. RNA-Seq Reveals Different Gene Expression in liver-Specific Prohibitin 1 Knock-Out Mice
  3025. PRODUCTIVITY OF MULBERRY LEAF AND ITS USE
  3026. Transcriptome profiling reveal Acanthopanax senticosus improves growth performance, immunity and antioxidant capacity by regulating lipid metabolism in GIFT …
  3027. Nicotinamide mononucleotide ameliorates acute lung injury by inducing mitonuclear protein imbalance and activating the UPRmt
  3028. FOS Inhibits the Differentiation of Intramuscular Adipocytes in Goats
  3029. Extracellular matrix remodelling in obesity and metabolic disorders
  3030. A comprehensive systematic review of the effectiveness of Akkermansia muciniphila, a member of the gut microbiome, for the management of obesity and associated …
  3031. Impact of TOTUM-63, a fibre and polyphenol rich plant-based composition, on gut and pancreatic hormone secretion in diet-induced obese mice
  3032. Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans
  3033. Oxidative stress mediated by the TLR4/NOX2 signalling axis is involved in polystyrene microplastic-induced uterine fibrosis in mice
  3034. Effects of 4-hexylresorcinol administration on the submandibular glands in a growing rat model
  3035. Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
  3036. Therapeutic strategies for diabetes: immune modulation in pancreatic β cells
  3037. Di-(2-ethylhexyl) phthalate-induced hepatotoxicity exacerbated type 2 diabetes mellitus (T2DM) in female pubertal T2DM mice
  3038. Therapeutic effects of Bifidobacterium breve YH68 in combination with vancomycin and metronidazole in a primary Clostridioides difficile-infected mouse model
  3039. Metformin combats obesity by targeting FTO in an m6A-YTHDF2-dependent manner
  3040. A head-to-head comparison review of biological and toxicological studies of isomaltulose, d-tagatose, and trehalose on glycemic control
  3041. Edible hydrogel from gelatin and alginate as functional low‐calorie noodle
  3042. Nicotinamide adenine dinucleotide augmentation in overweight or obese middle-aged and older adults: a physiologic study
  3043. Bioactive compounds for metabolic diseases
  3044. Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach
  3045. RESPONSIBLE EATING AND REJUVENATION FOR HEALTHY RETIREMENT
  3046. Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects
  3047. Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases
  3048. Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone …
  3049. A Systematic Review of Phenolic and Flavonoid Compounds of Oryza sativa (Balatinaw Rice) Extracts against Cancer
  3050. The life experiences of living liver donors: A qualitative meta‐synthesis
  3051. Please let us know how this document benefits you.
  3052. The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics
  3053. Role of extracted phytochemicals from Rosa sterilis SD Shi in DSS-induced colitis mice: potential amelioration of UC
  3054. The role of PKM2 in metabolic reprogramming: insights into the regulatory roles of non-coding RNAs
  3055. Evaluation of the Treatment with Akkermansia muciniphila BAA-835 of Chemotherapy-induced Mucositis in Mice
  3056. Improvements in the growth performance, morphology, gut microbiota, hepatic health, and immune response of juvenile tilapia (Oreochromis niloticus) fed …
  3057. A Novel Method for Predicting Time of Alcohol Use Based on Personality Traits and Demographic Information
  3058. Betaine as a Functional Ingredient: Metabolism, Health-Promoting Attributes, Food Sources, Applications and Analysis Methods
  3059. Plasma proteome alterations in prediabetic, obese Zucker rats-possible cardiovascular risk implications.
  3060. Olive cake reduces obesity by decreasing epididymal adipocyte size, inhibiting oxidative stress and pancreatic lipase, in rat fed high fat diet
  3061. Akkermansia muciniphila, a New Generation of Beneficial Microbiota in Modulating Obesity: A Systematic Review
  3062. Decaffeinated coffee and its benefits on health: Focus on systemic disorders
  3063. 1Research Scholar of Microbiology, Sri Lakshmi Narayana Institute of Medical Sciences, Bharath University, Puducherry. 2Research Scholar of Biochemistry …
  3064. Dietary supplementation of Allium hirtifolium essence supports gut bacteria, and health status in fuelleborn’s cichlid (Labeotropheus fuelleborni) juveniles
  3065. Dietary supplementation with NAD +-boosting compounds in humans: Current knowledge and future directions
  3066. New horizons: is obesity a disorder of neurotransmission?
  3067. Standpoints in mitochondrial dysfunction: Underlying mechanisms in search of therapeutic strategies
  3068. Inclusion of a fish oil processing fraction as additive in diets for weaning piglets
  3069. Effectiveness of dietary vitamin C on the performance of common carp (Cyprinus carpio).
  3070. Gut microbiota composition and fecal metabolic profiling in patients with diabetic retinopathy
  3071. SIRT7 Deficiency Protects against Aβ42-Induced Apoptosis through the Regulation of NOX4-Derived Reactive Oxygen Species Production in SH-SY5Y Cells
  3072. Effects of metformin on bone mineral density and adiposity-associated pathways in animal models with type 2 diabetes mellitus: A systematic review
  3073. The transition period updated: A review of the new insights into the adaptation of dairy cows to the new lactation
  3074. Vegetable choline as a replacement for choline chloride in broiler feed
  3075. Nicotinamide adenine dinucleotide attenuates acetaminophen-induced acute liver injury via activation of PARP1, Sirt1, and Nrf2 in mice
  3076. β-Carotene: beyond provitamin A
  3077. Boron Isotopic Systematics and Its Significance in Natural Processes: An Overview
  3078. Naringenin in the prevention of colon cancer–An updated review
  3079. Cheating Death: The New Science of Living Longer and Better
  3080. Effect of Metformin and Simvastatin in Inhibiting Proadipogenic Transcription Factors
  3081. Regulation of Cytochrome c Oxidase by Natural Compounds Resveratrol, (–)-Epicatechin, and Betaine
  3082. An Overview on Total Valorization of Litsea cubeba as a New Woody Oil Plant Resource toward a Zero-Waste Biorefinery
  3083. Malnutrition in the Elderly: A Recent Update
  3084. The role of the electron transport chain in immunity
  3085. NAD+ Precursors in Human Health and Disease: Current Status and Future Prospects
  3086. Molecular cloning and characterization of endoplasmic reticulum stress related genes grp78 and atf6α from black seabream (Acanthopagrus schlegelii) and their …
  3087. Butanol Extract of Acanthopanax senticosus (Rupr. et Maxim.) Harms Alleviates Atherosclerosis in Apolipoprotein E‐Deficient Mice Fed a High‐Fat Diet
  3088. Lipid metabolism and cancer
  3089. Production of Single Cell Protein from Fruit Waste
  3090. Regulation of cancer metabolism by deubiquitinating enzymes: The Warburg effect
  3091. Effect of various exercise regimens on selected exercise-induced cytokines in healthy people
  3092. Extracellular vesicles regulate the transmission of insulin resistance and redefine noncommunicable diseases
  3093. Comparative metabolomics analysis reveals the unique nutritional characteristics of breed and feed on muscles in chinese taihe black-bone silky fowl
  3094. Effects of emulsifier, betaine, and L-carnitine on growth performance, immune response, gut morphology, and nutrient digestibility in broiler chickens exposed to cyclic …
  3095. Adipose Tissue Lipolysis and the Regulation of Hepatic Lipid Metabolism
  3096. Options for capsulotomy and capsulectomy in the treatment of capsular contracture: Are there clinical treatment alternatives to surgery? A literature review
  3097. Mitofusin-2: a new mediator of pathological cell proliferation
  3098. Potential efficacy of nutrient supplements for treatment or prevention of COVID-19
  3099. State of art on the mechanisms of laparoscopic sleeve gastrectomy in treating type 2 diabetes mellitus
  3100. Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
  3101. Investigating the opposing effect of two different green tea supplements on oxidative stress, mitochondrial function and cell viability in HepG2 cells
  3102. Correlation Analysis of Gut Microbiota and Serum Metabolome With Porphyromonas gingivalis-Induced Metabolic Disorders
  3103. A review of phytic acid sources, obtention, and applications
  3104. Roles of mitochondrial unfolded protein response in mammalian stem cells
  3105. Malnutrition in the Elderly: A Recent Update
  3106. Insights into effects of sodium phytate on gut microbiome of mice by high-throughput sequencing
  3107. Effects of additional dietary choline on food intake, body weight and composition, respiratory quotient, serum lipid profile, and serum metabolic signature in post …
  3108. Hesperidin and naringenin
  3109. Metformin prevents Key Mechanisms of Obesity-Related Complications in Visceral White Adipose Tissue of Obese Pregnant Mice
  3110. Effects of Pera Orange Juice and Moro Orange Juice in Healthy Rats: A Metabolomic Approach
  3111. SIRT7 affects autophagy and activation of hepatic stellate cells by regulating the acetylation level of high mobility group protein 1
  3112. A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging
  3113. Dietary effects of aucubin on growth and flesh quality of grass carp (Ctenopharyngodon idellus) based on metabolomics
  3114. Research progress of gut microbiota and obesity caused by high-fat diet
  3115. The Effect of Coumestrol on Hub Genes in Lung Squamous Cell Carcinoma Based on Bioinformatic Strategy
  3116. Dietary vasodilator and vitamin C/L-arginine/choline blend improve broiler feed efficiency during finishing and reduce woody breast severity at 6 and 7 wks
  3117. Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy
  3118. Protective effect of matcha green tea (Camellia sinensis) extract on high glucose-and oleic acid-induced hepatic inflammatory effect
  3119. Co-ingestion of NUTRALYS® pea protein and a high-carbohydrate beverage influences the glycaemic, insulinaemic, glucose-dependent insulinotropic polypeptide …
  3120. Sirtuins—Novel Regulators of Epigenetic Alterations in Airway Inflammation
  3121. Nutraceuticals for targeting NAD+ to restore mitochondrial function
  3122. Nicotinamide Riboside Preserves Ovarian Injury in an Experimental Sepsis Model in Rats
  3123. Fabrication of nanoparticulate system for oral delivery of Naringenin against paraquat-induced Parkinson’s disorder in Wistar rats
  3124. Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication
  3125. Effects of short-term endurance and strength exercise in the molecular regulation of skeletal muscle in hyperinsulinemic and hyperglycemic Slc2a4+/− mice
  3126. RETRACTED ARTICLE: Effects of emulsifier, betaine, and L-carnitine on growth performance, immune response, gut morphology, and nutrient digestibility in broiler …
  3127. Supplementation with Akkermansia muciniphila improved glucose metabolism disorder in common carp (Cyprinus carpio L.)
  3128. MIF-2/D-DT is an atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis
  3129. Sirtuins: Subtle Regulators Involved in Convoluted Mechanisms of Pregnancy.
  3130. Betaine affects abdominal flare fat metabolism via regulating m6A RNA methylation in finishing pigs fed a low-energy diet
  3131. Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome
  3132. Green tea-derived theabrownin induces cellular senescence and apoptosis of hepatocellular carcinoma through p53 signaling activation and bypassed JNK …
  3133. Meta-hallmarks of aging and cancer
  3134. Novel prebiotics and next-generation probiotics: opportunities and challenges
  3135. Akkermansia muciniphila–multifunctional bacteria
  3136. Sirtuins and Metabolic Health
  3137. Is nuclear sirtuin SIRT6 a master regulator of immune function?
  3138. Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases
  3139. Growth performance, meat quality and lipid metabolism in finishing lambs fed diets containing rumen-unprotected and rumen-protected betaine
  3140. Nucleolus and nucleolar stress: from cell fate decision to disease development
  3141. Coordinated metabolic transitions and gene expression by NAD+ during adipogenesis
  3142. The intersection of metformin and inflammation
  3143. Function of Akkermansia muciniphila in type 2 diabetes and related diseases
  3144. Effectiveness of “Moro” Blood Orange Citrus sinensis Osbeck (Rutaceae) Standardized Extract on Weight Loss in Overweight but Otherwise Healthy Men and …
  3145. Metformin and bone metabolism in endogenous glucocorticoid excess: an exploratory study
  3146. The effects of dietary myo-inositol on growth and physiological, biochemical, and molecular responses in the Pacific white shrimp Litopenaeus vannamei
  3147. Immunometabolism modulation, a new trick of edible and medicinal plants in cancer treatment
  3148. The specific mitochondrial unfolded protein response in fast-and slow-twitch muscles of high-fat diet-induced insulin-resistant rats
  3149. A colon-targeted delivery system of torularhodin encapsulated in electrospinning microspheres, and its co-metabolic regulation mechanism of gut microbiota
  3150. Sustainable Management and Valorization of Agri-Food Industrial Wastes and By-products as Animal Feed: For Ruminants, Non-Ruminants and as Poultry Feed
  3151. Hydroxysafflor Yellow A Regulates Inflammation and Oxidative Stress by Suppressing the HIF-1α/JAK/STAT3 Signaling Pathway to Attenuate Osteoarthritis
  3152. Polyphenols as prebiotics in the management of high-fat diet-induced obesity: A systematic review of animal studies
  3153. NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
  3154. Using mass spectrometry imaging to visualize age-related subcellular disruption
  3155. Pharmacological importance of Kunxian Capsule in clinical applications and its adverse effects: A review
  3156. Modulating sirtuin biology and nicotinamide adenine diphosphate metabolism in cardiovascular disease—from bench to bedside
  3157. Oil chemical traits of kernels of different almond cultivars from China
  3158. Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction: a …
  3159. An up-to-date review: differential biosynthesis mechanisms and enrichment methods for health-promoting anthocyanins of citrus fruits during processing and storage
  3160. A centum of valuable plant bioactives
  3161. Exercise alters the mitochondrial proteostasis and induces the mitonuclear imbalance and UPRmt in the hypothalamus of mice
  3162. Metformin Impairs Intestinal Fructose Metabolism
  3163. NAD+-Consuming Enzymes in Stem Cell Homeostasis
  3164. Enhancing NAD+ Metabolome in Cardiovascular Diseases: Promises and Considerations
  3165. Metformin-loaded PLGA microspheres combined with an in situ-formed injectable SA/BG hydrogel alleviate rotator cuff muscle degeneration
  3166. Role of creatine supplementation in conditions involving mitochondrial dysfunction: A narrative review
  3167. Evaluation of the therapeutic effect and dose–effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice
  3168. Improving Theaflavin-3, 3′-digallate Production Efficiency Optimization by Transition State Conformation of Polyphenol Oxidase
  3169. A comprehensive review on beneficial effects of catechins on secondary mitochondrial diseases
  3170. The central role of the NAD+ molecule in the development of aging and the prevention of chronic age-related diseases: strategies for NAD+ modulation
  3171. Roles of therapeutic bioactive compounds in hepatocellular carcinoma
  3172. Vitamin E (α-Tocopherol) Does Not Ameliorate the Toxic Effect of Bisphenol S on the Metabolic Analytes and Pancreas Histoarchitecture of Diabetic Rats
  3173. Celastrol and Melatonin Modify SIRT1, SIRT6 and SIRT7 Gene Expression and Improve the Response of Human Granulosa-Lutein Cells to Oxidative Stress
  3174. The influence of probiotics consumption on management of prediabetic state: a systematic review of clinical trials
  3175. Identification des régulateurs de la sirtuine de type 1 (SIRT1): acteur clé de l’altération osseuse et la capacité de différenciation des cellules stromales en situation de …
  3176. Sirtuins in hematopoiesis and blood malignancies
  3177. Baobab-fruit shell and fibrous filaments are sources of antioxidant dietary fibers
  3178. Distribution, Antioxidant Capacity, Bioavailability and Biological Properties of Anthocyanin Pigments in Blood Oranges and Other Citrus Species
  3179. Exposure to triphenyltin impairs gut integrity, disturbs gut microbiota, and alters fecal metabolites
  3180. Diet composition and biomarkers of one-carbon metabolism and B-vitamin status
  3181. Empagliflozin and/or Metformin: A Combination Approach for Uncontrolled Type 2 Diabetes
  3182. Green Tea-Derived Theabrownin Induces Cellular Senescence and Apoptosis of Hepatocellular Carcinoma via P53 Signaling-Mediated Mechanism Bypassed by …
  3183. Seasonal Variation of Phenolic Component Contents in the Stems of Korean Acanthopanax senticosus
  3184. The Lipotropic Effects of Dietary Choline Supplementation in Overweight Cats During Weight Maintenance
  3185. Physiological benefits of Akkermansia muciniphila under high-altitude hypoxia
  3186. The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics
  3187. Anthocyanins: from mechanisms of regulation in plants to health benefits in foods
  3188. Preparation, characterization and wound healing effect of alginate/chitosan microcapsules loaded with polysaccharides from Nostoc Commune Vaucher
  3189. NAD+ homeostasis in human health and disease
  3190. Sirt7 associates with ELK1 to participate in hyperglycemia memory and diabetic nephropathy via modulation of DAPK3 expression and endothelial inflammation
  3191. Immunometabolism of methyl donors by dairy cattle during periods of negative nutrient balance and heat stress
  3192. Metabolomic Profiling Reveals the Distinct Nutritional Properties of Breed and Feed on the Muscles in Chinese Taihe Black-bone Silky Fowl (Gallus gallus domesticus …
  3193. Akt-dependent glycolysis-driven lipogenesis supports proliferation and survival of human pulmonary arterial smooth muscle cells in pulmonary hypertension
  3194. Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
  3195. Improving Mitochondrial Metabolism Restores the Exercise Capacity of a Drosophila Model of Barth Syndrome
  3196. Sirt7 deficiency attenuates neointimal formation following vascular injury by modulating vascular smooth muscle cell proliferation
  3197. Tissue Repair and Regeneration Process Regulation
  3198. Single cell protein: Sources, mechanism of production, nutritional value and its uses in aquaculture nutrition
  3199. FAT DEPOSITION, ANTIOXIDANT CAPACITY, DIGESTIVE ENZYMES AND GUT MICROBIOME ASSOCIATED WITH DIETS CONTAINING SIBERIAN GINSENG IN …
  3200. New developments in T cell immunometabolism and therapeutic implications for type 1 diabetes
  3201. Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy
  3202. Transcriptional regulation of CDKN2A/p16 by sirtuin 7 in senescence
  3203. Comparative bioactivity profile of phospholipids from three marine byproducts based on the zebrafish model
  3204. Evaluation of the ameliorative effect of Spirulina (Arthrospira platensis) supplementation on parameters relating to lead poisoning and obesity in C57BL/6J …
  3205. Polyphenols as Prebiotics in the Management of High-Fat Diet-Induced Obesity: A Systematic Review of Animal Studies. Foods 2021, 10, 299
  3206. The mitochondrial unfolded protein response regulates hippocampal neural stem cell aging
  3207. SIRT3-mediated mitochondrial unfolded protein response weakens breast cancer sensitivity to cisplatin
  3208. Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review. Nutrients 2022, 14, 529
  3209. Next-generation prebiotics: Maillard-conjugates of 2′-fucosyllactose and lactoferrin hydrolysates beneficially modulate gut microbiome composition and health …
  3210. Culturomics and Circular Agronomy: Two Sides of the Same Coin for the Design of a Tailored Biofertilizer for the Semi-Halophyte Mesembryanthemum …
  3211. Exercise Improves the Coordination of the Mitochondrial Unfolded Protein Response and Mitophagy in Aging Skeletal Muscle
  3212. Effect of NAD+ boosting on kidney ischemia-reperfusion injury
  3213. Sirtuin 7 deficiency reduces inflammation and tubular damage induced by an episode of acute kidney injury
  3214. Formulation and stability of silkworm pupae oil microemulsion
  3215. Wnt/β-catenin antagonists: Exploring new avenues to trigger old drugs in alleviating glioblastoma multiforme
  3216. Mitochondrial protein import and UPRmt in skeletal muscle remodeling and adaptation
  3217. Phytic acid and phytase
  3218. Enhancement of Swimming Endurance by Herbal Supplement M3P
  3219. Metformin as a potential treatment option for endometriosis
  3220. Nursing piglet ionomics-metabolome responses to different dietary copper levels in antibiotic-free creep feed
  3221. Circular RNA-and microRNA-Mediated Post-Transcriptional Regulation of Preadipocyte Differentiation in Adipogenesis: From Expression Profiling to Signaling …
  3222. NAD+ depletion and altered mitochondrial function are key to the establishment of placental dysfunction in an inflammatory-driven subclass of preeclampsia
  3223. Antidiabetic features of AdipoAI, a novel AdipoR agonist.
  3224. Effect of Inclusion of Arthrospira maxima Microalgae in Laying Hen Diets on Production Parameters and Egg Characteristics
  3225. LncRNA, PLXDC2-OT Promoted the Osteogenesis Potentials of MSCs by Inhibiting the Deacetylation Function of RBM6/SIRT7 Complex and OSX Specific Isoform
  3226. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking …
  3227. SIRT7 Acts as a Guardian of Cellular Integrity by Controlling Nucleolar and Extra-Nucleolar Functions
  3228. A protocol study to investigate the acute vascular and metabolic effects of nicotinamide riboside and pterostilbene co-supplementation
  3229. Peptides Derived from Soybean β-Conglycinin Induce the Migration of Human Peripheral Polymorphonuclear Leukocytes
  3230. Effects of aleurone supplementation on glucose-insulin metabolism and gut microbiome in untrained healthy horses
  3231. Impaired Mitochondrial Unfolding Protein Response in the Spinal Cord During Aging in Mice
  3232. Vitamin and Antioxidant Composition in Grape Seeds and Pomace of Wine Grape Varieties Cultivated in Georgia after Fermentation and Distillation
  3233. Therapeutic role of sirtuins targeting unfolded protein response, coagulation, and inflammation in hypoxia-induced thrombosis
  3234. The involvement of hormone-sensitive lipase in all-trans retinoic acid induced cleft palate
  3235. High-intensity exercise training induces mitonuclear imbalance and activates the mitochondrial unfolded protein response in the skeletal muscle of aged mice
  3236. SIRT7 modulates the stability and activity of the renal K‐Cl cotransporter KCC4 through deacetylation
  3237. Crosstalk of Immuno-Oncology and Metabolism: Influence of Akkermansia muciniphila and Personalized Therapy Approach
  3238. Sensing of amino acids: Critical role of nanomaterials for the efficient biomedical analysis
  3239. PROTECTIVE ROLE OF SITAGLIPTIN IN THE TREATMENT OF OBESITY AND ASSOCIATED METABOLIC COMPLICATIONS IN ANIMAL MODEL OF HIGH-FAT DIET …
  3240. ARTICLE INFO ABSTRACT
  3241. Progresses in both basic research and clinical trials of NAD+ in Parkinson’s disease
  3242. Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer
  3243. SIRT7 is a deacetylase of N4-acetylcytidine on ribosomal RNA
  3244. Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
  3245. The mitochondrial unfolded protein response and its diverse roles in cellular stress
  3246. Nutritional vitamin B12 regulates RAS/MAPK-mediated cell fate decisions through the one-carbon metabolism
  3247. The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice
  3248. Regulatory T cells and diabetes mellitus
  3249. Effects of Vitamin D Supplementation on CD4+ T Cell Subsets and mTOR Signaling Pathway in High-Fat-Diet-Induced Obese Mice
  3250. Sustainable Application of Flavonoid‐Based Natural Colorants
  3251. Aging-Conferred SIRT7 Decline Inhibits Rosacea-Like Skin Inflammation by Modulating Toll-Like Receptor 2‒NF-κB Signaling
  3252. Inflammasomes and the maintenance of hematopoietic homeostasis: new perspectives and opportunities
  3253. Data integration in systems genetics and aging research
  3254. Common proanthocyanidin-rich foods modulate gastrointestinal blooms of Akkermansia muciniphila in a diet-dependent manner
  3255. Everyday Superfoods
  3256. Neuroinflammatory and Metabolomic Temporal Dynamics from Inhaled Wildfire Smoke with Attenuation via Pharmacological Intervention
  3257. Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges
  3258. Creatine in health and disease
  3259. Epigenomic and metabolomic integration reveals dynamic metabolic regulation in bladder cancer
  3260. Green Tea Catechins as Therapeutic Antioxidants for Glaucoma Treatment
  3261. The effects of green tea on cognitive impairments in the rat model of Alzheimer’s disease: Protection against inflammatory and oxidative damage
  3262. Structure, activity and function of the protein arginine methyltransferase 6
  3263. The effect of care program on the Compliance of patients awaiting liver transplantation
  3264. Sirt1 promotes tissue regeneration in zebrafish through regulating the mitochondrial unfolded protein response
  3265. Anti-Osteoporosis Effects of the Eleutherococcus senticosus, Achyranthes japonica, and Atractylodes japonica Mixed Extract Fermented with Nuruk
  3266. Nicotinamide Adenine Dinucleotide (NAD+)-Dependent Signaling in Neurological Disorders
  3267. Diabetes mellitus and amyotrophic lateral sclerosis: a systematic review
  3268. Effect of Spirulina platensis supplementation on growth, performance and body conformation of two Omani goat breeds
  3269. Box–Behnken design to determine optimal fermentation conditions for apple-fortified mulberry wine using Saccharomyces bayanus
  3270. Phytic acid modulates the morphology, immunological response of cytokines and β-defensins in porcine intestine exposed to deoxynivalenol and fumonisin B1
  3271. Coordination between metabolic transitions and gene expression by NAD+ availability during adipogenic differentiation in human cells
  3272. Utilization of mildly fractionated pea proteins for the development of thermally stable beverage emulsions
  3273. Increased Dependence on the Mitochondrial Unfolded Protein Response (UPRmt) in Prostate Cancer Growth
  3274. The spatial landscape of the bacterial community and bile acids in the digestive tract of patients with bile reflux
  3275. Targeting osteoclast-derived DPP4 alleviates inflammation-mediated ectopic bone formation in ankylosing spondylitis.
  3276. ANTI-INFLAMMATORY AND ANTI-GLYCOLYTIC EFFECT OF MOMORDICA CHARANTIA AQUEOUS EXTRACT AND CHARANTIN IN …
  3277. Effects of Creatine Supplementation Protocols and Doxorubicin on Cardiac and Skeletal Muscle Phosphocreatine System
  3278. Nutritional supplementation alters associations between one-carbon metabolites and cardiometabolic risk profiles in older adults: a secondary analysis of the …
  3279. 20 Parenteral Nutrition in Neonates
  3280. Application of natural polysaccharides and their novel dosage forms in gynecological cancers: therapeutic implications from the diversity potential of natural …
  3281. Enhancing food waste reduction efficiency and high-value biomass production in Hermetia illucens rearing through bioaugmentation with gut bacterial agent
  3282. ARTICLE INFO ABSTRACT
  3283. TBK1-medicated DRP1 phosphorylation orchestrates mitochondrial dynamics and autophagy activation in osteoarthritis
  3284. The bridge between cell survival and cell death: reactive oxygen species-mediated cellular stress
  3285. Metabolomics and transcriptomics provide insights into the flavonoid biosynthesis pathway in the roots of developing Aster tataricus
  3286. Nutritional Requirements–General Information
  3287. Metformin Reduces Repeat Mild Concussive Injury Pathophysiology
  3288. Regulators of Sirtuin Type 1 (SIRT1): a key player in bone alterations and bone marrow stromal cells differentiation capacity in a mouse model of Anorexia nervosa
  3289. Efeito do sanitizante natural combinada com terapia fotodinâmica na higienização de teteiras
  3290. Improving the antioxidant activity of yogurt through black and green tea supplementation
  3291. Viktorija AVILKINA
  3292. Nicotinamide riboside enhances in vitro brown adipose tissue in humans, but not in vivo
  3293. Enhancing Gut Beneficial Bacteria and High-Value Biomass of Hermetia Illucens by Coculture of Bacillus Cereus and Bacterium Yc-Lk-Lkj45 in Food Waste Feeding
  3294. Integrated Anatomical and Transcriptomic Analysis Revealed the Molecular Mechanism of the Healing Process in Homografted and Heterografted Seedlings …
  3295. A comprehensive review on natural phenolic compounds as alternatives to in-feed antibiotics
  3296. Brown adipose tissue and GRIM-19 attenuate autoimmune diseases via inhibition of Th17 cells
  3297. Sirtuins: Enzymes with multidirectional catalytic activity
  3298. HPU2 Journal of Sciences: Natural Sciences and Technology
Related Posts

Hsl (Hormone Sensitive Lipase) – Lipolysis Activator

FNDC5

Extinction Training

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping